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have	 analysed	 the	 effect	 of	 these	 analgesics	 on	 fetal	 germ	 cells	 and	 possible	
consequences	on	fertility.		
	







consequences	 of	 exposure	 of	 therapeutically	 relevant	 doses	 of	 paracetamol	 and	
ibuprofen	on	human	gonads,	with	a	special	attention	to	the	germ	cells.	Fetal	gonads	












E2	 pathway.	 For	 these	 studies,	 a	 human	 GC	 tumour-derived	 cell	 line	 (NT2)	 that	
exhibits	fetal	GC	characteristics	was	used.	Exposure	to	analgesics	or	prostaglandin	E2	
(PGE2)	 antagonists	 reduced	 NT2	 cell	 number.	 Furthermore,	 exposure	 to	 PGE2	
agonists	 prevented	 paracetamol-induced	 NT2	 cell	 loss.	 Following	 roles	 of	


















Pregnant	 women	 are	 generally	 advised	 to	 avoid	 any	 kind	 of	 medication	 during	
pregnancy.	 However,	 the	 majority	 of	 them	 use	 one	 or	 more	 ‘over	 the	 counter’	
analgesics,	 which	 are	 also	 sometimes	 prescribed	 by	 doctors.	 These	 analgesics,	
including	paracetamol,	ibuprofen	or	aspirin,	have	been	shown	to	be	associated	with	
increased	risk	of	autism	and	allergies	and	other	consequences.	Moreover,	analgesic	
exposure	 of	 fetal	 testes	 has	 been	 shown	 to	 reduce	 production	 of	 the	 male	 sex	
hormone	 (testosterone),	which	 can	 result	 in	male	 reproductive	 disorders	 such	 as	







effects	 occur	 in	 the	 human	 as	 a	 consequence	 of	 fetal	 exposure	 to	 analgesics.	
Therefore,	 this	 thesis	 focused	on	analgesic	effects	on	germ	cells	 and	 the	possible	
mechanisms	 involved	using	a	variety	of	model	 systems	using	human	and	 rat	 fetal	
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in	 specific	 pathways	 can	 result	 in	 a	 spectrum	 of	 conditions.	 Some	 of	 these	
modifications	can	be	mild	and	may	not	be	diagnosed	or	noticed	(Bonde	et	al.,	2017).	
On	the	other	hand,	some	can	cause	severe	abnormalities,	even	fetal	death.	There	are	
several	 studies	which	 show	 links	 between	occurrence	 of	 these	 abnormalities	 and	
different	factors	during	pregnancy,	such	as	diet,	lifestyle,	environment,	and	also	drug	
intake	(Gabrielsen	&	Tanrikut,	2016;	Panchenko	et	al.,	2016).	Many	disorders	have	
been	 associated	 with	 alterations	 during	 fetal	 development	 and	 reproductive	
disorders	 are	 examples	 of	 this.	 In	 males,	 this	 is	 known	 as	 Testicular	 Dysgenesis	
Syndrome	(TDS).	Yet	little	attention	has	been	paid	to	whether	or	not	the	germ	cells	









fact	 that	 they	 are	 perceived	 as	 being	 safe	 and	 are	 widely	 used	 in	 the	 normal	
population	without	medical	prescription	(Werler	et	al.,	2005).		
	
Some	 recent	 studies	 have	 shown	 various	 effects	 on	 the	 fetal	 gonads	 as	 a	





























NHS	 recommends	 to	 speak	 with	 a	 doctor	 before	 any	 use	 of	 medications	
(http://www.nhs.uk/Conditions/pregnancy-and-baby/Pages/medicines-in-


















As	 outlined	 earlier,	 the	majority	 of	 women	 take	 one	 or	more	 analgesics	 such	 as		





analgesic	use	 (81%)	 in	pregnant	women	 (Philippat	et	 al.,	 2011).	 Furthermore,	 the	










the	 placenta	 and	 hence	 have	 the	 potential	 to	 cause	 direct	 effects	 on	 the	 fetus,	





























in	 adulthood,	 resulting	 in	 a	 30-60%	 risk	 of	 infertility	 (Niedzielski	 et	 al.,	 2016).	
Hypospadias	 is	 also	 a	 relatively	 common	disorder	occurring	 in	 approximately	 0.2-
0.6%	 of	 male	 newborns	 (Springer	 et	 al.,	 2016).	 The	 term	 Testicular	 Dysgenesis	
Syndrome	(TDS)	is	frequently	used	to	describe	the	association	of	these	disorders	as	
a	 result	of	events	 that	occur	during	 fetal	 life	and	 their	 relationship	with	deficient	
androgen	 production	 or	 action	 (Skakkebaek	 2001).	 Indeed,	 a	 critical	 period	 from	
embryonic	day	(e)	15.5	–	e18.5,	known	as	the	‘masculinization	programming	window’	
(MPW),	 has	 been	 described	 in	 fetal	 rats	 during	 which	 reduction	 in	 testosterone	









over	 recent	 decades,	 	 indicating	 that	 in	 addition	 to	 genetic	 abnormalities,	
environmental	factors	such	as	lifestyle,	diet	and	chemical	(including	pharmaceutical)	
exposures	are	likely	to	play	a	role	in	their	development	(Gabrielsen	&	Tanrikut,	2016;	
Skakkebæk	et	 al.,	 2016).	 Recently,	 there	has	been	an	 increasing	 literature	on	 the	




1.2.3 Analgesic	 exposure	 in	 pregnancy	 and	 the	 development	 of	 male	
reproductive	disorders		
It	 is	 not	 ethical	 to	 test	 the	 effects	 of	 analgesics	 on	pregnant	women	directly	 and	
hence	the	evidence	for	associations	between	analgesic	use	during	pregnancy	and	the	






and	 subsequent	 cryptorchidism	 in	 the	 offspring	 has	 been	 demonstrated	 in	 four	
studies	with	adjusted	ORs	of	1.33	(1.00-1.77)	(Jensen	et	al.,	2010),	1.93	(CI	1.03-3.62)	
(Berkowitz	&	Lapinski,	1996),	2.04	(CI	1.15	–	3.62)	(Snijder	et	al.,	2012)	and	2.30	(CI	












2011;	 Snijder	 et	 al.,	 2012).	 Interestingly,	 Kristensen	 et	 al	 describe	 data	 on	 two	
separate	Scandinavian	populations.	 The	 significant	associations	were	 restricted	 to	
the	Danish	cohort,	whilst	in	the	Finnish	cohort	there	were	no	statistically	significant	
associations	(Kristensen	et	al.,	2011).	Differences	between	these	cohorts	may	relate	
to	 variations	 in	 methodology,	 underlying	 prevalence	 of	 cryptorchidism	 or	 study	









al.,	2010;	Kristensen	et	al.,	2011;	Snijder	et	al.,	2012);	however,	only	 the	 last	 two	
found	this	association	to	be	statistically	significant.	In	one	of	these	studies,	exposure	






which	was	 significant	 for	 a	 duration	 of	 exposure	 >4	weeks	OR	 1.38	 (1.05	 –	 1.83)	
(Jensen	et	al.,	2010).	A	second	study	also	demonstrated	a	significant	association	OR	
2.78	(1.13–6.84)	following	prolonged	(>2	weeks)	exposure	to	paracetamol,	similar	to	
that	 described	 for	mild	 analgesics	 in	 general	 (Kristensen	 et	 al.,	 2011).	 Again,	 this	
































conception,	 a	 significantly	 increased	 risk	 of	 hypospadias	 has	 been	 described	 for	
ibuprofen	 (OR	 1.20;	 (CI	 1.00–1.30)	 whilst	 no	 such	 association	 was	 reported	 for	































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Cryptorchidism	 and	 hypospadias	 have	 been	 linked	 with	 a	 reduction	 in	 androgen	
production	or	action	during	fetal	life	(Welsh	et	al.,	2008).	Anogenital	distance	(AGD)	










36.2mm;	 p=0.03).	 No	 such	 association	 was	 demonstrated	 for	 AGDAP	 (ano-penile	
AGD)	which	may	 relate	 to	 technical	 issues	 in	 conducting	 these	measurements.	 In	
addition,	this	group	included	relatively	small	numbers	(n=20).	Further	investigation	
of	 the	association	between	AGD	and	 in-utero	exposure	 to	analgesics	would	 seem	
warranted.			
	
Taken	 together,	 the	 epidemiological	 evidence	 indicates	 that	 there	 may	 be	 an	
association	between	in-utero	exposure	to	analgesics,	particularly	during	the	second	
trimester,	 and	 cryptorchidism.	 The	 evidence	 for	 such	 an	 association	 with	
hypospadias	is	less	convincing,	but	there	is	little	data	and	this	malformation	is	far	less	
common	than	cryptorchidism	and	mild	cases	are	generally	under-diagnosed.	There	
are	 a	 number	 of	 limitations	 to	 these	 studies	 relating	 to	 obtaining	 accurate	












Testicular	 descent	 requires	 the	 action	of	 two	hormones	produced	by	 fetal	 Leydig	
cells,	namely	testosterone	and	Insulin-like	growth	factor	3	(Insl3)	(Hughes	&	Acerini,	
2008).	 Given	 the	 reported	 association	 between	 analgesic	 exposure	 and	
cryptorchidism	 a	 number	 of	 studies	 have	 investigated	 the	 effect	 of	 exposure	 to	
various	analgesics	on	Leydig	cell	function	in	the	fetal	testis.	This	includes	in-vivo,	ex-





can	 be	 determined	 indirectly	 by	 measuring	 AGD	 or	 androgen-dependent	 tissue	
weights.	 Paracetamol	 exposure	 has	 been	 linked	 to	 a	 reduction	 in	 fetal	 testicular	
testosterone	production	 in	 several	 studies	 (Kristensen	et	al.,	2011;	2012;	van	den	





studies	 there	 was	 an	 associated	 significant	 40%	 reduction	 in	 intratesticular	




although	 there	 was	 a	 significant	 effect	 of	 exposure	 to	 a	 chemical	 ‘mixture’	 that	
included	 paracetamol	 (Axelstad	 et	 al.,	 2014).	 In-vitro	 studies	 in	 rats	 have	 also	







50%	 reduction	 in	 testosterone	 production,	 with	 significant	 reductions	 described	
across	a	range	of	paracetamol	doses	(0.5-10µM)	at	72	hours.	A	similar	approach	using	
in-vitro	 culture	 of	 human	 fetal	 testis	 tissue	 (8-12	 weeks	 gestation)	 did	 not	
demonstrate	 any	 effect	 on	 testosterone	 production	 following	 exposure	 to	 10µM	
paracetamol	 for	 24,	 48	or	 72	hours	 (Mazaud-Guittot	 et	 al.,	 2013).	One	 study	has	
investigated	 the	 effect	 of	 exposure	 to	 a	 therapeutic	 regimen	 (3x	 daily	 doses	 of	
20mg/kg	giving	a	total	exposure	of	60mg/kg/d)	of	paracetamol	on	human	fetal	testis	
(14-20	weeks	gestation)	xenografts.	In	this	study,	a	7	day	exposure	to	paracetamol	



























































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































also	 been	 performed	 using	 NSAIDs.	 In-vivo	 studies	 in	 pregnant	 mice	 have	
demonstrated	a	significant	 reduction	 in	AGD	(20%	reduction)	 in	males	exposed	 in	





2013).	However,	 in-vitro	 rat	 fetal	 testis	 studies	have	demonstrated	a	 reduction	 in	
testosterone	 production	 following	 24	 hours	 exposure	 to	 aspirin	 (70%	 reduction;	
10µM)	or	indomethacin	(30%	reduction;	10µM)	from	e14.5	(Kristensen	et	al.,	2011;	
2012).	 These	 findings	 contrast	with	 studies	 using	 in-vitro	 culture	 of	 human	 testis	
tissue	 (8-12	 GW),	 where	 exposure	 to	 indomethacin	 for	 48	 hours	 resulted	 in	 a	
significant	 increase	 in	 testosterone	 (20%;	 10µM).	 A	 similar	 increase	 was	
demonstrated	for	aspirin	exposure,	although	this	was	restricted	to	8-10GW,	with	no	
effect	 at	 10-12GW	 (Mazaud-Guittot	 et	 al.,	 2013).	 The	 reason	 for	 the	 discrepancy	
between	the	effect	of	NSAID	exposure	on	testosterone	production	 in	the	fetal	rat	
and	 human	 testis	 is	 unclear	 and	may	 relate	 to	 the	model	 systems	 or	 to	 genuine	







Given	 the	 association	 between	 analgesic	 exposure	 and	 cryptorchidism	 in	 humans	



















exposure	 to	 1µM	paracetamol	 (Kristensen	 et	 al.,	 2011).	 However,	 there	were	 no	
significant	reductions	across	a	range	of	doses	(1-100µM)	after	culture	for	24,	48	and	
72h	 in	 a	 subsequent	 study	by	 the	 same	authors	 (Kristensen	et	 al.,	 2012).	 In-vitro	
exposure	of	human	fetal	testis	tissue	(7-12	weeks)	to	paracetamol	(10µM)	for	72h	
did	not	 reduce	prostaglandin	D2	 (PGD2)	production,	but	 it	did	significantly	 reduce	
prostaglandin	E2	(PGE2)	(Mazaud-Guittot	et	al.,	2013).		
	




study,	 with	 non-significant	 reductions	 only	 occurring	 after	 exposure	 to	 100	 µM	
aspirin	 (Kristensen	 et	 al.,	 2012).	 	 Similarly,	 for	 human	 fetal	 testis	 cultures	 (7-12	
weeks),	 no	 effect	 on	 PGD2	 was	 observed	 following	 aspirin	 (10µM)	 exposure.	
However,	similar	to	results	for	paracetamol	there	was	a	significant	reduction	in	PGE2	
production	 following	 aspirin	 exposure	 (Mazaud-Guittot	 et	 al.,	 2013).	 For	
indomethacin,	there	was	a	reduction	in	PGD2	following	in-vivo	and	in-vitro	exposure	











decrease	was	not	significant	 for	paracetamol	 (p=0.06)	 (Dean	et	al.,	2016).	 	 	Taken	








of	 pregnant	 rats	 to	 350mg/kg/day	 paracetamol	 or	 0.8mg/kg/day	 indomethacin,	
during	 a	 period	 of	 gestation	 that	 includes	 the	 MPW.	 The	 pups	 exposed	 to	
indomethacin	 (male	 and	 female)	 showed	 ~50%	 decrease	 in	 GC	 number	 and	 a	
decrease	in	gonadal	weight	at	e21.5		(Dean	et	al.,	2016).	For	females	this	resulted	in	
adulthood	in	reduced	fertility,	as	indicated	by	a	reduced	number	of	pups	per	litter,	
















reduced	 germ	 cell	 number	 at	 e21.5;	 however,	 the	 reduction	 in	 GC	 number	 was	
compensated	 for	 by	 early	 puberty	 (Dean	 et	 al.,	 2016).	 Another	 study	 involving	
paracetamol	 (50mg/kg/d)	 exposure	 in	mice	 (e7-e13.5)	 showed	no	 effect	 on	male	
germ	cells	at	e13.5	or	on	germ	cells	or	testicular	weight	in	adulthood	(Holm	et	al.,	





the	 demonstration	 of	 effects	 on	 the	 F2	 generation	 of	 rats,	 which	 derived	 from	
matings	of	the	F1	exposed	to	paracetamol	 in-utero	and	wild-type.	The	F2	females	
exhibited	a	significant	reduction	in	ovarian	weight	and	in	primordial	follicle	number	
at	 pnd25.	 Remarkably,	 these	 effects	 were	 seen	 independent	 of	 whether	 the	 F1	




Over	 the	 past	 5	 years	 several	 studies	 have	 investigated	 the	 potential	 effect	 of	
exposure	 to	 analgesics	 (paracetamol	 and	 NSAIDS)	 on	 the	 development	 of	 male	
reproductive	 disorders.	 Epidemiological	 evidence	 exists	 for	 associations	 between	
exposures	 to	 several	 analgesics	 and	 the	 development	 of	 cryptorchidism	 in	 boys.	
Experimental	 studies	 in	 rodents	 have	 also	 demonstrated	 effects	 of	 exposures	 to	
analgesics	 (particularly	 paracetamol)	 during	 fetal	 life	 on	 Leydig	 cell	 function	




































temporal	 manner	 by	 complex	 regulatory	 networks.	 The	 founder	 cells	 of	 the	 GC	
lineage	 are	 the	 primordial	 germ	 cells	 (PGC).	 They	 first	 appear	 early	 in	 embryonic	
development,	 in	week	4	of	human	pregnancy	and	e11	in	the	mouse	(Culty,	2009).	
Different	 species	 have	 different	 mechanisms	 for	 specification	 of	 the	 PGCs.	 For	
example,	 some	 invertebrates,	 such	 as Caenorhabditis	 elegans	 or	 Drosophila	
Melanogaster	have	the	factors	needed	already	in	the	maternal	eggs,		localized	in	one	
pole	of	 the	cell	 (Strome	&	Lehmann,	2007).	 In	other	animals,	 including	mammals,	
some	cells	in	the	epiblast	differentiate	to	become	PGCs	by	expressing	Blimp1/Prdm1,	
PRDM14	 and	 Fragilis	 (Hayashi	 et	 al.,	 2007).	 	 At	 this	 stage,	 epiblast	 cells	 are	 still	
pluripotent	but	they	are	getting	signals	that	will	shift	them	towards	a	somatic	fate.	
However,	Bone	morphogenetic	proteins	(BMP),	such	as	BMP2,	BMP4	and	BMP8b,	
signals	 induce	 the	expression	of	 the	aforementioned	PGC	markers.	Not	only	 that,	















2002;	Richardson	&	 Lehmann,	2010;	 Saitou	et	 al.,	 2012).	 These	modifications	will	
define	their	role	as	GCs	and	prepare	them	for	meiosis.	(Figure	1.1).		
	

























females.	 This	 different	 behaviour	 is	 presumed	 to	 be	 driven	 by	 sex	 differences	 in	
gonad	 somatic	 cell	 composition	 (She	 &	 Yang,	 2014).	 In	 mammals,	 male	 gonad	
differentiation	is	initiated	by	the	presence	(and	expression)	of	the	Sex	determining	







(Figure	 1.2)	 (Sekido	 &	 Lovell-Badge,	 2008).	 These	 cells	 are	 essential	 for	 testis	
development	 and	 orchestrate	 cord	 formation,	 sex-specific	 GC	 development,	 the	
differentiation	of	fetal	Leydig	cells,	etc.	(She	&	Yang,	2016).	Sox9	expression	persists	






Even	 if	 expression	 of	 a	 single	 gene	 is	 enough	 to	 produce	 a	male	 phenotype,	 the	















CATENIN	 (Elzaiat	 et	 al.,	 2016).	 The	 products	 of	 these	 genes	 actively	 inhibit	 SOX9	
expression	 at	 the	 same	 time	 as	 they	 promote	Müllerian	 duct	 differentiation	 and	
oocyte	development	and	hence,	female	development	(figure	1.2)	(Biason-Lauber	&	
Chaboissier,	 2015).	 FOXL2	 is	 the	 earliest	 known	marker	 of	 ovarian	 differentiation	
(Cocquet	et	al.,	2002).	FOXL2	is	expressed	in	somatic	cells	that	will	develop	as	pre-
granulosa	 cells	 and	 It	 is	 an	 essential	 transcription	 factor	 in	 ovarian	 development	
(Georges	 et	 al.,	 2014).	 In	 mice,	 Foxl2(-/-)	 ovaries	 showed	 activation	 of	 male	 sex	
determination	 genes	 including	 Sox9,	 with	 consequently	 partial	 secondary	 sex	
reversal	 including	 the	 development	 of	 Sertoli-like	 cells	 (Ottolenghi	 et	 al.,	 2005).		
Partial	 sex	 reversal	 is	 seen	 after	 conditional	 loss	 of	 Foxl2	 in	 the	 adult,	 where	
granulosa	 and	 theca	 cells	 start	 expressing	 Sertoli	 and	 Leydig	 cell	 factors,	
consequently	 leading	 to	 an	 inappropriate	 (for	 females)	 increase	 in	 testosterone	
levels	 (Uhlenhaut	et	al.,	2009).	Larger	mammals,	such	as	the	goat,	also	undergo	a	
complete	sex	reversal	in	the	absence	of	FOXL2.	This	is	a	well	described	phenotype	
and	 is	 known	as	polled	 intersex	 syndrome	 (Boulanger	et	 al.,	 2014).	However,	 the	
literature	 shows	 differences	 in	 the	 effects	 of	 FOXL2	 mutations	 between	 other	











accumulated	 in	 the	 cytoplasm	 and	 then	 translocated	 into	 the	 nucleus	 where	 it	










Wnt4	 and	 Rspo1,	 at	 the	 same	 time	 as	 it	 promotes	 Sox9	 expression	 (Figure	 1.2)	





The	 process	 of	 gonad	 differentiation	 continues	 throughout	 the	 period	 of	 fetal	
development.	 Different	 molecular	 factors,	 including	 hormones,	 coordinate	 the	













cell	 differentiation	 by	 the	 repression	 of	 Sox9.	 As	 a	 consequence,	β-catenin	 levels	
accumulate	sufficiently	to	repress	Sox9	activity.	In	XY	supporting	cell	precursors,	Sry	
is	 activated	 as	 a	 consequence	 of	 increasing	 levels	 of	 Sf1.	 Sry,	 together	 with	 Sf1,	
triggers	Sox9	expression.	Once	Sox9	levels	reach	a	critical	threshold,	several	positive	




The	 majority	 of	 the	 research	 performed	 on	 the	 development	 of	 the	 male	
reproductive	 system	 has	 been	 derived	 using	 mice	 as	 a	 model,	 and	 hence	 the	
translation	of	our	knowledge	into	humans	must	be	taken	with	a	degree	of	caution.	
Sry	expression	 in	 the	XY	genital	 ridge	 induces	various	morphological	changes.	The	










migrated	 from	the	adjacent	mesonephros	 into	 the	 testis.	The	developing	vascular	
system	 surrounds	 the	 somatic	 and	 germ	 cell	 aggregates,	 and	may	 play	 a	 role	 in	
inducing	 or	 supporting	 seminiferous	 cord	 formation	 via	 the	 vascular	 endothelial	
growth	factor	(VEGF)	signal	(Sargent	et	al.,	2015).	The	mesonephros	also	undergoes	






to	 the	 failure	 of	 Sertoli	 cell	 differentiation	 (Hiramatsu	 et	 al.,	 2009).	 A	 similar	
phenotype	 is	 seen	 after	 inactivation	 of	 Wt1,	 presumably	 due	 to	 the	 reduced	
expression	of	Sox9	that	results	(Gao	et	al.,	2006).	
	




community	 to	 explain	 the	mechanism	 of	 somatic	 sex	 differentiation	 (Jost,	 1956).	
AMH	signalling	is	an	essential,	but	also	sufficient,	player	to	induce	regression	of	the		
Müllerian	ducts	 (Behringer	 et	 al.,	 1990;	Behringer	 et	 al.,	 1994;	 Tsuji	 et	 al.,	 1992).	
Different	mutations	have	been	found	in	the	human	AMH	gene.	As	a	consequence,		
individuals	with	these	mutations	showed	highly	reduced	AMH	levels,	which	resulted	












factors.	 These	 factors	 will	 promote	 	 the	 differentiation	 of	 the	 Wolffian	 duct	 to	














of	 gestation	 and	 at	 e17	 in	mice	 (Timms	 et	 al.,	 1994).	 Similar	 to	 the	 gonads,	 the	
external	genitalia	is	formed	as	a	bipotential	anlagen	in	males	and	females.	In	males,	
DHT	 increases	 cellular	 proliferation	 in	 the	 genital	 tubercle	 and	 the	 subsequent	
developing	penis	internalizes	the	urethra	by	the	invasion	of	the	urorectal	septum	into	















human	development	 (Flück	 et	 al.,	 2011).	 However,	 different	mutations	 in	 human	
produces	 fetal	 phenotypes	 that	 can	 only	 explain	 by	 the	 act	 of	 this	 alternative	
pathway.	For	example,	fetuses	with	21-hydroxylase	deficiency	have	high	amounts	of	
17-hydroprogesterone,	which	cannot	be	converted	to	testosterone	by	the	gonads.	





























Figure	 1.3:	Comparative	 timelines	of	 primordial	 follicle	 formation	 in	mouse	 and	




meiotic	onset.	Cysts	break	around	birth	 in	mice,	while	 in	humans,	 it	begins	during	
second	trimester	(around	16	weeks)	(Obtained	from	Grive	et	al.,	2015).	
	




















2004),	 but	 also	 in	 invertebrates	 such	 as	 the	 grasshopper	 and	 Drosophila	
melanogaster	(de	Cuevas	et	al.,	1997).	The	nests	eventually	break	down	to	form	the	
primordial	follicles.	This	process	occurs	during	the	second	trimester	of	gestation	in	
humans,	while	 in	mice	 it	 occurs	 just	 after	birth	 (Bayne	et	 al.,	 2004;	 Tingen	et	 al.,		
2009).		
	
As	outlined	earlier,	AMH	secretion	 causes	degeneration	of	 the	Müllerian	ducts	 in	
males.	As	AMH	is	not	produced	by	the	fetal	ovary,	the	Müllerian	ducts	persist	and	
develop	to	form	the	fallopian	tubes,	uterus,	cervix	and	upper	portion	of	the	vagina.	
However,	 the	development	of	 the	 female	 reproductive	 system	 is	not	passive	or	a	









However,	 in	 some	 species,	 such	 as	 in	 zebrafish,	 they	 are	 also	 involved	 in	




















normal	 development	 along	 the	 male	 or	 female	 pathway,	 leading	 to	 failure	 of	
oogenesis	and	spermatogenesis	(Gill	et	al.,	2011).	
	
The	environment	 created	by	 the	 somatic	 and	germ	cells	 in	 fetal	 gonads,	which	 is	
different	in	male	and	female,	will	determine	the	timing	of	meiosis	onset.	Female	GCs	






al.,	1986;	Kerr	et	al.,	2008),	 the	oogonia	enter	meiosis	as	a	 result	of	 somatic	cell-
derived		signals,	including	retinoic	acid	(RA)	in	rodents	and	humans,	although	some	
aspects	of	the	regulation	process	seem	to	differ	between	these	species	(Feng	et	al.,	


















of	 Stra8	 (Bowles	 &	 Koopman,	 2010;	 Souquet	 et	 al.,	 2012;	 Suzuki	 &	 Saga,	 2008).	










role	 in	 the	 commitment	 to	meiosis.	However,	Oct4	 is	 then	downregulated	during	
oogenesis	and	spermatogenesis	(Pesce	et	al.,	1998).	
	
GC	 expression	 profiles	 have	 been	 highly	 studied.	 Shortly	 after	 their	 specification,	
PGCs	express	markers	of	pluripotency.	 Expression	of	 these	markers	 is	maintained	
through	development	until	the	stage	of	fetal/infantile	spermatogonia	in	the	case	of	
the	 testis	 and	 oogonia	 in	 the	 ovary.	 GCs	 express	 some	 genes	 in	 common	 with	
embryonic	stem	cells,	such	as	Oct3/4	and	Nanog,	but	also	some	that	are	GC-specific,	
such	as	blimp1.	The	gene	expression	profile	evolves	with	GC	development.	Human	













products,	which	 bring	 the	 phenotype	 into	 being”	 (Waddington,	 1942).	 In	 a	more	
modern	 perspective,	 an	 epigenetic	 trait	 is	 defined	 as	 a	 heritable	 change	 in	 gene	
expression	 or	 cellular	 phenotype,	 which	 does	 not	 change	 the	 DNA	 sequence	
(Deichmann,	2016).	The	epigenetic	field	has	been	deeply	studied	during	the	last	two	
decades,	however	its	role	in	physiology,	disease	and	intergenerational	effects	 	are	
still	 largely	 unknown	 (Goldberg	 et	 al.,	 2007).	 Epigenetic	modifications	 have	 been	
described	across	all	 species	of	animals	and	plants,	but	also	 in	bacteria	and	yeasts	
(Capuano	et	al.,	2014).	The	epigenome	of	a	cell	can	vary	for	many	different	reasons	









so,	modifications	 in	 the	DNA	structure	and/or	 in	 the	proteins	 interacting	with	the	
DNA	can	change	gene	expression	by	altering	the	transcription	machinery	access	(Jin	
et	 al.,	 2011).	 	 Different	 main	 mechanisms	 of	 epigenetic	 regulation	 have	 been	

















There	 are	 other	 types	 of	 histones	 involved	 in	 the	 dynamics	 of	 the	 chromatin	 in	














the	 form	 of	 added	 residues,	 especially	 in	 their	 tails	 (Di	 Croce	 &	 Helin,	 2013).	
Literature	 has	 shown,	 so	 far,	 eight	 distinct	 types	 of	 PTMs:	 Acetylation,	 lysine	









The	 variety	 of	 histone	 modifications	 is	 not	 only	 due	 to	 the	 number	 of	 different	
existing	modifications,	but	also	to	the	position	where	they	can	be	added	within	the	
histones.	 Residues	 have	 been	 found	 in	 over	 60	 histone	 tails.	 An	 extra	 level	 of	
complexity	 is	 added	 from	 the	 fact	 that	 each	 residue	may	 contain	more	 than	one	
modification,	especially	methylations	and	acetylations,	which	can	be	mono-,	di-	or	
tri-	 methylated/acetylated	 (Kouzarides,	 2007).	 Differences	 in	 location	 and/or	 the	
residues	 involved	 may	 result	 in	 a	 different	 functional	 change,	 as	 such	 a	 system	
provides	 incredible	 flexibility	 (as	 well	 as	 complexity).	 For	 example,	 histone	 3	
methylation	can	result	in	gene	repression	when	it	is	added	to	the	lysine	27	of	histone	
3	 (H3K27me3),	 but	 gene	 activation	 when	 it	 is	 added	 to	 lysine	 4	 of	 histone	 3	
(H3K4me3)	(Di	Croce	&	Helin,	2013;	Smith	et	al.,	2004).	
	




















phosphorylation	 (Nowak	 &	 Corces,	 2004),	 sumoylation	 (Huang	 et	 al.,	 2016),	
deamination	 (Cuthbert	 et	 al.,	 2004),	 ubiquitination	 (Shilatifard,	 2006)	 and	 proline	





Many	 of	 the	 enzymes	 in	 charge	 of	 adding	 or	 removing	 histone	modifications	 act	
within	a	group	of	proteins,	 such	as	Trithorax	group	 (TrxG)	or	 the	Polycomb	group	
(PcG).	These	examples	were	discovered	many	years	ago	in	Drosophila	melanogaster	
because	of	their	activator/repressor	roles	in	homeotic	(Hox)	genes	(Lewis,	1978).	A	



























by	 adding	 three	 methylations	 to	 lysine	 27	 of	 histone	 3	 (H3K27me3),	 a	 common	
marker	of	gene	repression.	In	mammals,	PRC2	is	created	by	the	association	of	three	
different	proteins	named	 suppressor	of	 zeste	12	 (SUZ12),	 ectoderm	development	
(EED)	and	enhancer	of	zeste	2	(EZH2)	(Di	Croce	&	Helin,	2013).	In	some	situations,	
EZH2	 is	 substituted	 by	 a	 close	 homolog,	 EZH1	 (Margueron	 et	 al.,	 2008).	 The	
composition	of	the	PRC1	core	 is	more	variable	as	 it	 is	 formed	by	one	chromobox-
domain	(CBX2-CBX8),	one	member	of	the	PCGF	family	(PCGF1-PCGF6),	one	member	
of	the	HPH	family	(HPH1-HPH3)	and	one	of	the	RING1	family	(RING1a	and	RING1b)	
(Cao	 et	 al.,	 2005;	 Wang	 et	 al.,	 2004).	 Some	 researchers	 have	 focused	 on	 the	
requirement	of	specific	homologues	of	these	proteins.	Studies	on	different	CBX	KO	
























transcription	 factors	 called	 polycomb	 response	 elements	 (PREs).	 In	 Drosophila	
















is	 needed	 to	 amplify	 the	 signal	 by	 mono-ubiquitination	 of	 H2A	 on	 lysine	 119	
























be	 divided	 into	 three	 different	 groups:	metyltransferases,	 such	 as	 ASH1	 and	 TRX	
which	 mostly	 target	 H3K4	 (Smith	 et	 al.,	 2004),	 ATP-	 dependent	 chromatin	
remodelling	factors	(able	to	read	histone	methylation	marks)	and	DNA	binders,	which	
are	 able	 to	 attach	 to	 specific	DNA	 sequences	 (Beisel	 et	 al.,	 2002;	 Papoulas	 et	 al.,	
1998).		
	
The	mechanism	 of	 action	 of	 TrxG	 is	 similar	 to	 that	 of	 PcGs	 and	 TrxG	 are	 able	 to	
recognize	Trithorax	response	elementes	(TREs)	as	well	as	PREs,	meaning	that	they	
can	be	recruited	to	the	same	loci	as	the	PcGs	(Chinwalla	et	al.,	1995).	However,	TrxG	
















the	 genes	 were	 enriched	 in	 H3K27me3	 (repression)	 (Bernstein	 et	 al.,	 2006;	
Chambeyron	et	al.,	2005).	Deeper	analysis	using	ChIP	confirmed	that	these	active	and	
inactive	 histone	marks	 were	 present	 in	 the	 same	 physical	 space,	 a	 phenomenon	
termed	“bivalent	(poised)	chromatin”	(Bernstein	et	al.,	2006).	This	situation	is	found	
in	highly	conserved	ES	genes	and	transcription	factors	of	the	Sox,	Pax,	Po,	Fox	and	Irx	
families,	and	 it	seems	to	be	the	hallmark	of	genes	 	 that	are	 ‘poised’	 to	be	quickly	
switched	on/off	when	required	for	cell	development	such	as	differentiation	(Figure	
1.5)	 (Spivakov	&	Fisher,	2007).	Moreover,	mammalian	GC	are	enriched	 in	bivalent	
chromatin	 at	 promoters	 of	 different	 genes	 that	 regulate	 the	 somatic	 fetal	
development.	 This	 poised	 state	 in	 the	 fetal	 germ	 line	 is	 maintained	 from	 sexual	
differentiation	and	during	the	postmeoitic	stages	and	they	have	been	proposed	to	







Figure	 1.5:	 The	 bivalent	 chromatin	 state.	 H3k27me3	 and	 H3k4me3	 produce	







can	only	be	added	 to	a	cytosine,	although	methylated	adenosine	can	be	 found	 in	
prokaryotes	 (Jin	et	al.,	2011;	 Low	et	al.,	2001).	The	 role	of	DNA	methylation	 is	 to	
regulate	gene	expression	by	affecting	chromatin	structure		and	interfering	with	the	





role	 in	 normal	 cell	 development.	 It	 is	 especially	 relevant	 during	 embryo	
















this	 does	 not	 occur	 in	 GCIs,	 which	 show	 low	 levels	 of	 methylation	 (Strichman-
Almashanu	et	al.,	2002).	 It	has	been	shown	 that	CpGs	are	more	highly	 conserved	
among	 different	 species	 if	 they	 are	 located	 within	 CGIs.	 This	 can	 be	 explained	
because	methylated	CpGs	can	derive	easier	into	uracil,	which	is	less	stable	(and	less	
maintained)	 than	 the	 thymine	 produced	 by	 the	 methylation	 of	 unmethylated	
cytosine.	This	means	that	methylation	regions	have	higher	chances	of	losing	CpG	due	






















by	 two	 simultaneous	 publications	 showing	 how	 pronuclear	 exchange	 between	
fertilized	 zygotes	 resulted	 in	 abnormal	 embryos	 (with	 two	 paternal	 or	 maternal	
genomes)	 (Barton	 et	 al.,	 1984;	 McGrath	 &	 Solter,	 1984).	 Since	 then,	 over	 one	
thousand	imprinted	genes	have	been	described	(Kelsey	and	Bartolomei.,	2012).	The	
silencing	of	one	of	the	copies	of	an	imprinted	gene	is	coordinated	by	short	sequences	
of	 DNA	 (imprinting	 control	 regions),	 which	 exhibit	 different	 DNA	 methylation	
depending	 on	 the	 parental	 origin	 of	 that	 gene	 (Bajrami,	 2016).	Moreover,	 many	
imprinted	genes	are	localized	together	in	the	genome,	forming	clusters	(Ferguson-




allowing	 a	 different	 transcription	 between	 alleles	 in	 the	 same	 nucleus	 (Hanna	 &	
Kelsey,	2014;	Proudhon	et	al.,	2012).	
	








proposed	 in	 1961	 (Lyon,	 1961).	 The	 inactivation	 starts	 after	 fertilization	 by	 the	
accumulation	of	X-inactive	specific	transcript	(XIST),	a	non-translated	RNA	that	coats	
the	 X	 chromosome.	 This	 process	 is	 followed	 by	 other	 epigenetic	 changes	 which	


























the	 process	 of	 DNA	methylation.	 	 DNMT1	 is	 associated	 with	 the	 replication	 foci	
targeting	sequences	(RFTS),	which	are	able	to	attract	the	enzyme	to	replication	sites	
(Leonhardt	et	al.,	1992).	DNMT1	has	a	higher	affinity	for	hemi-methylated	DNA	(one	




























&	 Reich,	 2010;	 Okano	 et	 al.,	 1999).	 Unlike	 DNMT3A	 and	 3B,	 DNMT3L	 lacks	 the	
catalytic	 domain	 to	 transfer	 the	 methylation	 to	 the	 cytosine	 (Holz-Schietinger	 &	
Reich,	2010).	Studies	have	shown	that	DNMT3A	and	3B	target	different	loci	across	
the	genome,	although	there	 is	some	level	of	compensation	of	activity	(Kato	et	al.,	
2007).	DNMT3A	and	3B	are	 essential	 for	 normal	 development	 and	 knockouts	 are	
highly	 detrimental.	 Knockout	 mice	 for	 Dnmt3a	 present	 with	 poor	 growth	 and	
normally	die	in	the	first	4	weeks	after	birth,	while	Dnmt3b	knockout	mice	die	earlier,	
at	e9.5	during	fetal	life	(Okano	et	al.,	1999).	Dnmt3l	knockouts	are	viable,	but	show	
a	 reduced	 rate	 of	 early	methylation	 in	 the	 zygote	which	 specifically	 affects	 some	
regions	 in	 the	genome	(Guenatri	et	al.,	2013).	Dnmt3L	 is	also	essential	 for	proper	
















DNA	 demethylation,	 oxidizing	 the	 5-methylcytosine	 (5mc)	 to	 5-
hydroxymethylcytosine	(5hmc)	(Gong	&	Zhu,	2011;	Zhu,	2009)	(Figure	1.6).	Tet1	can	
be	 found	 in	 transcription	 start	 sites,	 but	 also	 at	 promoters	 of	 PcG	 target	 genes	
(Williams	et	al.,	2011).	The	mechanism	of	Tet1	also	involves	the	conversion	of	5hmc	
























The	 double	 knockout	 animals	 are	 viable,	 but	 suffer	 high	 perinatal	 mortality	 and	
surviving	adults	show	a	decrease	in	gonadal	size	(Dawlaty	et	al.,	2013).	TET3	has	been	





































neural	 stem	 cells,	 there	 was	 an	 increase	 in	 H3K27me	 (Wu	 et	 al.,	 2010).	 Deeper	
analysis	using	ES	cells	from	triple	DNA	methyltransferases	(DNMT1,	DNMT3A	and	3B)	
mice	 knockouts,	 where	 DNA	 methylation	 is	 reduced,	 indicated	 that	 hundreds	 of	
thousands	 of	 genes	 normally	 methylated	 showed	 the	 presence	 of	 H3K27me3	
instead.	 However,	 in	 the	 opposite	 scenario,	 where	 PRC2	 is	 lost,	 only	 a	 small	
percentage	 of	 genes	 normally	 regulated	 by	 H3K27me3	 showed	 DNA	methylation	
(Hagarman	et	al.,	2013).	 Interestingly,	 this	 relationship	between	DNA	methylation	
and	 H3K27m3	might	 be	 disrupted	 in	 cancer	 cells.	 Genes	 containing	 CpG	 islands,	











this	 epigenetic	 remodelling	 remains	 highly	 active	 in	 GC,	 from	 their	 initial	
differentiation	until	 their	 final	 transformation	 into	gametes	 (Hajkova	et	al.,	2008).	
Moreover,	GCs	show	a	unique	epigenetic	machinery,		involving	particular	proteins	to	
undergo	specific	epigenetic	remodelling	(Hajkova	et	al.,	2008;	Santos	&	Dean,	2004).	









Since	 the	 early	 beginning	 of	 PGC	 differentiation,	 GCs	 already	 show	 epigenetic	
differences	compared	with	the	somatic	cells	surrounding	them.	Studies	in	Drosophila	
showed	 that	 PGCs	 exhibit	 low	 levels	 of	 the	 activational	 H3K4me3	mark	 and	 high	
levels	 of	 H3K9me,	 a	 marker	 of	 repression.	 These	 histone	 modification	 patterns	
suggest	 that	 these	 cells	 are	 probably	 repressing	 the	 somatic	 cell	 gene	 expression	
program	 (Schaner	 et	 al.,	 2003).	 In	mice,	 in	which	PGC	 fate	 is	 established	at	 e7.5,	
repressive	 markers,	 such	 as	 genome-wide	 DNA	 methylation,	 levels	 of	 H3K9	
dimethylation	(H3K9me2)	and	H3K27me3,	are	similar	to	somatic	cells.	However,	DNA	
methylation	 levels	 start	 to	 decrease	 after	 e8.0.	 The	 global	 decrease	 in	 DNA	
methylation	in	PGCs	does	not	affect	all	DNA	regions	and	there	are	mechanisms	to	
protect	specific	genes	from	DNA	demethylation.	Mvh,	Dazl	and	Sycp3,	important	PGC	
markers	 that	 are	 only	 expressed	 after	 migration	 to	 the	 genital	 ridge,	 and	 DNA	
methylation	analysis	in	mice	showed	methylated	flanking	regions	in	these	genes	by	
e10.5.	However,	 these	 genes	undergo	demethylation	and	are	expressed	by	e13.5		
(Maatouk	 et	 al.,	 2006).	 Further	 analysis,	 using	 DNMT1	mutant	 embryos,	 showed	
expression	 of	 these	 genes	 by	 e9.5,	 suggesting	 an	 important	 role	 of	 DNMT1	 in	
maintenance	of	gene	repression	 in	earlier	stages	of	development	(Maatouk	et	al.,	
2006).	Another	factor	playing	a	role	in	DNA	methylation	is	STELLA,	which	is	expressed	
in	 PGCs	 at	 e7.0-e7.5.	 STELLA	 has	 been	 shown	 to	 protect	 and	 	 maintain	 the	
methylation	state	of	PGCs	and	the	methylation	of	the	maternal	genome	in	zygotes	
by	 inhibiting	 	 the	 conversion	 of	 5mC	 into	 5hmc,	 which	 preserves	 maternal	
chromosome	integrity	(Nakamura	et	al.,	2007;	2012;	Nakatani	et	al.,	2015).	
After	arriving	 to	 the	genital	 ridge	 (e9.5	 in	mice),	PGCs	undergo	a	 second	wave	of	
extensive	epigenetic	reprogramming.	This	process	includes	the	erasure	of	parental	























































from	 other	 cell	 types.	 Within	 histone	 modifications,	 there	 is	 a	 high	 presence	 of	















al.,	 2016).	 Introduced	 into	 the	 pharmaceutical	 market	 in	 1955,	 it	 is	 an	 over	 the	
counter	drug	 (no	prescription	needed)	 and	 its	 consumption	has	been	generalised	
within	our	 society.	 It	 is	 recommended	as	a	 first	 line	 treatment	 for	 fever	and	pain	
associated	 with	 many	 different	 conditions,	 including	 cancer.	 It	 is	 also	 the	 most	
common	choice	for	children,	and	patients	unable	to	use	NSAIDs,	such	as	people	with	





NSAIDS,	 such	 as	 its	 anti-pyretic	 properties,	 although	 it	 does	 not	 show	 anti-


































drugs	used	worldwide.	Similar	 to	paracetamol,	 the	consumption	of	 ibuprofen	and	
aspirin	is	increasing	in	our	society	(Kristensen	et	al.,	2016).	Ibuprofen	was	introduced	
into	UK	in	1969	and	worldwide	during	the	1970s.	It	is	often	prescribed	as	a	first	line	
NSAID	 instead	of	other	NSAIDS,	 such	as	 aspirin,	 indomethacin	or	phenylbutazone	
(Rainsford,	2003)	and	is	also	available	over	the	counter	without	prescription.		
	















epigenetic	 alterations	 is	 the	 PG	 pathway.	 PGs	 are	 lipid	 compounds,	 whose	
physiological	activity	is	similar	to	hormones,	but	acting	in	a	more	auto/paracrine	way,	
being	able	to	target	themselves	and	neighbour	cells.	They	were	first	discovered	in	
seminal	 fluid	 in	1935	and	received	that	name	because	they	were	 thought	 to	be	a	




to	 a	wide	 variety	 of	mechanisms,	 such	 as	 cell	 growth	 (Yun	 et	 al.,	 2009),	 calcium	
movement	(Seifi	et	al.,	2015),	contraction	and	relaxation	of	vascular	smooth	muscle	
cells	(Markiewicz	et	al.,	2016),	kidney	filtration	(Pugliese	&	Ciabattoni,	1984),	platelet	
disaggregation	 (Kikura	et	 al.,	 2000),	 sensitivity	of	 neurons	 (Latremoliere	&	Woolf,	






or	ketoreductases	 (Frungieri	et	al.,	2004).	So	 far,	 four	principal	 types	of	PGs	have	
been	described:	PGE2,	PGI2,	PGD2	and	PGF2α.	These	can	activate	different	receptors,	
which	 are	G-protein	 coupled	 (Table	1.5).	Different	 second	messengers	have	been	









The	 role	 of	 PGs	 in	 fertility	was	 found	 thanks	 to	 the	 study	 of	Cox	 knockout	mice.	
Female	 Cox2	 knockout	 mice	 are	 infertile,	 while	 Cox1	 knockout	 females	 produce	


















































is	 still	 largely	 unknown.	 However,	 the	 presence	 of	 different	 PG	 receptors	 in	 bot,	
somatic	and	germ	cells,	suggest	that	they	might	play	an	important	role	in	different	
stages	of	ovary	and	testis	development.	For	example,	PGE2	has	been	shown	to	be	
important	 in	 Sox9	 regulation	 during	 fetal	 testis	 development.	 When	 Sox9	 is	
expressed	 in	 the	 male	 differentiating	 gonad,	 it	 activates	 the	 expression	 of	

































to	 activate	 the	 epidermal	 growth	 factor	 receptor	 (EGFR)	 via	 EP4.	 This	 resulted	 in	
activation	 of	MAPK	which	modified	 cell	 proliferation	 (Mendez	&	 LaPointe,	 2005).		
Similar	 experiments	 using	 hepatocytes	 revealed	 a	 different	 mechanism,	 as	 PGE2	
induced	 cell	 proliferation	 was	 mediated	 by	 EP1	 activation,	 which	 increased	 the	
secretion	 of	 TGF-α,	 affecting	 the	 tyrosine	 kinase	 /MAPK	 pathway	 (Kimura	 et	 al.,	
2001).	Moreover,	PGE2	is	able	to	modify	more	than	one	of	these	mechanisms	in	the	
same	 cell	 type.	 Studies	 on	 fibroblasts	 using	 specific	 antagonists	 for	 EP1	 or	 EP4	
receptors	revealed	a	similar	phenotype	of	cell	reduction	by	both	treatments,	but	via	
different	mechanisms.	 The	 EP1	 inhibitor	was	 able	 to	 arrest	 cells	 in	G0/G1	phase,	
while	the	EP4	inhibitor	arrested	the	cells	in	the	synthesis	phase	(Sanchez	&	Moreno,	
2002).	Other	studies	have	performed	experiments	targeting	different	EPs	and	their	
role	 in	 proliferation.	 Studies	 on	 skeletal	 muscle	 myoblasts	 using	 PGE2,	 and	




cancer	 cell	 types,	 such	 as	 colon	 cancer,	 lung	 cancer,	 gastric	 cancer,	 laryngeal	
papilloma,	breast	 cancer	or	 endometrial	 cancer	 amongst	others	 (Bhooshan	et	 al.,	
2016;	Ke	et	al.,	2016;	Nandi	et	al.,	2017;	Ren	et	al.,	2016).	Many	of	these	cancers	
exhibit	 increased	 COX-2	 expression	 and	 PGE2	 production	 compared	 with	 their	
respective	healthy	tissue	(Ke	et	al.,	2016;	Ren	et	al.,	2016;	Zelenay	&	Sousa,	2016).		
Similarly	to	non-tumoural	cell	types,	the	mechanism	of	PGE2	action	on	cancer	cells	










studies	 using	 COX-2-expressing	 rodent	 breast	 cancer	 cell	 lines,	 showed	 how	
proliferation	and	migration	was	mediated	by	COX2,	PGE2	and	the	EP4	receptor.	COX2	




when	 these	 cell	 lines	were	 treated	with	 EP4	 receptor	 siRNA	 (Nandi	 et	 al.,	 2017).	
Another	 study	 found	 a	 relationship	 between	 the	 use	 of	 EP4	 agonists	 and	 overall	
survival	 or	 recurrence	 of	 lung	 cancer	 (Bhooshan	 et	 al.,	 2016).	 One	 study,	 using	
endometrial	cancer	cells,	also	showed	increased	cancer	cell	proliferation	as	a	result	
of	PGE2	exposure.	Further	analysis	found	that	enhanced	proliferation	was	mediated	




by	 PGs.	 	Diverse	publications	 have	 studied	how	PGs	 can	promote	proliferation	 in	
undifferentiated	 and	 differentiating	 neuroectodermal	 stem	 cells,	 adult	 stem	 cells	
from	cord	blood	or	adipose	tissue,	tendon	stem	cells,	as	well	as	in	mice	embryonal	
stem	cells	(mESCs)	(Lee	et	al.,	2016;	Wong	et	al.,	2014;	Wong	et	al.,	2016;	Yun	et	al.,	





similar	 stem	 cell	 type	 are	 the	 mESCs.	 PGE2	 exposure	 of	 these	 cells	 was	 able	 to	













to	 PGE2	 could	 modify	 the	 expression	 of	 differentiation	 markers	 and	 modify	 the	
pluripotency	 state.	 Exposure	 to	 PGE2	 in	 neuroectodermal	 stem	 cells	 resulted	 in	







state.	 When	 exposed	 to	 PGE2,	 the	 expression	 of	 the	 well-known	 mESCs	
differentiation	markers	Sox2,	Nanog	and	Oct4,	was	reduced	(Yun	et	al.,	2009).		In	a	
more	 relevant	 model	 for	 this	 thesis,	 one	 paper	 using	 human	 testicular	 explant	






range	of	 studies.	Whether	 these	 alterations	 are	 a	 cause	or	 a	 consequence	of	 the	
other	phenotypes	reported,	 is	not	well	studied.	Modifications	of	DNA	methylation	
are	probably	the	most	studied	phenotype	of	PGs	within	the	epigenome,	and	have	






regulatory	 factors,	 such	 as	 DNMTs.	 PGE2	 has	 the	 ability	 to	 silence,	 via	 DNA	
methylation,	 certain	 tumor	 suppressor	 and	 DNA	 repair	 genes	 which	 promoted	
intestinal	tumor	growth,	suggesting	a	relationship	between	this	and	the	mentioned	






responses	were	down-regulated	when	 the	skin	was	 treated	with	 indomethacin	or	
EP2	 antagonists,	 demonstrating	 that	 the	modifications	 in	 DNA	methylation	 were	
driven	by	 the	PGE2	pathway	 (Prasad	&	Katiyar,	2013).	Other	studies	have	 tried	 to	
study	 the	 DNA	 methylation	 modifications	 in	 more	 detail,	 including	 mechanistic	
studies.	One	study,	using	 fetal	and	adult	 fibroblasts,	was	able	 to	 identify	multiple	








modifications	 in	 DNMT3a	 activity	 and	 revealed	 other	 modifications,	 such	 as	
increased	 expression	 of	 specificity	 proteins	 1	 (SP1)	 and	 3	 (SP3).	 SP1	 and	 SP3	 are	











the	 histone	 modifications	 markers,	 as	 well	 as	 changes	 in	 the	 expression	 of	 key	
epigenetic	regulatory	factors.	This	publication	showed	how	using	a	combination	of	























and	 length	 of	 exposure.	 The	 discrepancies	 in	 the	 literature	 and	 the	 inherent	
difficulties	 in	 translating	 experimental	 research	 findings	 into	 robust	 evidence	 for	










a	 cellular	model	 to	 allow	 deeper	 study	 of	 the	mechanistic	 pathways	modified	 by	
analgesics.	
		
Diverse	 studies	 have	 shown	 a	 link	 between	 fetal	 analgesic	 exposure	 and	
development	 of	 male	 reproductive	 disorders	 (cryptorchidism	 or	 hypospadias)	
(Kristensen	et	al.,	2011;	Snijder	et	al.,	2012),	which	are	known	to	be	related	to	altered	








The	 study	 of	 the	 mechanisms	 of	 action	 of	 analgesics	 is	 important	 because	 by	
understanding	these	mechanisms,	we	are	better	placed	to	prevent	adverse	effects	
and	to	exploit	any	beneficial	effects.	A	possible	common	mechanistic	pathway	that	
might	 link	analgesics	and	the	phenotypes	seen,	 is	 the	PGE2	pathway.	Somatic	and	












were	 able	 to	 affect	 not	only	 the	exposed	 generation	 (F1),	 but	 also	 showed	 inter-
generational	consequences,	affecting	the	F2	generation	that	resulted	from	mating	
the	F1	generation	(males	or	females)	with	wild-type	rats	(Dean	et	al.,	2016).	In	this	






















• To	 study	 the	 consequences	 of	 analgesics	 exposure	 on	 human	 fetal	
testicular	GCs	in	a	xenograft	model.	























Little	 France	 Biomedical	 Research	 Facility	 (BRF)	 according	 to	 the	UK	Home	Office	







day	 from	 07:00	 to	 19:00),	 humidity	 (55%)	 and	 temperature	 (20-25ºC).	 Rats	were	
housed	under	standard	conditions	and	had	free	access	to	tap	water	and	a	soy-free	
























prepared	 in	advance	and	 stored	at	 room	temperature	prior	 to	use.	 Indomethacin	




directly	before	each	daily	 treatment.	Treatment	was	administered	 in	 the	morning	











After	 treatment,	 pregnant	 rats	were	 killed	 by	 cervical	 dislocation	 after	 increasing	















cold	 lights	 (Leica	 CLS	 150x)	 in	 order	 to	minimise	 temperature	 rise.	 Gonads	 were	
excised	using	the	bevelled	edge	of	27G	needles	(Monoject,	sterile	needles,	0.4mm	x	
12mm)	 attached	 to	 disposable	 plastic	 1ml	 syringes.	 These,	 and	 a	 scalpel	 (Swann-
Morton)	were	then	used	to	remove	the	epididymis	and	the	mesonephros	from	the	


























and	 thus	 to	 separate	 them	 from	possible	 indirect	 effects	 caused	by	 the	maternal	
exposure,	fetal	rat	gonads	were	cultured	in	vitro	in	the	presence	of	paracetamol	or	
ibuprofen.	 Moreover,	 further	 studies	 using	 prostaglandin	 receptor	 (EP2+EP4)	







10μL/mL	 penicillin/streptomycin	 (Sigma-Aldrich),	 1%	 200mM	 L-glutamine	 (100X)	
(Gibco),	 1%	 MEM	 NEAA	 non-essential	 amino	 acids	 (100X)	 (Gibco),	 2%	 sodium	
pyruvate	100mM	(100X)	(Gibco)	and	1%	Insulin-transferrin-Selenium	(100x)	(Gibco).	

























































ibuprofen	 (10μM;	 Sigma-Aldrich)	 or	 L-161,982	 (EP2	 antagonist;	 10μM;	 Cayman	




















Further	analyses	were	undertaken	on	human	 fetal	gonadal	 tissue.	Human	 fetuses	




approved	 by	 the	 respective	 Local	 Research	 Ethics	 Committee	 (reference	 number	
LREC08/S1101/1	 for	 Edinburgh).	 For	 the	 induction	 of	 termination,	 women	 were	




















Sex	was	determined	by	morphology	when	possible	 (2nd	 trimester	 only)	 or,	 for	 1st	
trimester	 samples,	 by	 qPCR	 to	 detect	 the	 presence	 of	 the	male	 SRY	 gene.	When	
possible,	qPCR	was	performed	using	skin	tissue.	This	tissue	was	digested	in	100μL	of	
digestion	 buffer	 (25mM	 NaOH/0.2mM	 EDTA;	 Sigma)	 for	 20	 minutes	 at	 95ºC.	
Digestion	was	 stopped	 by	 adding	 100μL	 of	 neutralization	 buffer	 (40mM	Tris-HCL,	
Sigma)	 before	 being	 vigorously	 vortexed	 and	 being	 stored	 at	 -20ºC.	 Sex	
determination	was	analysedby	the	expression	of	SRY	using	the	SYBR	green	method.	
The	process	of	qPCR	 is	explained	 in	detail	below	(Section	2.8.5).	The	reaction	was	













































gestational	weeks)	were	cultured	 following	a	 similar	protocol	as	described	 for	 rat	
fetal	gonad	cultures.	This	protocol	was	adapted	for	human	cultures,	increasing	the	
culturing	 time	 and	 adding	 hCG	 to	 the	 medium	 in	 order	 to	 mimic	 the	 in-utero	
environment.	 Our	 lab	 found	 that	 the	 presence	 of	 hCG	 in	 the	 medium	 partially	
prevented	the	culture-induce	GC	loss,	showing	higher	number	of	GC	present	in	the	








the	 medium	 was	 supplemented	 with	 hCG	 plus	 vehicle	 or	 analgesic	 (10μM	
paracetamol	or	10μM	ibuprofen)	for	the	remainder	of	the	culture	period	(Figure	2.5).	
	















xenografting	 it.	 This	 	 system	offers	 a	more	physiological	model	 in	which	 to	 study	





to	 the	 host	mice	 before	 they	were	 castrated	 through	 a	 scrotal	 incision	 at	 least	 2	






described	previously	 (van	 den	Driesche	 et	 al.,	 2015).	An	 average	 of	 4-6	 pieces	 of	
gonadal	tissue	were	inserted	subcutaneously	under	the	dorsal	skin	of	each	host	on	
either	side	of	the	dorsal	midline	with	the	help	of	a	13-gauge	cancer	implant	needle	















additional	20	 IU	hCG	 treatment	 (Pregnyl,	Organon	 Laboratories)	by	 subcutaneous	
injections	every	72h	(van	den	Driesche	et	al.,	2015).	Host	mice	were	administered	
either	 vehicle	 (corn	 oil),	 paracetamol	 (20mg/kg,	 three	 times	 daily)	 or	 ibuprofen	
















accurate	 counting	 of	 the	 different	 cell	 populations.	 Only	 fluorescence	
immunohistochemistry	was	used	in	the	experiments	for	this	thesis.	This	technique	is	
based	on	the	capacity	of	antibodies	to	detect	specific	peptides,	which	can	be	targeted	










a	 substrate	 that	will	be	able	 to	produce	a	colour	 substance	 that	 stains	 the	places	
where	the	protein	of	interest	is	localised.	In	this	case,	HRP	was	used	in	combination	

















Figure	 2.7.	 Fluorescence	 immunohistochemistry	 detection.	 Schematic	
representation	 of	 fluorescence	 immunohistochemistry	 detection	 of	 proteins.	 The	
antigen	of	interest	is	bound	by	the	primary	antibody.	This	primary	antibody	is	then	
detected	by	 the	 secondary	antibody,	which	 is	attached	 to	horseradish	peroxidase	
molecule.	This	last	molecule	catalyses	a	reaction	between	the	surface	of	the	tissue	


























Tissue	 samples	 embedded	 in	 paraffin	 blocks	 were	 cut	 into	 sections	 using	 a	
microtome	 (Leica#RM212	5RT).	Blocks	were	cooled	on	 ice	 for	at	 least	30	minutes	
before	cutting	in	order	to	allow	a	cleaner	cut.	Serial	sections	(5μm)	were	obtained	
from	the	blocks,	which	were	placed	into	30%	(v/v)	industrial	methylated	spirits	(IMS;	
Fischer	 Scientific)	 before	 placing	 them	 onto	 a	 45ºC	 water	 bath	 (Lamb)	 to	 allow	
creases	to	unfold.	Sections	were	then	separated	with	the	help	of	fine	brushes	and	
mounted	onto	coated	slides	(BDH	Chemicals).	Slides	were	kept	at	45ºC	during	cutting	
























(STWS)	 for	30	seconds	before	being	washed	again	and	submerged	 in	Eosin	 for	10	
seconds	and	washed.	After	these	steps,	the	samples	were	already	stained	and	they	





During	Bouin´s	 fixation,	proteins	undergo	cross	 linking,	which	 improves	 the	 tissue	
integrity,	but	which	may	hide	the	detectable	antigens.	Antigen	retrieval	allows	these	
antigens	 to	 be	 exposed	 again	 to	 the	 antibodies.	 To	 achieve	 this,	 sections	 were	
pressure-cooked	in	0.01M	citrate	buffer	(pH	6.0).	The	decloaking	chamber	(Biocare	





Slides	were	 immediately	 incubated	 in	methanol	 (Fischer,)	with	3%	 (v/v)	hydrogen	









5	minutes	 at	 room	 temperature	 on	 a	 rocking	 platform.	 Samples	were	 then	 dried	
carefully	to	remove	the	TBS	but	so	as	not	to	disrupt	the	tissue,	and	then	the	sections	
were	 incubated	 in	a	humidified	chamber	 for	30	min	with	20%	chicken	serum,	5%	





final	 results	 were	 compared	 in	 order	 to	 select	 the	 conditions	 giving	 the	 best	







Tissue	 was	 then	 incubated	 with	 the	 appropriate	 secondary	 antibody,	 which	 was	
raised	 in	 the	 same	 species	 as	 the	 blocking	 serum	 and	 against	 a	 species-specific	















































































































































































the	 slides	 to	 cool	 for	 20	minutes	 before	washing	 the	 slides	 in	 TBS	 twice	 at	 room	
temperature	 on	 a	 rocking	 platform	 in	 the	 dark.	 This	 allowed	 the	 primary	 and	
secondary	antibodies	to	be	removed	from	the	tissue,	but	maintained	the	Tyramide	
signal.	After	one	of	the	last	two	options,	this	was	followed	by	blocking	with	chicken	




In	 some	 cases,	 and	 to	 help	 with	 visualisation	 of	 tissue	 architecture,	 a	 nuclear	
counterstain	was	performed	as	well.	After	the	Tyramide	step,	and	following	washes,	


























To	analyse	and	validate	 the	 rat	 fetal	 gonad	cultures,	 culture	viability	and	gonadal	
development	 were	 compared	 with	 a	 corresponding	 age-matched	 (non-cultured)	
control	 sample.	 To	 do	 so,	 rat	 testis	 and	 ovary	 culture	 tissue	 were	 processed	 as	
explained	above,	and	then	immunostained	for	Vasa,	to	determine	the	presence	of	
GC,	and	for	Sox9,	in	order	to	study	the	presence	of	Sertoli	cells	(male	gonads	only).	
Moreover,	 to	 study	 fetal	 gonad	 culture	 development,	 two	 other	 antigens	 were	











As	variably-sized	pieces	of	whole	 testicular	and	ovarian	 fetal	 tissue	were	used	 for	
culture	or	xenografting,	GC	number	was	determined	in	relation	to	the	tissue	section	
area	 (ovaries)	 or	 to	 seminiferous	 cord	 area	 (1st	 trimester	 testes).	 The	 delineated	
structures	 containing	 Sertoli	 cells	 (SOX9+)	 were	 defined	 as	 the	 seminiferous	 cord	
area.	 In	 the	 case	 of	 2nd	 trimester	 fetal	 testes,	 seminiferous	 cord	 area	 was	 not	





was	 co-immunostained,	 following	 the	 same	 protocol	 explained	 above,	 using	
antibodies	 for	 SOX9	 (Sertoli),	 AP2!	 (pluripotent	 gonocytes)	 and	 MAGE-A4	 (non-





cords	 in	 that	 section.	 Three	 different	 ratios	were	 determined:	 Total	 GC	 (AP2!+	 +	





















and	 ovarian	 sections	 were	 immunostained	 for	 AP2!,	 MAGE-A4	 (testis	 only),	 as	







more	tractable	system,	 in	this	case	a	cellular	model,	 to	study	 in	deeper	detail	 the	
possible	 effects	of	 analgesics	on	different	 cellular	mechanisms.	Currently	 it	 is	 not	
possible	to	culture	fetal	germ	cells	in	vitro,	due	to	difficulties	in	maintaining	cellular	














carcinoma	 cells,	 such	 as	 a	 high	 nuclear-cytoplasmic	 ratio,	 prominent	 nucleoli	 and	
expression	of	the	antigen	SSEA-3	(Andrews	et	al.,	1984).		
	
As	 a	 tumoural	 cell	 line,	 they	 have	 a	 fast	 and	 consistent	 cell	 cycle,	 being	 able	 to	
duplicate	their	cell	number	in	48h.	GC	tumors	are	believed	to	derive	from	arrested	





NT2	 cells	 were	 obtained	 as	 a	 gift	 from	 Anne	 Jorgensen	 in	 Copenhagen.	 After	 an	
original	expansion,	vials	containing	1	million	cells	on	passage	23,	suspended	in	1mL	
Bambaker	 solution	 (Nippon	 Genetics)	 were	 stored	 at	 -80ºC	 during	 the	 time	 the	
present	experiments	performed.	A	new	vial	was	thawed	and	expanded	for	each	new	
set	of	experiments,	so	each	set	was	started	with	cells	 from	the	same	original	vial.	
Experiments	 were	 carried	 out	 inside	 a	 sterile	 hood	 (BioMat2;	 Medical	 Air	
Technologies),	 regularly	 decontaminated	 with	 H202	 vaporization.	 Hoods	 were	
carefully	 cleaned	 and	 decontaminated	 on	 a	 regular	 3-month	 basis.	 Before	 every	
experiment,	the	hood	was	also	decontaminated	with	30	min	ultraviolet	light	followed	





























Cells	were	maintained	 in	 T75	 filtered	 caps	 until	 80-90%	 confluence	was	 reached,	
before	 being	 split.	 Cell	 confluence	was	 regularly	 checked	 using	 a	 cell	microscope	
(CK40;	Olympus).	For	splitting,	medium	was	discarded	and	the	cells	washed	with	pre-
warmed	1x	PBS,	and	disaggregated	with	3mL	TrypLE™	Express	(Gibco)	for	5	minutes	
at	 37ºC.	 TrypLE	 is	 a	 highly	 purified	 cell-disassociation	 enzyme	 that	 replaces	 the	
traditional	use	of	trypsin	and	is	able	to	disassociate	attachment-dependent	cell	lines.	
After	cells	were	detached,	the	enzymatic	activity	of	TrypLE	was	stopped	by	adding	





For	 seeding	 or	 treatment	 effects,	 cell	 number	 was	 determined	 using	 a	





















EP2+EP4	 antagonists	 to	 see	 if	 consistent	 treatment	 effects	were	 obtained	 and	 to	
study	 the	possibility	 that	 the	effects	 seen	are	a	 consequence	of	disruption	of	 the	
prostaglandin	E2	pathway.	For	these	reasons,	cells	were	treated	with	10	or	50μM	






first	 exposed	 to	10μM	Butaprost	 (EP2	agonist;	Abcam)	and	10nM	CAY10598	 (EP4	
























modification	 of	 the	 expression	 of	 epigenetic	 regulatory	 genes,	 it	 was	 decided	 to	
investigate	if	these	effects	had	consequences	at	the	protein	level.	To	do	so,	Elisas	for	
H3K27me3	 and	 DNA	 methylation	 (5-mC	 and	 5-hmC)	 were	 used.	 NT2	 cells	 (n=3	





















treated	 with	 1mL	 TRIzol,	 which	 causes	 cell	 disaggregation	 and	 disruption.	 The	
solution	was	 then	transferred	 into	a	2mL	Eppendorf	and	 instantly	 frozen	at	 -80ºC	
until	all	the	experiments	from	the	same	set	were	finished.	TRIzol	reagent	was	used	
because	 it	allows	a	phase	separation	and	enables	RNA	and	protein	 to	be	 isolated	
from	the	same	samples,	so	final	results	can	be	compared.	For	extraction,	all	of	the	
samples	were	thawed	on	ice	before	adding	0.2	mL	chloroform	to	each	tube.	After	a	






















fluorescence	 only	 when	 is	 bound	 to	 DNA.	 This	 ability,	 in	 combination	 with	 flow	
cytometry,	is	used	for	measuring	the	amount	of	DNA	present	in	each	cell	and	to	then	
relate	that	to	the	different	cycle	stage	of	the	cell	at	that	specific	moment.	The	cell	
cycle	 can	 be	 divided	 into	 different	 stages:	G0,	G1,	 Synthesis,	G2	 and	mitosis.	 The	
amount	 of	 DNA	 in	 the	 different	 stages	 will	 be	 different,	 because	 DNA	 is	 only	
replicated	 during	 the	 synthesis	 phase.	 Taking	 into	 account	 the	 amount	 of	 DNA,	
enables	easy	distinction	between	three	different	phases:	G0/G1,	with	the	minimum	
amount	of	DNA;	 synthesis,	where	 the	amount	of	DNA	 is	higher	 than	 in	G0/G1	but	












was	 stopped	by	adding	1mL	PBS	and	 the	 tubes	were	centrifuged	under	 the	 same	
conditions	 as	 before.	 Two	 further	 washes	 were	 done	 with	 PBS	 under	 the	 same	
conditions.	After	the	last	centrifugation,	the	supernatant	was	discarded	and	the	cells	
were	resuspended	in	300μL	1%	FCS	on	PBS	made	up	from	a	10%	FCS	frozen	Stock.	











































































































immediately	 transferred	 to	 a	 new	 Eppendorf	 tube	 and	 neutralized	 with	 200μL	
neutralization	 buffer	 containing	 1M	 Sodium	 phosphate	 (Sigma),	 dibasic	 pH	 12.5	
supplemented	 with	 2.5mM	 dithiothreitol	 (DTT;	 Sigma)	 and	 COmplete	 ™	 protein	






protein	 in	 these	 samples	 was	 then	 determined	 by	 the	 Bradford	 protein	 assay.	
Standards	 (0,	 125,	 250,	 500,	 750,	 1000,	 1500	 and	 2000ng)	 were	 prepared	 using	
2mg/mL	stock	of	albumin	(Thermo	Fisher)	by	serial	dilution.	5μL	of	each	standard	and	
sample	were	 added	 to	 250μL	 of	 Bradford	 reagent	 at	 room	 temperature	 (Thermo	
Fisher)	 in	duplicate,	 in	96-well	plates.	Samples	were	 incubated	for	15	mins	before	






























Elisa	was	 also	 used	 to	 calculate	 the	 PGE2	 content	 of	 hanging	 drop	 cultures	 of	 1st	
trimester	human	fetal	testis	samples	to	investigate	if	paracetamol	or	ibuprofen	had	
any	effect	on	it.	The	medium	was	collected	each	day,	pooing	the	medium	from	all	
culture	 pieces	 from	 the	 same	 fetus/treatment	 together.	 This	 allowed	 me	 to	 get	
enough	medium	to	perform	the	ELISA.	An	ELISAkit	(Enzo	life	science)	was	used,	which	

















or	 rat	 fetal	 gonads/cultures	 to	 the	 different	 treatments	 was	 investigated	 by	
determining	 the	 mRNA	 expression	 level	 of	 specific	 genes.	 To	 do	 so,	 mRNA	 was	
extracted	and	converted	into	cDNA,	which	enabled	qRT-PCR	for	the	genes	of	interest	














RNA	material	 for	 analysis,	 all	 tissue	 pieces	 from	 the	 same	 gonad	were	 pooled	 in	
hanging	drop	cultures.	For	in-vivo	rat	studies,	both	ovaries	from	the	same	fetus	were	




to	 homogenization	 with	 a	 tissue	 lysser	 (Qiagen)	 at	 25Hz	 for	 5	mins	 (2.5	mins	 in	
opposite	 positions),	 causing	 tissue	 disruption	 and	 release	 of	 RNA.	 Tubes	 were	
immediately	centrifuged	for	3	mins	at	14,000	x	g,	which	helps	to	remove	the	fat	and	
other	 parts	 of	 the	 tissue	 that	 could	 be	 detrimental	 for	 the	 RNA	 extraction.	 The	
supernatant	 was	 then	 transferred	 to	 another	 1.5	 mL	 Eppendorf	 containing	 70%	
ethanol	 made	 up	 from	 absolute	 ethanol	 and	 RNAse	 free	 water	 (Ambion).	 The	
samples	were	 then	manually	mixed	by	pipetting	and	 transferred	 to	PureLink	mini	
columns	(supplied	in	the	kit)	and	placed	inside	a	collection	tube.	Columns	were	then	















1	min	 incubation,	 the	 columns	were	 centrifuged	 at	 14,000	 x	 g	 for	 1	min	 for	 final	


















reaction	 (RT-PCR)	 using	 a	 Vilo	 kit	 (Invitrogen)	 according	 to	 the	 manufacturer’s	
instructions	(Table	2.3).	A	master	mix	was	made	by	mixing	the	reagents	and	19μL	






























species	 specific,	 so,	 when	 required,	 a	 different	 set	 of	 primers	 was	 designed	 for	
human	and	rat	genes.	To	avoid	possible	DNA	amplification,	primers	were	designed	
so	 that	 the	 probe	 spans	 introns.	 The	 system	 provides	 different	 primer/probe	
combinations	and	one	was	selected	according	to	the	availability	of	probes.		Forward	












































































































































































































































































































































DNA	 (ssDNA)	 at	 95ºC	 by	 disrupting	 the	 hydrogen	 bonds	 holding	 the	 strands;	 2.	





















at	 the	 3´end	 a	 non-fluorescent	 quencher	 (6-carboxy-tetramethyl-rhodamine:	
TAMRA)	and	a	reporter	dye	(6-carboxyfluorexcein:	FAM)	at	the	5’	end.	The	former	
maintains	 the	 probe	 in	 a	 non-fluorescent	 state.	 During	 the	 denaturation	 step	






more	probe	will	be	 linked	 to	cDNA	and	more	 reporter	 is	 cleaved	producing	more	


























polymerase	 removes	 the	 fluorophore	 from	 the	 Taqman	 probe	 as	 a	 result	 of	 the	








case	 of	 NT2	 cells,	 an	 extra	 reference	 gene	was	 added:	 TATA-box	 binding	 protein	
(TBP).	 These	 genes	 were	 chosen	 from	 a	 list	 of	 recommended	 candidates	 of	
housekeeping	genes	for	gonad	studies	(O'Shaughnessy	et	al.,	2011).	The	expression	
of	 TBP	and	beta-2-microgobulin	 (B2M)	were	 studied	with	 the	different	 analgesics	




18S	 ribosomal	 probe	 with	 53μL	 of	 each	 primer	 in	 150μL	 TE	 buffer	 (Invitrogen).	
Negative	controls	(two	produced	in	the	cDNA	conversion	and	one	extra	made	with	
no	RNA)	were	included	in	all	runs.	All	Taqman	reagents,	primers	and	samples	were	



































Because	 primers	 are	 designed	 following	 theoretical	 rules,	 it	 does	 not	 take	 into	
account	all	the	different	interactions	that	they	can	suffer	in	normal	conditions	and	
can	 sometimes	 result	 in	 primers	 not	 working	 or	 not	 amplifying	 the	 target	 cDNA	









the	 set	of	primers	was	able	 to	produce	 the	 correct	 amplification	of	 the	 region	of	
interest	 from	 the	 cDNA,	 there	 should	 be	 an	 exponential	 correlation	 between	 the	
cDNA	concentration	and	the	number	of	cycles	resulting	from	the	RT-qPCR.	This	was	











(Thermofisher).	 In	 this	 plot,	 the	 amount	of	 fluorescence	produced	 in	 each	well	 is	
plotted	against	 the	number	of	 cycles.	 Indirectly,	 it	 shows	 the	amplification	or	 the	
region	of	cDNA	of	interest.	In	the	plot,	there	are	4	distinguished	points	of	interest:	
the	baseline,	which	 refers	 to	 the	basal	 fluorescence	 in	 the	 reaction	plate	 (a),	 the	
background	fluorescence	(b),	the	exponential	growth	phase	(c)	and	the	plateau	(d).	
The	exponential	phase	starts	once	the	 level	of	 fluorescence	has	 increased	enough	
and	this	is	referred	to	as	the	threshold.	Hence,	the	threshold	is	manually	set	at	the	















Xn=X0	x	 (1+Ex)n,	where	Xn	 is	 the	number	of	 target	molecules	at	 threshold	 level,	n=	
cycle	number,	X0=number	of	target	molecules	at	the	start,	1+Ex=	the	efficiency	of	the	
target	amplification.	This	 formula	 can	be	used	 to	derive	2-ΔΔCt	 (Livak	&	Schmittgen	









and	 trends	 in	gene	expression	are	easier	 to	understand,	 the	 final	values	obtained	
were	then	normalised	to	the	respective	vehicle.	This	was	done	by	dividing	the	final	
















the	 results	 shown	 in	 this	 thesis	 needed	 this	 transformation.	 For	 human	 tissue		
studies,	including	fetal	gonad	cultures	and	xenografts,	results	were	analysed	by	two-






averaged	 to	 yield	 a	 single	 mean	 value,	 this	 would	 have	 discarded	 data	 on	
experimental	error	(ie	the	variation	between	replicates),	and	it	was	considered	that	
retaining	this	represented	a	more	robust	and	searching	analysis	of	the	data.	Values	





































































Chapter	 1	 introduced	 the	 different	 publications	 that	 have	 studied	 the	 effects	 of	
analgesics	during	pregnancy	so	far.	The	majority	of	these	are	epidemiological	studies	














of	 these	analgesics,	 focusing	 in	more	detail	on	 the	 fetal	gonads	 (Kristensen	et	al.,	
2011;	Dean	et	al.,	2016)6.	Yet,	one	of	the	limitations	of	these	studies	is	the	fact	that	
it	is	difficult	to	separate	the	direct	effects	of	the	analgesics	on	the	fetal	gonads	from	
the	 indirect	 effects	 that	 could	 derive	 from	 the	 effects	 of	 the	 analgesics	 on	 the	
mother.	To	study	the	direct	consequences	of	common	analgesics	on	the	fetal	gonads,	

















which	 includes	 important	 GC	 changes.	 Thus,	 ovarian	 GCs	 are	 in	 the	 process	 of	
entering	meiosis	and	they	have	already	started	expressing	important	factors	for	this	
process	such	as	Notch	or	Stra8	(Le	Bouffant	et	al.,	2010).	On	the	contrary,	meiosis	is	
blocked	 in	male	 GCs	 until	 puberty	 thanks	 to	 an	 active	 process	 that	 needs	 to	 be	
continuously	 regulated	 (Bowles	 &	 Koopman,	 2010;	 Guerquin	 et	 al.,	 2010).	




The	 in	 vitro	 model,	 fetal	 rat	 gonad	 cultures,	 was	 used	 to	 study	 the	 effect	 of	
paracetamol	and	ibuprofen	on	epigenetic	regulators.	Moreover,	to	 investigate	the	





Several	 studies	 in	 the	 Sharpe	 group	were	 undertaken	 to	 investigate	 the	 effect	 of	











window	 (MPW)	 in	 rodents	 (Dean	 et	 al.,	 2016).	 Hence,	 experiments	 were	 done	
predominantly	using	e17.5	testes	as	standard.	
	
In	 the	 in	vivo	 rat	model,	 I	 firstly	performed	a	study	 focusing	on	 the	expression	of	
some	 important	and	well-studied	 testicular	 and	ovarian	genes.	 These	genes	were	
selected	based	on	their	importance	during	gonad	development	or	their	relationship	
with	 male	 reproductive	 disorders.	 This	 included	 genes	 related	 to	 retinoic	 acid,	
regulators	of	sexually	dimorphic	gonad	development.	Previous	studies	by	this	lab	on	
the	 same	 rat	 in	 vivo	 model	 showed	 that	 in	 utero	 exposure	 to	 paracetamol	 or	
indomethacin	 increased	expression	of	Stimulated	by	Retinoic	Acid	8	 (Stra8)	 in	 the	
fetal	 ovary	 on	 e17.5	 and	 e18.5	 (Dean	 et	 al.,	 2016).	 Stra8,	 as	 its	 name	 implies,	 is	
regulated	by	retinoic	acid	(RA)	and	thus,	one	focus	of	my	studies	was	RA,	which	plays	
important	roles	in	general	fetal	development	as	well	as	in	fetal	gonad	development.	
In	the	rodent	gonad	RA	 is	 important	 in	controlling	the	start	of	GC	meiosis,	as	 it	 is	
required	 for	 pre-meiotic	 DNA	 replication	 	 (Le	 Bouffant	 et	 al.,	 2010;	 Baltus	 et	 al.,	
2006).	The	study	of	RA	was	done	indirectly,	as	it	is	usually	performed,	with	study	of	
the	enzymes	 involved	 in	RA	synthesis	 from	Vitamin	A	(Aldehyde	dehydrogenase	1	
family	;	Aldh1a1,	Aldh1a2	and	Aldh1a3)	and	its	metabolic	inactivation	(via	Cyp26b1),	

















the	 small	 rat	 gonads	 into	 exactly	 1mm3	 pieces,	 an	 initial	 optimization	 study	 that	




Moreover,	 antagonists	 of	 the	 prostaglandin	 E2	 receptors,	 EP2	 and	 EP4,	 were	
incorporated	to	the	studies	as	an	extra	treatment	to	study	if	blockage	of	the	PGE2	







NSAID,	 indomethacin	was	 administered	 by	 subcutaneous	 injection	 (0.8mg/kg/day	
x1).	Treatments	were	administered	from	e13.5	until	the	day	before	sampling	(either	
e15.5,	e17.5	or	e18.5)	as	explained	in	section	2.1.3.	The	doses	of	paracetamol	in	rats	
were	 calculated	 from	 human	 relevant	 doses	 taking	 the	 body	 surface	 area	 into	
consideration	(Reagan-Shaw	et	al.,	2008).	Following	the	method	in	this	article,	each	
species	has	a	different	conversion	factor,	depending	on	the	body	surface	area,	which	
is	 37	 for	 an	 adult	 human	 and	 6	 for	 an	 adult	 rat.	 Using	 these	 conversion	 factors,	
60mg/kg	per	day	in	a	human	is	equivalent	to	350mg/kg/day	in	the	rat.	Furthermore,	



















with	 paracetamol	 (10	µM),	 ibuprofen	 (10	µM)	 or	 EP2+EP4	 antagonists	 [10μM	 L-








The	expression	of	Aldh1a1	was	 increased	 in	e17.5	 testes	and	e17.5-e18.5	ovaries	
exposed	 to	 paracetamol	 or	 indomethacin	 in	 utero,	 but	 this	 was	 only	 statistically	
significant	in	testes	(Figure	3.1).	In	contrast,	expression	of	Aldh1a2	was	unaffected	in	
e17.5	 testes	of	 analgesic-exposed	F1	 fetuses	 (Figure	3.1).	On	 the	other	hand,	 the	
expression	of	all	RA	receptors	and	Cyp26b1	showed	no	significant	modification	in	F1	
e17.5	 fetal	 testes	 from	 analgesic-exposed	 fetuses	 (Figure	 3.1).	 Aldh1a1	 was	 also	


















































3.3.2. Effect	 of	 in	 utero	 exposure	 to	 analgesics	 on	 expression	 of	 genes	
involved	in	fetal	rat	gonad	development		
One	 of	 the	 genes	 found	 to	 be	 affected	 by	 paracetamol	 and	 indomethacin	 was	
Dishevelled	 Binding	 Antagonist	 of	 Beta	 Catenin	 1	 (Dact1),	 which	 showed	 a	
significantly	increased	expression	in	the	e17.5	fetal	testis	(Figure	3.3)	and	e18.5	fetal	
ovary	 (paracetamol	 only)	 (Figure	 3.4).	Dact	 2	 and	 Dact	 3	 were	 also	 studied,	 but	
showed	 no	 treatment-induced	 modification	 (Figure	 3.3).	 Dact	 proteins	 are	
antagonists	of	β-catenin,	a	key	player	in	gonad	development,	especially	in	the	ovary,	
but	also	important	in	the	testis.	β-catenin	acts	together	with	Wnt	protein	(see	section	
1.3.2.1	 and	 Fig.	 1.2)	 and	 thus,	 it	 was	 decided	 to	 focus	 on	 the	 Wnt4/β-catenin	
pathway.	 The	 expression	 of	Wnt4	 in	 e17.5	 testis	 was	 reduced	 by	 paracetamol	
exposure	only	(Figure	3.3).	The	expression	of	β-catenin	was	not	modified	by	in	utero	
exposure	 to	 either	 of	 the	 analgesics	 (Figure	 3.3)	 in	 e17.5	 testes.	 β-catenin	 is	
translocated	 to	 the	 nucleus	 once	 the	 pathway	 is	 activated	 and	 therefore	 the	
















Figure	 3.3.	 Effect	 of	 in	 utero	 exposure	 of	 pregnant	 rats	 to	 paracetamol	 (Para)	 or	
indomethacin	(Indo)	on	mRNA	expression	of	important	genes	for	gonad	development	in	
e17.5	 testes.	 Pregnant	 rats	 were	 administered	 vehicle	 (Veh;	White),	 paracetamol	 (Para;	
350mg/kg/day	x1;	blue)	or	indomethacin	(Indo;	0.8mg/kg/day	x1;	purple)	commencing	on	
e13.5,	 and	 fetal	 gonadal	 tissue	was	 collected	 on	 e17.5,	 3	 hours	 after	 the	 final	maternal	
treatment.	mRNA	expression	is	expressed	relative	to	the	vehicle	cDNA	for	the	same	genes	





















of	 pregnant	 rats	 to	 paracetamol	
(Para)	 or	 indomethacin	 (Indo)	 on	
mRNA	expression	of	important	genes	
for	 gonad	 development	 in	 the	 fetal	
e18.5	 ovary.	 Pregnant	 rats	 were	
administered	 vehicle	 (Veh;	 White),	
paracetamol	(Para;	350mg/kg/day	x1;	
blue)	 or	 indomethacin	 (Indo;	
0.8mg/kg/day	 x1;	 purple)	 commencing	 on	 e13.5,	 and	 fetal	 gonadal	 tissue	 was	
collected	on	e18.5,	3	hours	after	the	final	maternal	treatment.	mRNA	expression	is	






e17.5	 fetal	 rat	ovary.	Pregnant	rats	were	administered	vehicle	 (left),	paracetamol	
(350mg/kg/day	x1;	middle)	or	indomethacin	(0.8mg/kg/day	x1;	right)	commencing	













Previous	 rat	 studies	 by	 our	 lab	 using	 in	 vivo	 exposure	 to	 paracetamol	 and	
indomethacin	showed	male	and	female	GC	loss	during	fetal	life.	This	GC	reduction	
was	 compensated	 for	 postnatally	 in	 males,	 but	 these	 effects	 had	 long-term	
consequences	 in	females	 including	a	 lower	adult	ovary	weight	(Dean	et	al.,	2016).	
The	development	and	proliferation	of	 fetal	GC	 is	 regulated	by	a	variety	of	known	
factors,	although	the	process	as	a	whole	is	not	fully	understood.	The	present	studies	
focussed	on	the	effect	of	paracetamol	and	indomethacin	on	some	of	the	most	well-
known	regulators	of	GC	development	and	 formation	of	 the	 follicle	pool,	 including	
Forkhead	 box	 O3	 (Foxo3),	 Notch2,	 Epiregulin,	 Epidermal	 growth	 factor	 receptor	


























in	 fetal	 e17.5	 testes.	 Pregnant	 rats	 were	 administered	 vehicle	 (Veh;	 White),	
paracetamol	(Para;	350mg/kg/day	x1;	blue)	or	indomethacin	(Indo;	0.8mg/kg/day	x1;	
purple)	 commencing	on	e13.5,	and	 fetal	gonadal	 tissue	was	collected	on	e17.5,	3	
hours	after	the	final	maternal	treatment.	mRNA	expression	is	expressed	relative	to	
the	vehicle	cDNA	for	the	same	genes	after	the	treatment	exposure.	(Means	±	SEM	




















Following	 previous	 studies	 in	 our	 laboratory	 showing	 inter-generational	
consequences	 of	 in	 utero	 paracetamol	 exposure	 (Dean	 et	 al.,	 2016),	 it	 was	
hypothesized	 that	exposure	 to	paracetamol	or	 indomethacin	might	 interfere	with		
the	epigenetic	machinery	of	the	fetal	gonads.	My	studies	focused	on	DNA	and	histone	
methylation.	Thus,	 the	expression	of	Tet1,	which	plays	a	 role	 in	DNA	and	histone	
methylation,	was	 studied,	 as	was	Ezh2	which	 is	 the	 enzymatic	 component	 of	 the	
polycomb	repressive	group	2	(PRC2)	complex,	which	is	responsible	for	the	repressive	




ovaries	 of	 fetuses	 exposed	 in	 utero	 to	 paracetamol	 or	 indomethacin	 was	
investigated.	However,	only	the	effect	of	paracetamol	exposure	on	the	e17.5	ovary	
could	 be	 investigated,	 because	 no	 indomethacin-exposed	 ovarian	 samples	 were	
available	 for	 e15.5	 females.	 Paracetamol	 and	 indomethacin	 exposure	 resulted	 in	
increased	 expression	 of	Tet1	 in	 both	 the	 fetal	 testis	 (e15.5	 and	 e17.5)	 and	 ovary	
(e15.5),	while	Ezh2	expression	was	increased	only	in	e15.5	ovaries	and	e17.5	testes	

















e17.5	 testis.	 Pregnant	 rats	 were	 administered	 vehicle	 (Veh;	White),	 paracetamol	
(Para;	 350mg/kg/day	 x1;	 blue)	 or	 indomethacin	 (Indo;	 0.8mg/kg/day	 x1;	 purple)	
commencing	on	e13.5,	and	 fetal	 gonadal	 tissue	was	 collected	on	e15.5	 (Top)	and	
e17.5	 (Bottom),	 3	 hours	 after	 the	 final	 maternal	 treatment.	 mRNA	 expression	 is	





















indomethacin	 (Indo)	on	mRNA	expression	of	epigenetic	 regulators	 in	 fetal	e15.5	
and	e17.5	ovary.	Pregnant	rats	were	administered	vehicle	(Veh;	White),	paracetamol	
(Para;	 350mg/kg/day	 x1;	 blue)	 or	 indomethacin	 (Indo;	 0.8mg/kg/day	 x1;	 purple)	
commencing	on	e13.5,	and	 fetal	 gonadal	 tissue	was	 collected	on	e15.5	 (Top)	and	
e17.5	 (Bottom),	 3	 hours	 after	 the	 final	 maternal	 treatment.	 mRNA	 expression	 is	



























effect	 of	 these	 analgesics	 on	 PG	 downstream	messengers,	 such	 as	 the	 specificity	
proteins	 (Sp)	were	studied.	Once	PGs	have	activated	their	 receptors,	a	cascade	of	
factors	 control	 Sp,	 which	 are	 translocated	 to	 the	 nucleus	 and	 act	 as	 expression	
regulators	(Li	&	Davie,	2010).	The	expression	of	Sp1	and	Sp2	was	significantly	reduced	














testes.	 Pregnant	 rats	were	administered	vehicle	 (Veh;	White),	 paracetamol	 (Para;	
350mg/kg/day	 x1;	 blue)	 or	 indomethacin	 (Indo;	 0.8mg/kg/day	 x1;	 purple)	
commencing	on	e13.5,	and	fetal	gonadal	tissue	was	collected	on	e17.5,	3	hours	after	
the	final	maternal	treatment.	mRNA	expression	is	expressed	relative	to	the	vehicle	





fetal	 rat	 ovary.	 Pregnant	 rats	 were	 administered	 vehicle,	 paracetamol	
(350mg/kg/day	once	daily;)	or	indomethacin	(0.8mg/kg/day	once	daily)	commencing	

















½	and	¼	 pieces	 both	 showed	minimal	 necrosis	 and	 appeared	 viable.	 However,	½	
gonad	pieces	showed	a	higher	decrease	in	GC	number	after	culture	compared	with	
¼	pieces,	 so	 the	 latter	was	chosen	as	 the	culture	standard	 (Figure	3.11).	Previous	
experiments	in	the	lab	had	used	48h	rat	fetal	gonads	cultures	and	so,	this	length	was	
decided	to	be	the	main	choice.	Nevertheless,	rat	fetal	testis	cultures	lasting	6	and	10	









in	 rat	 fetal	 testis	 GC	 during	 e15.5	 but	 is	 downregulated	 by	 e17.5	 (Culty,	 2009).	




matched	 controls	 (Figure	 3.11).	 In	 the	 case	 of	 the	 ovaries,	 age-matched	 controls	
showed	that	Dmrt1	was	immunoexpressed	in	e15.5	samples,	but	was	downregulated	
in	 e17.5	 samples.	 Ovaries	 cultured	 for	 48h	 showed	 some	 immunoexpression	 of	





































































































3.3.7. Analgesic	 exposure	 causes	 changes	 in	 expression	 of	 epigenetic	
regulatory	genes	in	fetal	rat	gonad	cultures	
Once	 the	 cultures	 were	 optimized	 and	 proved	 to	 be	 a	 viable	model,	 I	 studied	 if	
analgesic	exposure	of	the	fetal	rat	gonad	cultures	could	mimic	the	modifications	to	
epigenetic	 regulatory	 gene	 (Tet1,	 Ezh2)	 expression	 seen	 in	 vivo	 (Section	 3.3.4).		
Similar	 to	 the	 in	 vivo	 exposure,	Tet1	 and	Ezh2	 expression	were	 both	 significantly	









induce	 similar	 effects	 to	 paracetamol	 and	 ibuprofen.	 Tet1	 expression	 was	
significantly	 increased	 after	 exposure	 to	 the	 EP	 antagonists	 in	 both	 cultured	 rat	
ovaries	 and	 testes,	 whilst	 Ezh2	 expression	 was	 unmodified	 in	 testes	 and	 slightly	










Figure	 3.13.	 Effect	 of	 exposure	 of	 rat	 fetal	 gonad	 cultures	 to	 analgesics	 or	
prostaglandin	E2	antagonists	on	mRNA	expression	of	epigenetic	regulatory	genes.	
Testis	and	ovary	tissue	pieces	(¼)	from	e15.5	fetal	rats	were	cultured	for	48h	with	
either	 vehicle	 (White,	 Paracetamol	 (blue;	 10µM),	 ibuprofen	 (orange;	 10µM)	 or	
EP2+EP4	 antagonists	 [Maroon;	 10μM	 L-161,982	 (EP2	 antagonist)	 +	 10μM	
PF04418948	EP4	antagonist)].	Panels	A	to	F	show	mRNA	expression	relative	to	the	
vehicle	complementary	DNA	for	Tet1,	Ezh2,	Dnmt3a	and	Dnmt3b	for	cultured	fetal	













3.4.1. Effect	of	 in	vivo	exposure	of	 rat	 fetal	gonads	 to	analgesics	on	 the	
retinoic	acid	pathway	
Retinoic	 acid	 (RA)	 is	 one	 of	 the	 most	 well-known	 factors	 participating	 in	 fetal	
development.	It	plays	roles	in	some	of	the	most	important	events	in	the	development	
of	 the	 functional	 fetus,	 such	 as	 cell	 growth	 and	differentiation,	 somatogenesis	 or	
organogenesis	(Kam	et	al.,	2012).	Within	the	rodent	gonad,	RA	controls	the	onset	of	
GC	meiosis.	In	the	testis,	RA	is	inactivated	by	its	metabolizing	enzyme	(CYP26B1)	and	





prematurely,	 which	 were	 then	 arrested	 at	 the	 pachytene	 phase	 and	 exhibited	
increased	apoptosis	(MacLean	et	al.,	2007).	Previous	experiments	in	our	lab	on	the	









fetal	 life,	Aldh1a1	 increases	 according	 to	 gestational	 age	 in	 the	 testis,	 while	 the	










however	this	gene	 is	 increased	 in	human	gonads	when	meiosis	starts,	providing	a	
source	of	RA	(Le	Bouffant	et	al.,	2010).	 	The	increase	in	Aldh1a1	seen	in	e17.5	rat	
fetal	 testes	 exposed	 to	 paracetamol	 or	 indomethacin	 in	 vivo	 could	 produce	 an	
increase	 in	 RA	 and	 hence	 cause	 an	 advance	 in	 entry	 to	meiosis.	 Increased	 RA	 is	
normally	linked	with	an	increased	expression	of	its	receptors	(Rarα,	Rarβ,	Rxrα,	Rarγ	
and	Rxrγ)	and	metabolizers	(Cyp26b1)	(Childs	et	al.,	2011).	However,	in	these	studies	
expression	 of	 these	 receptors	 showed	 no	 change	 after	 in	 vivo	 exposure	 to	
paracetamol	or	indomethacin	in	e17.5	fetal	testes.	With	all	these	results	together,	
the	 increase	 in	the	 levels	of	RA	by	paracetamol	or	 indomethacin	 in	e17.5	rat	fetal	
testes	cannot	be	confirmed.	However,	some	of	the	results	do	raise	the	possibility.	A	
deeper	analysis	and	study	could	be	addressed	with	models	involving	the	use	of	lacZ-
coupled	 transgenes	 controlled	by	an	RA	 response	element	 (RARE)	 (Rossant	et	al.,	
1991).		
	




















have	 shown	 that	 complete	 inhibition/ablation	 of	 Wnt4	 in	 the	 testis	 can	 also	 be	
detrimental	 for	 testis	 formation,	 including	 decreased	 proliferation	 and	 increased	
apoptosis	of	GC		(Das	et	al.,	2013;	Boyer	et	al.,	2012).	Furthermore,	if	we	presume	




β-catenin,	 the	 role	of	which	 is	 tightly	 linked	with	Wnt4	was	also	studied.	 Its	gene	
expression	was	not	modified	by	 in	vivo	paracetamol	or	 indomethacin	exposure	 in	
e17.5	 testes,	although	 this	was	partially	expected,	as	β-catenin	action	 is	normally	
studied	by	 localisation.	 Fluorescence	 immunohistochemistry	 studies	did	not	 show	
any	 difference	 in	 β-catenin	 localization	 in	 rat	 e17.5	 fetal	 ovaries	 after	 analgesic	
exposure.	 However,	 previous	 publications	 on	 fetal	 gonads	 reported	 difficulties	 of	
studying	 β-catenin	 localization,	 as	 its	 nuclear	 translocation	 is	 a	 dynamic	 process	
difficult	to	monitor	by	immunohistochemistry	(Liu	et	al.,	2009).				
	




















vivo	 to	 paracetamol	 or	 indomethacin.	 This	 could	 mean	 that	 paracetamol	 and	










Previous	 experiments	 in	 the	 lab	 have	 shown	 that	 one	 of	 the	 effects	 of	 analgesic	
exposure	on	rat	fetal	ovaries	is	a	decrease	in	GC	number,	as	well	as	decreased	adult	
ovary	weight	 (Dean	et	al.,	2016).	The	creation	of	an	oocyte	pool	 in	 the	ovary	 is	a	
complex	process	and	modifications	to	any	of	the	mechanisms	involved	can	cause	a	




the	 follicle	 pool	 (John	 et	 al.,	 2008;	 Xu	&	 Gridley,	 2013;	 Feng	 et	 al.,	 2014b)	were	











of	 all	 of	 them	 have	 consequences	 for	 fetal	 gonad	 development.	 Foxo3	 has	 been	
proposed	as	a	preserver	of	the	follicle	pool	(Pelosi	et	al.,	2013)	and	different	studies	
show	 how	 knockdown	 of	 Foxo3	 develops	 into	 an	 ovarian	 burn-out	 (early	 loss	 of	
oocytes)	 (Castrillon	 et	 al.,	 2003),	 while	 up-regulation	 delays	 follicle	 development	
(Pelosi	et	al.,	2013).	Notch2	is	involved	in	the	initiation	of	oocyte	nest	breakdown	and	
follicle	formation	(Xu	&	Gridley,	2013)	and	its	knockdown	shows	decreased	follicle	
formation	 and	 abnormal	 follicular	 growth	 (Trombly	 et	 al.,	 2009).	 Furthermore,	 in	
males,	Notch2	expression	is	directly	related	to	testosterone	levels	via	regulation	of	




growth	 factor	 superfamily.	 Upregulation	 of	 Inha	 expression	 in	 fetal	 ovary	 is	
associated	with	 impaired	fetal	ovarian	folliculogenesis	 (Billiar	et	al.,	2003).	Loss	of	








Furthermore,	 I	 decided	 to	 study	 Dmrt1,	 which	 is	 tightly	 related	 to	 RA	 via	 its	












of	 paracetamol	 and	 indomethacin	 effect	 on	 these	 gene	 regulators	 of	 gonad	
development,	including	the	study	on	ovary	and	on	other	time	points.	All	the	analyses	










































2009;	 Dean	 et	 al.,	 2016;	 Jobling	 et	 al.,	 2011).	 The	 reduction	 in	 Oct4	










































fetal	 gonads	 during	 gestation	 is	 largely	 unknown.	 However,	 this	 could	 affect	 the	




















apoptosis	or	differentiation.	SP	are	 	 regulated	by	different	modifications	 including	







after	 exposure	 in	 vitro	 of	 fetal	 gonad	 cultures	 (Sections	 3.3.4	 and	 3.3.7).	 The	
expression	 of	 SP1	 and	 SP2	 was	 significantly	 reduced	 after	 in	 vivo	 exposure	 to	
indomethacin	 in	 the	 e17.5	 testis,	 but	 paracetamol	 exposure	 only	 reduced	 SP2	
expression.	SP	targets	depends	on	the	type	of	modification	that	it	undergoes	and	the	







suffer	 a	 modification,	 they	 are	 translocated	 into	 the	 nucleus,	 where	 they	 target	
different	gene	promoters.	When	studied	by	Immunohistochemistry	in	e17.5	ovaries	







and	 indomethacin,	 in	 this	 concentration,	 are	 able	 to	 substantially	 modify	 the	
localisation	of	SP1	in	order	to	be	seen	by	immunofluorescence.	On	the	other	hand,	
there	are	no	previous	reports	of	the	localization	of	SP1	in	fetal	gonads,	and	hence	it	
is	 more	 difficult	 to	 study	 the	 possible	 consequences	 of	 the	 analgesics	 on	 their	
localization.		
	







PGE2	 receptor	 antagonists.	 These	 results	 are	 in	 consonance	 with	 other	 studies	
relating	PGE2	with	epigenetic	 regulators,	 such	as	DNTM3A	and	DNMT3B,	but	 also	
histone	modifications,	such	as	H3K9me3,	H3K27me3	or	H3K9ac	(Arosh	et	al.,	2015;	
Xia	 et	 al.,	 2012;	 Venza	 et	 al.,	 2012).	 	My	 results	 show	 comparable	modifications,	
although	it	would	be	relevant	to	perform	a	deeper	study	on	histone	modifications	in	
order	 to	 obtain	 more	 information	 regarding	 the	 exact	 modifications,	 including	
affected	 genes	 and	 related	 protein	 levels	 and	 possible	 further	 consequences	 of	
epigenetic	modifications.	It	is	important	to	mention	that	previous	studies	on	fetal	rat	













regulators,	 as	 well	 as	 to	 the	 different	 genes	 important	 for	 gonad	 and	 GC	
development,	 show	 some	 possible	 mechanisms	 affected.	 Whether	 these	
modifications	are	the	cause	of	the	phenotypes	reported	in	previous	studies,	remains	
to	 be	 addressed.	 Furthermore,	 these	 modifications	 might	 be	 a	 cause	 or	 a	
consequence	of	modifications	 to	 the	 epigenetic	 regulatory	 genes	described.	 Even	
more	 important,	 the	 analgesic-induced	modifications	 to	 the	 epigenetic	 regulators	
might	 be	 the	 first	 mechanism	 able	 to	 explain	 the	 transgenerational	 effects	 of	
analgesics	shown	by	our	lab	in	the	past	(Dean	et	al.,	2016).		
	
The	development	and	optimization	of	 the	 in	 vitro	 fetal	 rat	 gonad	cultures	 can	be	
useful	 for	 future	 studies	 aimed	 at	 elucidating	 the	 mechanism	 of	 action	 of	
paracetamol	and	ibuprofen.	Meanwhile,	these	cultures	were	able	to	show	that	this	
mechanism	 is	probably	mediated	by	PGE2	as	evidenced	by	 the	experiments	using	























number.	 Yet,	 no	 relevant	 studies	 have	 focused	 on	 fertility	 consequences	 of	 fetal	
analgesic	 exposure	 in	 human	 models.	 Hence,	 the	 effect	 of	 paracetamol	 and	
ibuprofen	on	GC	in	human	fetal	gonad	tissue	was	studied.	As	explained	in	chapter	1,	
the	 consequences	 of	 analgesic	 exposure	 during	 pregnancy	 might	 depend	 on	 the	
gestational	 period	 (Hurtado-Gonzalez	 &	 Mitchell	 2017;	 Kristensen	 et	 al.,	 2011;	




In	 this	 chapter,	 I	 will	 describe	 the	 different	 experiments	 performed	 to	 study	 the	
effects	 of	 paracetamol	 and	 ibuprofen	 on	 fetal	 human	 gonadal	 GC.	 The	 relative	
number	 of	 GC	 present	 after	 analgesic	 exposure	 was	 studied	 to	 find	 possible	
similarities	to	the	decrease	in	GC	number	found	in	previous	studies	performed	in	rats		















elective	 abortions.	 These	 samples	 came	 from	 the	 Royal	 Infirmary	 Hospital	

















were	 counted	 in	 each	 tissue	 cross-section	 and	 this	 number	 was	 then	 expressed	
relative	to	the	total	surface	area	of	seminiferous	tubules	in	those	sections.	This	was	
done	to	correct	differences	in	testis	tissue	size/composition	between	cultures.	Two	
different	 ratios	 were	 calculated:	 total	 GC	 number	 and	 the	 ratio	 of	 the	 specific	
subpopulation	of	gonocytes	(AP2!+).	The	results	obtained	were	analysed	by	two-way	







1st	 trimester	 cultured	 ovaries	 were	 immunostained	 for	 AP2!,	 to	 detect	 GCs	 and	
Hoechst	 as	 a	 counterstain.	 Fetal	 ovarian	 GCs	 do	 not	 express	 MAGE-A4	 and	
therefore	it	cannot	be	used	as	a	GC	development	marker.	Another	difference	from	
the	testis	is	that,	unlike	males,	fetal	ovaries	do	not	develop	cords.	Fetal	ovarian	









A	 7	 days	 high	 dose	 paracetamol	 (350mg/kg	 daily)	 was	 also	 studied	 using	 the	
xenograft	model.	 	Samples	were	 fixed	and	 immunostained	 in	 the	same	way	as	1st	
trimester	 fetal	 testis	 cultures.	 The	 number	 of	 AP2!+	 and	MAGE-A4+	GC	was	 then	
















a	 general	 loss	 of	 GC	 as	 a	 consequence	 of	 the	 culture,	 independent	 of	 treatment	
effects,	when	the	cultured	samples	were	compared	to	the	pre-culture	control	tissue		
Figure	 4.1.	 Effect	 of	 analgesic	 exposure	 on	 apoptosis	 in	 human	 fetal	
gonads.	Apoptosis	as	a	consequence	of	analgesic	exposure	was	studied	in	3	different	
systems:	1st	trimester	fetal	testis	(A-C)	and	ovary	(D-F)	cultures,	and	2nd	trimester	
fetal	 testis	 xenografts	 (G-I)	 exposed	 to	 human	 relevant	 doses	 of	 paracetamol	 or	
ibuprofen.	 Representative	 images	 from	 the	 tissue	 are	 shown.	 Tissue	 was	





































Figure	 4.2.	 Effect	 of	 human	 fetal	 gonad	 culture	 or	 xenografting	 on	 GC	
survival.	 The	 number	 of	 GC	 as	 a	 consequence	 of	 human	 gonad	 culture	 or	
xenografting	was	studied	in	3	different	systems:	1st	trimester	fetal	testis	(A	and	
B)	and	ovary	 (C	and	D)	culture,	and	2nd	trimester	 fetal	 testis	xenografts	 (E-F).	
Pregraft	controls	(A,	C	and	E)	were	compared	with	vehicle	(B,	D	and	F).	Testicular	
tissue	was	 immunostained	for	SOX9	(Sertoli	cells	-	red),	AP2γ	 (GC	-	green)	and	







Paracetamol	 exposure	 significantly	 reduced	 the	 ratios	 of	 total	 GC	 number	 and	
gonocyte	number	relative	to	the	total	surface	area	of	seminiferous	tubules	in	those	




were	 infrequent	 at	 this	 early	 stage	 of	 gonad	 development	 and,	 therefore,	 the	
number	 of	 cells	 expressing	 MAGE-A4	 was	 insufficient	 to	 perform	 a	 meaningful	
statistical	analysis.		
	
To	 investigate	 possible	 explanations	 for	 the	 analgesic-induced	 decrease	 in	 GC	
number	after	paracetamol	or	ibuprofen	exposure,	I	focused	on	increased	apoptosis	
or	 reduced	 proliferation	 as	 possible	 causes.	 As	 mentioned	 above,	 apoptosis	 was	
studied	 by	 fluorescence	 immunohistochemistry	 using	 cleaved	 caspase	 3,	 a	 well-
known	marker	of	apoptosis.	However,	the	presence	of	apoptotic	cells	was	minimal	
in	 all	 the	 samples	 studied,	 including	 samples	 exposed	 to	 analgesics	 (Figure	 4.3).	
Therefore,	proliferation	was	studied	by	co-immunostaining	1st	trimester	testis	and	
ovary	cultures	for	Ki-67	and	both	GC	markers.	Proliferative	GC	were	defined	as	GC	
expressing	 Ki-67	 and	 one	 of	 the	 GC	 markers.	 Cultured	 testis	 samples	 showed	 a	
























testis	 tissue	 section	 from	 a	 vehicle-exposed	 sample,	 triple-immunostained	 for	 the	
proliferation	marker	Ki67	 (red),	AP2γ	 (green)	and	MAGE-A4	 (blue).	White	arrows	 refer	 to	
proliferative	GC	showing	double	staining	for	Ki67	and	AP2γ	(upper	panel)	or	MAGE-A4	(lower	
panel).	Quantification	of	the	%	of	proliferative	(Ki67+)	AP2γ+	GC	from	the	different	treatment	





































with	samples	exposed	 to	vehicle.	The	effect	of	 the	analgesics	on	 the	different	GC	
subpopulations	 was	 also	 studied.	 The	 AP2!+	 GC	 subpopulation	 was	 significantly	















(7-day	 paracetamol)	 or	 3	 fetuses	 (ibuprofen),	 all	 within	 14-17	 gestational	 weeks,	 were	
xenografted	into	nude	mice.	Host	mice	were	administered	vehicle,	paracetamol	(20mg/kg	
x3	per	day)	or	ibuprofen	(10mg/kg	x3	per	day)	for	7	days	before	xenograft	recovery.	Tissue	
was	 fixed	 and	 triple-immunostained	 for	 SOX9	 (Sertoli	 cells	 -	 red),	 AP2γ	 (GC	 -	 green)	 and	
MAGE-A4	 (differentiated	 GC	 -	 blue)	 as	 depicted	 in	 panels	 A-C.	 Individual	 data	 points	
represent	GC	counts	from	a	single	tissue	piece	(replicates)	in	panel	panels	D	and	E	for	7-days	
paracetamol	exposure,	panels	F	and	G	for	ibuprofen	exposure.	Each	n	number	is	expressed	
as	a	different	 fetus	 (X-axis),	 together	with	the	mean	±	SEM	for	each	fetus/treatment;	 the	
overall	mean	±	SEM	for	each	treatment	group	is	also	shown	(Total)	together	with	the	results	












4	 fetuses	 (7-day	paracetamol)	or	3	 fetuses	 (ibuprofen)	were	xenografted	 into	nude	mice.	
Host	 mice	 were	 administered	 vehicle,	 paracetamol	 (20mg/kg	 x3	 per	 day)	 or	 ibuprofen	
(10mg/kg	 x3	 per	 day)	 for	 7	 days	 before	 xenograft	 recovery.	 Tissue	was	 fixed	 and	 triple-
immunostained	for	Ki67	(proliferating	cells)	and	MAGE-A4	(subpopulations	of	GCs).	MAGE-














human	 testis	 tissue	 xenografts	 on	 germ	 cell	 proliferation.	 Testis	 tissue	 pieces	
(~1mm3)	from	4	fetuses	(7-day	paracetamol)	or	3	fetuses	(ibuprofen),	all	within	14-
17	 gestational	 weeks,	 were	 xenografted	 into	 nude	 mice.	 Host	 mice	 were	
administered	vehicle,	paracetamol	(20mg/kg	x3	per	day)	or	ibuprofen	(10mg/kg	x3	
per	 day)	 for	 7	 days	 before	 xenograft	 recovery.	 Tissue	 was	 fixed	 and	 triple-
immunostained	for	AP2γ,	MAGE-A4	and	the	proliferation	marker	Ki67.	Quantification	
of	the	%	of	proliferative	(Ki67+)	GC	(AP2γ+	or	MAGE-A4+)	from	paracetamol	exposed	
samples	 (replicates)	 is	 shown	on	panel	A.	Quantification	of	 the	%	of	 proliferative	
(Ki67+)	AP2γ+	GC	from	paracetamol	and	ibuprofen	are	shown	on	panels	B	and	C.	Each	
n	number	is	expressed	as	a	different	fetus	(X-axis),	together	with	the	mean	±	SEM	for	each	









































Figure	 4.8.	 Effect	 of	 a	 single	 daily	 exposure	 of	 2nd	 trimester	 fetal	 human	 testis	 tissue	
xenografts	to	high	dose	paracetamol	for	7	days	on	germ	cell	number.	Testis	tissue	pieces	







(Total)	 together	with	 the	 results	 of	 statistical	 analysis	 (2-factor	 ANOVA);	 *p<0.05,	 versus	
corresponding	vehicle-exposed	group.	











































































































































































































































































































































































mice	were	 administered	 1	 day	 vehicle	 or	 paracetamol	 (20mg/kg	 x3	 daily)	 before	
xenograft	recovery.	Tissue	was	fixed	and	triple-immunostained	for	SOX9	(Sertoli	cells	
-	red),	AP2γ	(GC	-	green)	and	MAGE-A4	(differentiated	GC	-	blue)	as	depicted	in	panels	
A	 and	 B.	 Individual	 data	 points	 represent	 GC	 counts	 from	 a	 single	 tissue	 piece	
(replicates)	in	panel	panels	C-E.	Each	n	number	is	expressed	as	a	different	fetus	(X-axis),	
together	with	the	mean	±	SEM	for	each	fetus/treatment;	the	overall	mean	±	SEM	for	










































































































































































































































































































































































































4.3.3 Effects	 of	 1	 day	 (first	 day)	 paracetamol	 exposure	 on	 GC	 in	 2nd	
trimester	human	fetal	testis	xenografts	
In	 the	 previous	 experiment	with	 1	 day	 paracetamol	 exposure,	 the	 samples	were	
collected	 immediately	 after	 the	 paracetamol	 dose.	 If	 any	 delayed	 effects	 of	 the	
paracetamol	exposure	occurred,	 these	may	not	have	been	evident	by	 the	 sample	
day.	To	address	this	possibility,	a	similar	experiment	with	paracetamol	exposure	for	
1	 day	 (20mg/kg	 x3)	 was	 performed,	 but	 in	 this	 case	 the	 mice	 were	 exposed	 to	
paracetamol	the	day	after	xenograft	establishment	(i.e.	7	days	after	xenografting),	


































Figure	 4.10.	 Effect	 of	 1	 day	 exposure	 (first)	 of	 2nd	 trimester	 fetal	 human	 testis	 tissue	
xenografts	 to	 paracetamol	 on	 germ	 cell	 number.	 Testis	 tissue	 pieces	 (~1mm3)	 from	 4	
fetuses,	 all	within	 14-17	 gestational	weeks,	were	 xenografted	 into	 nude	mice.	Host	mice	
were	administered	1	day	vehicle	or	paracetamol	(20mg/kg	x3	daily),	followed	by	6	days	of	
vehicle	 doses	 before	 xenograft	 recovery.	 Tissue	 was	 fixed	 and	 triple-immunostained	 for	
SOX9	 (Sertoli	 cells	 -	 red),	 AP2γ	 (GC	 -	 green)	 and	MAGE-A4	 (differentiated	 GC	 -	 blue)	 as	
depicted	in	panels	A	and	B.	Individual	data	points	represent	GC	counts	from	a	single	tissue	


















using	 a	 commercial	 ELISA	 (section	 2.7.).	 This	 revealed	 no	 difference	 in	 the	 PGE2	






(~1mm3)	 from	 4	 fetuses	 (8-11	 gestational	 weeks)	 were	 cultured	 for	 7	 days	 with	
















paracetamol	 or	 ibuprofen.	 Previous	 studies	 have	 focused	 on	 human	 fetal	 gonads	








Human	 fetal	 gonads	 cultured	 in	 hanging	 drops	 have	 already	 been	 described	
previously	 (Jorgensen	 et	 al.,	 2012).	 This	 model	 offers	 a	 relatively	 easy	 culturing	
method	in	which	the	different	cell	types	show	good	survival	and	the	overall	tissue	
















4.3.3 Reduction	 in	 GC	 number	 after	 analgesic	 exposure	 of	 fetal	 human	
gonad	tissue	in	hanging	drop	culture	
1st	trimester	testis	and	ovary	samples	were	cultured	using	the	hanging	drop	system	
and	exposed	 to	paracetamol	 and	 ibuprofen	 for	 7	days.	 In	 the	 testis,	 paracetamol	
exposure	 significantly	 reduced	 total	 GC	 number,	 but	 also	 the	 specific	 AP2!+	 GC	
subpopulation.	However,	 the	population	of	MAGE-A4+	GC	 in	1st	 trimester	was	too	
low	to	be	counted.	GC	stop	expressing	AP2!	and	start	expressing	MAGE-A4	during	
fetal	 gonad	 development,	 a	 process	 that	 starts	 during	 1st	 trimester	 and	 slowly	
continues	until	 the	end	of	 the	2nd	 trimester	 (Mitchell	et	al.,	 2008).	This	 transition	
between	 AP2!	 and	 MAGE-A4	 is	 asynchronous	 and	 cells	 at	 different	
developmental	stages	are	found	in	an	individual	seminiferous	cord	 (Mitchell	et	
al.,	 2010).	 	 As	 it	 was	 not	 possible	 to	 calculate	 the	 MAGE-A4+	 GC	 subpopulation	
number,	 the	 comparison	 of	 the	 trends	 among	 the	 different	 subpopulations	 in	 1st	
trimester	 samples	 cannot	 be	 done.	When	 focusing	 on	 ibuprofen,	 the	 treatment-
induced	reduction	in	GC	was	seen	only	for	the	AP2!+	GC	with	the	decrease	in	total	
GC	number	being	statistically	non-significant.	The	lack	of	significance	in	the	reduction	
of	 total	GC	number	after	 ibuprofen	exposure	might	be	a	 consequence	of	 the	 low	




The	 reduction	 in	 GC	 number	 seen	 in	 1st	 trimester	 fetal	 gonads	 exposed	 to	



















































ovary	 and	 testis,	 translating	 into	 different	 levels	 of	 effect	 on	 GC	 numbers.	 For	
example,	an	increase	in	retinoic	acid	can	advance	GC	meiosis	entry	(Le	Bouffant	et	
al.,	 2010;	 Baltus	 et	 al.,	 2006)	 and	 will	 therefore	 decrease	 the	 period	 of	 GC	
proliferation,	which	would	be	more	important	in	ovary	than	testis.	This	would	fit	with	





4.3.3 Reduction	 in	 GC	 number	 in	 fetal	 testis	 xenografts	 after	 analgesic	
exposure		



















day	 for	 the	 lower	dose,	and	 it	 is	 the	 latter	 that	more	closely	compares	 to	normal	
human	usage.	Previous	work	by	my	lab	also	showed	that	this	single	high	daily	dose	
of	 paracetamol	 did	 not	 affect	 testosterone	production	 in	 the	 host	mice,	whereas	
administration	 of	 the	 lower	 dose	 of	 paracetamol	 3	 times	 a	 day	 did	 significantly	







increased	 compared	 with	 1st	 trimester	 samples.	 None	 of	 the	 treatment	 regimes	
resulted	 in	a	 significant	decrease	 in	MAGE-A4+	GC	number,	however,	 there	was	a	










Regarding	 GC	 proliferation	 in	 2nd	 trimester	 human	 fetal	 testis	 xenografts,	 the	









for	 this	 experiment	 to	 show	 significance	 and	 that	 if	 the	N	number	was	 increased	
sufficiently,	 a	 significant	 decrease	 in	 the	 GC	 proliferation	 rate	 would	 be	 found.	
Moreover,	measuring	proliferation	 rate	at	a	 specific	 time	point	 is	 likely	 to	be	 less	
sensitive	than	measuring	actual	GC	number,	as	the	latter	is	a	compounded	effect	of	







different	 1	 day	 paracetamol	 regimes,	 but	 also	 to	 compare	 these	 with	 the	 7	 day	
paracetamol	exposure	group.	Paracetamol	use	by	pregnant	woman	 is	not	 regular	
and,	 in	most	women,	 the	 intake	 is	 likely	 to	 be	 for	 short	 periods	 (<24h).	 For	 this	
reason,	 I	 investigated	whether	 shorter	exposures	 (1	day)	 to	paracetamol	 can	also	
affect	 fetal	 GC	 number	 and/or	 proliferation	 using	 the	 2nd	 trimester	 human	 fetal	
testis	 model.	 The	 difference	 between	 the	 two	 1	 day	 paracetamol	 regimes	 is	
interesting	as	it	shows	how	the	effect	of	paracetamol	needs	a	longer	time	in	order	to	
have	an	effect	on	GC	number	and	it	is	not	an	instant	process.	This	is	consistent	with	
the	 effect	 on	 proliferation,	 because	once	GC	number	 is	 reduced	 (due	 to	 reduced	
proliferation),	 even	 if	 this	 is	 a	 small	 effect	 and	 initially	 ‘difficult	 to	 detect’,	 this	






concern	 about	 paracetamol	 exposure,	 because	 it	 is	 quite	 common	 for	 pregnant	
women	to	take	paracetamol	in	this	way.	Nevertheless,	my	analysis	also	showed	that	







total	 GC	 number	 and	 a	 58%	 reduction	 in	 AP2!+	 GC	 number.	 The	 most	 logical	
explanation	for	this	difference	in	the	scale	of	effect	is	that,	if	the	effect	of	analgesics	
is	 to	 reduce	 the	 GC	 proliferation	 rate,	 then	 clearly	 the	 longer	 the	 exposure	 the	
greater	will	be	the	scale	of	the	effect.	There	might	be	more	complex	explanations,	
but	in	the	absence	of	direct	supporting	evidence,	those	possible	explanations	cannot	







4.3.3 Effect	 of	 analgesics	 on	 PGE2	 production	 by	 1st	 trimester	 human	
gonad	cultures	
Paracetamol	 and	 ibuprofen	 can	 alter	 the	 PG	 pathway.	 Previous	 publications,	





significant	 modification	 of	 the	 PGE2	 levels	 in	 the	 medium	 of	 1st	 trimester	 testis	
cultures	 after	 exposure	 to	 paracetamol	 or	 ibuprofen	 were	 not	 found.	 The	 PGE2	


















In	 this	 chapter	 I	 have	 shown	 and	 discussed	 the	 possible	 effects	 of	 analgesics	 on	
human	 fetal	gonads,	with	a	specific	 focus	on	GC.	The	results	 showed	how	human	
relevant	 doses/exposure	 regimens	 of	 paracetamol	 and	 ibuprofen	 consistently	
caused	reduced	GC	number	in	essentially	all	of	the	different	model	systems	used:	1st	
trimester	fetal	testis	and	ovary	exposed	to	7	days	paracetamol	or	ibuprofen	and	2nd	
trimester	 testis	 exposed	 to	 either	 1	 or	 7	 days	 paracetamol	 or	 7	 days	 ibuprofen.	
Moreover,	the	analgesic-induced	decrease	in	GC	seemed	to	be	more	specific	for	the	
gonocyte	 subpopulation,	 although	 this	 could	 be	 a	 reflection	 of	 their	 higher	
proliferation	rate	compared	with	pre-spermatogonia	(in	males),	which	seemed	to	be	





rate	seen	 in	2nd	 trimester	gonads	as	a	consequence	of	 the	presence	of	more	pre-
spermatogonial	cells,	which	are	less	proliferative	(Mitchell	et	al.,	2010).	A	decrease	
in	fetal	GC	number	can	have	different	consequences,	mainly	regarding	the	potential	










by	 these	 treatments	was	 compensated	 for	 postnatally,	with	no	 consequences	 for	
































models,	 such	 as	 qPCR,	 are	 not	 necessarily	 GC	 specific,	 but	 reflect	 the	 expression	
changes	of	the	whole	gonad.	For	that	reason,	a	more	tractable	system,	the	Ntera-2	
(NT2)	 cellular	 system	was	 used.	NT2	 is	 a	 human	embryonal	 carcinoma	 (germ	 cell	
tumour)	cell	line.	Despite	the	fact	that	NT2	cells	derive	from	adult	cells,	they	show	
many	 characteristics	 of	 fetal	 GC,	 including	 the	 expression	 of	 some	 fetal	 GC	
pluripotency	markers,	such	as	AP2γ	(Hoei-Hansen	et	al.,	2004).	The	widely	accepted	













Throughout	 this	 chapter,	 I	 will	 show	 and	 discuss	 the	 experiments	 performed	
exposing	 NT2	 cells	 to	 paracetamol,	 ibuprofen	 and	 EP2+EP4	 antagonists.	 The	
experiments	of	this	chapter	were	based	on	the	results	seen	with	the	rat	and	human	
models	in	the	previous	chapters	and	on	different	previous	studies	showing	some	of	




profile	 after	 the	 different	 treatments.	 Following	 the	 similar	 results	 seen	between	
EP2+EP4	antagonists	and	analgesics	on	fetal	rat	gonad	cultures,	another	main	focus	
was	 to	 study	 if	 the	 PGE2	 receptor	 antagonists	 could	 also	 mimic	 the	 effects	 of	











see	 if	 the	 phenotypes	 seen	 with	 paracetamol	 could	 be	 rescued.	 For	 the	 rescue	
analysis,	NT2	 cells	 (excluding	 vehicle)	were	 first	 exposed	 to	10μM	Butaprost	 (EP2	
agonist)	and	10nM	CAY10598	(EP4	agonist)	for	4h	before	the	medium	was	changed	


























using	Taqman	 technology	 to	 study	a	wide	variety	of	 genes	 including	pluripotency	



















in	 conjunction	 to	 paracetamol	 for	 48h	 before	 being	 counted.	 In	 this	 way,	 if	
paracetamol	is	acting	through	the	PGE2	pathway,	EP2+EP4	agonists	should	be	able	to	
protect	the	NT2	cells	from	the	paracetamol	effect.	NT2	cells	were	exposed	first	to	
EP2+EP4	 agonists	 for	 4h	 before	 media	 was	 supplemented	 with	 paracetamol.	




























Figure	 5.1.	 Effect	 of	 exposure	 of	 NT2	 cells	 to	 analgesics	 or	 prostaglandin	 E2-
receptor	modulators	on	cell	number.	NT2	cells	(2x105;	n=3-4)	were	cultured	for	48h	
in	 medium	 supplemented	 with	 either	 vehicle	 (Veh),	 paracetamol	 (10-50µM),	








***p<0.001,	 ****p<0.0001	 versus	 corresponding	 vehicle-exposed	 group.	 Panel	D	
















time	 of	 the	 end	 of	 the	 experiments	 was	 calculated	 and	 compared	 between	
treatments.	Cell	death	was	significantly	increased	by	both	doses	of	paracetamol	and	
EP2+EP4	antagonists	after	48h	exposure	(Figure	5.2).	However,	this	increase	in	cell	
death	was	quite	minor	with	 low	dose	paracetamol	 and	EP2+EP4	antagonists.	 The	
higher	dose	of	paracetamol	did	produce	a	considerable	increased	in	cell	death.		
	
Figure	 5.2.	 Effect	 of	 exposure	 of	 NT2	 cells	 to	 analgesics	 or	 prostaglandin	 E2-
receptor	modulators	on	 cell	death.	NT2	cells	 (105;	n=3)	were	 cultured	 for	48h	 in	
medium	supplemented	with	either	vehicle	(Veh),	paracetamol	(10-50µM),	ibuprofen	
(10µM)	 or	 EP2+EP4	 antagonists	 [EP-antags:	 10μM	 L-161,982	 (EP2	 antagonist)	 +	
10μM	 PF04418948	 (EP4	 antagonist)].	 The	%	 of	 NT2	 dead	 cells	 at	 the	 end	 of	 the	
experiment	for	each	treatment	is	shown	in	panels	A	–	C.	Graphs	show	means	±	SEM	
from	 three	 independent	 experiments	 with	 three	 replicates	 each	 and	 statistical	


















in	G0/G1,	 and	 cells	 in	 synthesis	 phase	have	 an	 intermediate	between	G0/G1	and	
G2/M.	Therefore,	Hoechst	staining	allows	distinction	of	the	cells	according	to	their	
cell	stage	depending	on	their	DNA	content.	With	this	method,	the	percentage	of	cells	
in	 each	 cell	 cycle	 stage	 (G0/G1,	 Synthesis	 or	 G2/M)	 was	 calculated	 using	 flow	
cytometry	and	the	BD	Facs	software	(section	2.6.7).		
	
The	 results	of	 these	analysis	 showed	differences	between	vehicle	 and	 treatment-
exposed	samples,	but	also	within	treatments.	NT2	cells	treated	for	48h	with	low	or	
high	doses	of	paracetamol	showed	a	decreased	percentage	of	cells	in	G0/G1,	shifting	
to	 synthesis	 (S)	 and	 especially	 to	 G2/mitosis	 (G2/M),	 when	 compared	 to	 vehicle	
(Figure	 5.3A).	 In	 contrast,	 Ibuprofen	 exposure	 of	 NT2	 cells	 did	 not	 produce	 any	

































Figure	 5.3.	 Cell	 cycle	 stage	 of	 NT2	 cells	 exposed	 to	 paracetamol,	 ibuprofen	 or	
EP2+EP4	 antagonists.	 NT2	 cells	 (2x105;	 n=3)	 were	 cultured	 for	 48h	 in	 medium	




from	 three	 independent	 experiments	 with	 three	 replicates	 each	 and	 statistical	




















(CCNE1),	 important	 in	 the	 formation	of	a	complex	with	cyclin	dependent	kinase	2	
(CDK2),	for	G1/S.	For	synthesis	phase,	the	expression	of	histone	cluster	1	H4	family	
member	4	(HIST1H4B)	and	ribonucleotide	reductase	regulatory	subunit	M2	(RRM2),	
which	 catalyzes	 the	 formation	of	 deoxyribonucleotides	 from	 ribonucleotides,	was	







doses	of	 paracetamol	 reduced	 the	expression	of	E2F2	 (borderline	 significance	 for	
high	dose),	 a	 gene	expressed	 in	G1,	 although	 it	 did	not	modify	 the	expression	of	







































cell	 cycle	 markers.	 	 NT2	 cells	 (105;	 n=3)	 were	 cultured	 for	 48h	 in	 medium	
supplemented	 with	 vehicle	 or	 paracetamol	 (10µM	 -	 LD	 para;	 50µM	 –	 HD	 Para).	
Results	 show	mRNA	expression	 relative	 to	 the	vehicle	complementary	DNA	 (open	
bars)	 after	 exposure	 of	 NT2	 cells	 to	 the	 different	 doses	 of	 paracetamol.	 (A)	
G1/Synthesis	markers	E2F2	and	CCNE1	and	the	Synthesis	phase	markers	HIST1H4B	
and	 RRM2.	 (B).	 G2	 marker	 CCNA2,	 G2/M	 markers	 CCNB1	 and	 BUB1	 and	 M/G1	
markers	RAD21	and	PPTG1.	 	Graphs	 show	means	±	 SEM	 from	 three	 independent	


























expression	 of	 cell	 cycle	 markers.	 	NT2	 cells	 (105;	 n=3)	 were	 cultured	 for	 48h	 in	






from	 three	 independent	 experiments	 with	 three	 replicates	 each	 and	 statistical	
















gestation	 resulted	 in	 premature	 loss	 of	 expression	 of	 the	 gonocyte	marker	 Oct4	
(Dean	et	al.,	2016).	It	was	therefore	investigated	if	NT2	cells	exposed	to	paracetamol,	
ibuprofen	 or	 EP2+EP4	 antagonists	 showed	 altered	 expression	 of	 established	 GC	
differentiation	markers,	 such	as	OCT4,	AP2γ	 or	NANOG	 (Rajpert-De	Meyts,	2006).	
Paracetamol	 exposure	 significantly	 reduced	 NT2	 expression	 of	 the	 pluripotency	
markers	 OCT4,	 AP2γ	 and	 NANOG	 (Figure	 5.6A).	 Ibuprofen	 led	 to	 a	 significant	
reduction	 in	OCT4	 expression,	 but	 did	 not	 modify	 expression	 of	 the	 rest	 of	 the	
pluripotency	markers	(Figure	5.6B).	Similar	to	paracetamol,	NT2	cells	cultured	with	




























were	 cultured	 for	 48h	 in	medium	 supplemented	with	 vehicle	 (Veh),	 paracetamol	
(Acet;	10-50µM),	ibuprofen	(Ibu;	10µM)	or	EP2+EP4	antagonists	[EP-antags	(10μM	L-
161,982;	EP2	antagonist	+	10μM	PF04418948;	EP4	antagonist)].	Results	show	mRNA	
expression	 relative	 to	 the	 vehicle	 complementary	 DNA	 (open	 bars)	 for	 the	 GC	
pluripotency	markers	OCT4,	AP2γ	and	NANOG	 (A-	C	and	E)	after	exposure	of	NT2	
cells	 to	 paracetamol	 (blue),	 ibuprofen	 (orange)	 or	 EP2+EP4	 antagonists	 (maroon)	
(n=3).	Graphs	show	means	±	SEM	from	three	independent	experiments	with	three	
replicates	each	and	statistical	analysis	was	by	2-factor	ANOVA;	*p<0.05,	**p<0.01,	









5.3.6. Effect	 of	 paracetamol,	 ibuprofen	 and	 EP2+EP4	 antagonists	 on	
expression	of	epigenetic	regulatory	genes	in	NT2	cells		
Previous	studies	by	this	lab	showed	inter-generational	consequences	as	a	result	of	


















expression	 of	 TET1	 was	 increased	 when	 NT2	 cells	 were	 cultured	 for	 48h	 with	
paracetamol,	 ibuprofen	 or	 EP2+EP4	 antagonists,	 while	 EZH2	 expression	was	 only	
increased	significantly	by	EP2+EP4	antagonists	(Figure	5.7A-C).	
		
Increased	 expression	 of	 TET1	 could	 result	 in	 increased	 recruitment	 of	 the	 PRC2	
complex,	 confirmed	by	 the	 increased	expression	of	EZH2.	 The	PRC2	complex	 is	 in	
charge	of	 trimethylating	 lysine	27	of	histone	3	 (H3K27me3).	 The	 increase	 in	TET1	
and/or	EZH2	seen	in	NT2	cells	after	exposure	to	paracetamol,	ibuprofen	or	EP2+EP4	






by	 ELISA	 (section2.7).	 H3K27me3	was	 significantly	 increased,	 relative	 to	 the	 total	






























the	 different	 treatments.	 Graphs	 show	 means	 ±	 SEM	 from	 three	 independent	











5.3.7. Effect	 of	 paracetamol,	 ibuprofen	 and	 EP2+EP4	 antagonists	 on	 the	
Wnt4/β-catenin	pathway	in	NT2	cells	
As	 explained	 in	 chapter	 1,	 the	Wnt4/β-catenin	 pathway	 is	 one	 of	 the	most	well-





















antagonists	on	mRNA	expression	of	WNT4	 and	β-CATENIN.	 	NT2	 cells	 (105;	 n=3)	
were	 cultured	 for	 48h	 in	medium	 supplemented	with	 vehicle	 (Veh),	 paracetamol	




(maroon)	 (n=3).	Graphs	 show	means	±	SEM	 from	 three	 independent	experiments	
with	three	replicates	each	and	statistical	analysis	was	by	2-factor	ANOVA;	*p<0.05,	














other	 effects	 seen,	 such	 as	 the	 decrease	 in	 cell	 number,	 change	 in	 cell	 cycle	 or	
decrease	 in	 pluripotency	 marker	 expression.	 Nonetheless,	 the	 other	 possible	
explanation	is	that	that	the	other	effects	seen	are	the	actual	cause	of	the	epigenetic	
modifications.	 Therefore,	 the	 PRC2	 complex	 was	 altered	 in	 NT2	 cells	 in	 order	 to	
compare	the	effects.	To	do	so,	NT2	cells	were	exposed	to	either	an	EZH2	(GSK-126)	














were	 exposed	 to	 the	 EZH2	 inhibitor.	 However,	 exposure	 to	 the	 JMJD3	 inhibitor	
modified	 the	 NT2	 cell	 cycle	 such	 that	 there	 was	 a	 significant	 increase	 in	 the	

































cells	 in	 the	different	 cell	 cycle	 stages	with	 the	different	 treatments.	Graphs	 show	
means	±	SEM	from	three	independent	experiments	with	three	replicates	each	and	

































For	 all	 these	 reasons,	 NT2	 cells	 provided	 a	 suitable	 human	 model	 to	 study	 the	





















chapter	4.	Moreover,	 these	 reductions	 in	NT2/GCs	as	a	 consequence	of	analgesic	
exposure	are	similar	 to	the	experiments	performed	 in	rodents,	 including	the	ones	
from	 this	 lab	 showing	 a	 decrease	 in	 fetal	GC	number	 after	 in	 utero	 exposure	 	 to	
paracetamol	or	 indomethacin	 in	rats	 (Dean	et	al.,	2016)	and	other	published	data	









ibuprofen	 or	 to	 EP2+EP4	 antagonists	 is	 not	 enough	 proof	 to	 confirm	 that	 both	





used	 to	 study	 the	 effect	 of	 paracetamol	 on	 NT2	 cell	 number	 and	 its	 possible	









Similar	 experiments	 using	 ibuprofen	 and	 EP2+EP4	 agonists	 were	 not	 performed.	
Ibuprofen’s	effect	on	the	PGE2	pathway	are	well	known	(Rainsford,	2003;	Burian	&	
Geisslinger,	2005),	but	even	if	it	is	reasonable	to	hypothesize	that	EP2+EP4	agonists	




example	 of	 mechanistic	 differences	 between	 both	 analgesics.	 Hence,	 whether	
EP2+EP4	 agonists	 can	 rescue	 the	 NT2	 cell	 reduction	 by	 ibuprofen	 should	 be	
addressed	in	future	experiments.		
	
5.4.3. Paracetamol,	 ibuprofen	 and	 EP2+EP4	 antagonists	 affect	 NT2	 cell	
death	
The	reduction	 in	NT2	cell	number	as	a	consequence	of	paracetamol,	 ibuprofen	or	
EP2+EP4	 antagonist	 exposure	 can	 derive	 mainly	 from	 two	 different	 reasons:	 an	
increase	in	cell	death	or	a	decrease	in	cell	proliferation.	In	my	experiments,	among	








that	 paracetamol	 at	 this	 concentration	 is	 probably	 detrimental	 to	 NT2	 cells.	 This	







to	 the	 lower	 dose	 of	 paracetamol,	 exposure	 to	 EP2+EP4	 antagonists	 caused	 a	
significant	increase	in	NT2	cell	death,	but	again,	such	a	small	change	that	it	seems	
unlikely	 to	 explain	 the	 reduction	 in	 NT2	 cells	 seen	 after	 exposure	 to	 EP2+EP4	
antagonists.		
	
5.4.4. NT2	 cell	 cycle	 is	 affected	by	paracetamol,	 ibuprofen	 and	 EP2+EP4	
antagonists		
Following	the	logic	from	the	previous	section	in	explaining	the	decrease	in	NT2	cell	
number	 after	 exposure	 to	 paracetamol,	 ibuprofen	 or	 EP2+EP4	 antagonists,	 if	 it	
cannot	be	explained	by	an	increase	in	cell	death,	the	reduction	in	NT2	cell	number	


































first	 difference	 between	 paracetamol	 and	 ibuprofen.	 The	 reasons	 for	 these	
differences	can	be	many,	starting	with	the	different	pathways	that	these	analgesics	
are	altering.	This	is	especially	relevant	in	the	case	of	paracetamol,	where	regardless	
of	 the	 multiple	 researches	 performed,	 its	 exact	 effect	 on	 cells	 is	 still	 unclear	
(Anderson,	2008).	
	


















is	a	complex	type	of	study.	With	the	 information	obtained,	 it	 is	difficult	to	discuss	
why	 not	 all	 the	 studied	 genes	 followed	 the	 expected	 patterns.	 Nonetheless,	 all	
together,	the	study	of	the	cell	cycle	by	specific	markers	reinforces	the	hypothesis	of	
arrested	 NT2	 cells	 in	 G2/M	 phases	 as	 a	 consequence	 of	 culturing	 them	 in	 the	
presence	of	paracetamol.		
	
The	 comparison	 of	 studies	 on	 cell	 cycle	 by	 qPCR	 as	 a	 consequence	 of	 EP2+EP4	
antagonists	also	revealed	differences	when	compared	with	paracetamol.	When	NT2	
cells	were	exposed	to	EP2+EP4	antagonists	for	48h,	only	HIST1H4B	was	significantly	














et	 al.,	 2016).	 A	 recent	 publication	 has	 also	 shown	 that	 ibuprofen	 reduced	 the	
expression	of	germ	cell	pluripotency	markers	such	as	OCT4	and	LIN28	in	fetal	human	
testis	explants	(Ben	Maamar	et	al.,	2017).	Moreover,	the	studies	of	this	thesis	also	

























analgesics	 are	 accelerating	 normal	 fetal	 GC	 development,	 as	 has	 been	 suggested	
before	 (Dean	et	al.,	2016),	 this	could	decrease	the	final	pool	of	GC	present	 in	 the	
gonads.	Because	of	the	lack	of	proliferation	in	female	GCs	after	the	maximum	peak	
















analgesics	on	pluripotency	markers	was	 studied	 in	NT2	 cells,	 a	GC	 cell	 line,	 these	
results	 could	 show	an	alternative	 link	between	analgesics	and	TGCC	and	 it	 is	 that	
these	 drugs	 might	 have	 some	 efficacy	 in	 the	 treatment	 of	 TGCC.	 However,	 the	
present	results	should	be	complemented	with	more	specific	studies	to	evaluate	this	
other	option,	 such	as	 culture	of	TGCC	samples	with	paracetamol	or	 ibuprofen,	or	






the	 expected	 results.	 Both	 paracetamol	 and	 ibuprofen	 significantly	 increased	 the	
expression	of	TET1	in	NT2	cells,	although	the	expression	of	EZH2	was	not	modified.	


















of	 exposing	 GC	 to	 analgesics.	 This	 is	 the	 first	 experiment	 showing	 an	 actual	
interaction	 between	 analgesics	 and	 the	 epigenetic	 machinery	 in	 GCs.	 The	




identified	 in	 fetal	 GC	 during	 their	 pluripotent	 phase	 (Lesch	 &	 Page,	 2014).	 It	 is	
established	that	the	process	of	permanent	switching	specific	genes	either	on	or	off	
via	H3K27me3	is	a	part	of	normal	fetal	GC	development	(Sachs	et	al.,	2013;	Lesch	et	













using	 NT2	 cells	 reinforce	 the	 hypothesis	 that	 analgesics,	 and	 PGE2,	 affect	 the	















The	 consequences	 of	 alterations	 in	 the	 Wnt4/β-catenin	 pathway	 are	 difficult	 to	
address,	particularly	with	the	present	results	showing	just	a	small	reduction	in	gene	
expression	and	no	demonstration	that	these	effects	altered	protein	expression	level.	
Complete	deletion	of	Wnt4	 has	been	 related	 to	 trans-differentiation	of	 granulosa	
cells	 into	Sertoli	cells	(Lavery	et	al.,	2012;	Nicol	&	Yao,	2015).	In	a	human	context,	
mutations	in	WNT4	are	usually	associated	with	a	spectrum	of	disorders	affecting	the	




The	 decrease	 in	 NT2	 cell	 number	 after	 48h	 exposure	 to	 an	 EZH2	 inhibitor	 was	




they	 showed	an	 increase	 in	H3K27me3	and	a	decrease	 in	proliferation.	 Following	
these	results,	cell	proliferation	(i.e.	cell	number	after	culture)	might	be	regulated	by	
H3K27me3	 (and	hence,	analgesic	 treatments),	 although	 these	 results	 seen	 in	NT2	
cells	exposed	 to	analgesics	 could	be	completely	 independent.	However,	based	on	
these	 studies,	 if	 cell	 proliferation	 is	 negatively	 controlled	 by	 H3K27me3,	 then	
inhibition	of	EZH2	should	decrease	H3K27me3	and	increase	proliferation,	producing	
an	effect	contrary	 to	 that	of	paracetamol,	 ibuprofen	or	EP2+EP4	antagonists.	This	














already	 be	 at	 a	 peak	 of	 proliferation	which	 cannot	 be	 increased	 further	 by	 PGE2.	
Furthermore,	if	GC/NT2	cell	proliferation	is	being	driven	by	PGE2,	it	implies	that	this	
drive	 is	 already	maximal.	 	Nonetheless,	NT2	 cells	 showed	a	 small	 decrease	 in	 cell	
number	when	exposed	to	an	EZH2	inhibitor,	but	this	decrease	was	not	supported	by	





The	 inhibition	 of	 JMJD3	 should	 stop	 the	 demethylation	of	H3K27me3	 and	hence,	
maintain	or	increase	the	levels	of	this	histone	marker.	If	proliferation	is	negatively	
controlled	 by	 PRC2/	 H3K27me3,	 the	 JMJD3	 inhibitor	 should	mimic	 the	 effects	 of	
analgesics	 and	 the	 EP2+EP4	 antagonists;	 the	 finding	 that	 the	 JMJD3	 inhibitor	 did	
decrease	 NT2	 cell	 number	 is	 thus	 consistent	 with	 this	 prediction.	 However,	 the	
decrease	in	cell	number	when	NT2	cells	were	exposed	to	JMJD3	inhibitor	was	much	
greater	than	with	the	analgesics	or	the	PGE2	receptor	antagonists,	and	its	effect	may	
have	 been	 as	 a	 result	 of	 inducing	NT2	 cell	 death.	 In	 this	 respect,	 its	 effect	 could	
perhaps	 be	 equated	 with	 that	 of	 high	 dose	 paracetamol	 which	 also	 caused	 a	
substantial	increase	in	NT2	cell	death,	similar	to	that	seen	after	exposure	to	a	JMJD3	
inhibitor,	although	the	possibility	of	non-specific	toxicity	by	such	exposure	cannot	be	





exposure	 to	 high	 dose	 paracetamol	 (cells	 shifted	 to	 the	 G2/M	 phase)	 and	 the	
exposure	to	the	JMJD3	inhibitor	(cells	shifted	to	the	G0/G1	phase).	It	is	difficult	to	
compare	 the	 concentration	 of	 JMJD3	 inhibitor	 with	 the	 action	 that	 paracetamol,	
ibuprofen	and	EP2+EP4	antagonists	might	have	on	PRC2	activity.	However,	previous	























patterns	 of	 response	 to	 analgesic	 exposure	 as	 did	 the	 other	 rat	 and	 human	 fetal	
gonad	models	used.	The	decrease	 in	NT2	cell	number	 in	response	to	paracetamol	






pluripotency	 gene	 expression	 after	 analgesic	 exposure,	 similar	 to	 that	 shown	 in	
previous	studies	in	rats	(Dean	et	al.,	2016)	and	in	human	(Ben	Maamar	et	al.,	2017).	




Moreover,	 all	 of	 the	 analgesic-related	 modifications	 seen	 in	 NT2	 cells	 could	 be	
reproduced	by	inhibiting	the	PGE2	pathway	by	EP2+EP4	antagonists.	Prevention	of	
the	paracetamol-induced	decrease	 in	NT2	cell	number	by	EP2+EP4	agonists	 is	 the	
final	evidence	to	highlight	the	hypothesis	that	the	majority	of	the	effects	induced	by	
paracetamol	and	 ibuprofen	on	 fetal	GCs	are	a	consequence	of	 their	effect	on	 the	
PGE2	pathway.	However,	the	differences	in	the	cell	cycle	studies	after	exposure	to	

















The	 aims	 of	 this	 thesis	 were	 to	 establish	 the	 consequences	 of	 exposure	 to	
paracetamol,	ibuprofen	and	indomethacin,	often	taken	by	pregnant	women	(Jensen	
et	al.,	2010;	Philippat	et	al.,	2011;	Werler	et	al.,	2005),	in	fetal	gonads.	Within	fetal	




seen	 as	 a	 consequence	 of	 analgesic	 exposure,	 were	 a	 reduction	 in	 GC	 number	
(probably	 via	 reduced	 proliferation),	 and	 reduction	 in	 gene	 expression	 of	 GC	
pluripotency	 markers	 and	 of	 factors	 involved	 in	 regulation	 of	 the	 epigenetic	
machinery.		
	
Different	models	 were	 used	 in	 this	 thesis,	 including	 human	 and	 rat	 systems.	 Rat	
models	entailed	in	utero	exposure	to	analgesics	(paracetamol	or	indomethacin),	or	
hanging	 drop	 fetal	 gonad	 cultures,	 which	 were	 optimized	 as	 part	 of	 this	 thesis.	










The	 experiments	were	performed	on	 gonads	 exposed	 in	 utero	 to	paracetamol	 or	
indomethacin	 with	 a	 developmental	 age	 between	 e15.5-e17.5.	 These	 studies	













The	expression	of	other	genes	affected	by	 in	vivo	exposure	 to	analgesics	 in	e17.5	
testes	was	studied,	including	Foxo3,	Notch2,	Epiregulin,	EGFR	and	Inha,	 	which	are	
involved	 in	 normal	 GC	 development	 (Feng	 et	 al.,	 2014a;	 John	 et	 al.,	 2008;	 Xu	 &	
Gridley,	2013).	Moreover,	changes	in	Wnt4	expression	were	also	found,	a	key	factor	





results.	 Further	 analysis	 using	 ovarian	 samples	 should	 be	 done	 to	 address	 this	
possibility.		
	
As	explained	 in	detail	 in	 section	3.4.3,	alterations	 in	expression	of	Foxo3,	Notch2,	
Epiregulin,	 EGFR	 and	 Inha,	 could	 have	 detrimental	 effects	 on	 normal	 GC	
development	or	produce	GC	loss	(Castrillon	et	al.,	2003;	Hsieh	et	al.,	2007;	Romero	











(Lavery	 et	 al.,	 2012).	 In	 the	 fetal	 testis,	Wnt4	 is	 expressed	 at	 low	 levels	 but	 its	
complete	 inhibition/ablation	 affects	 testis	 formation,	 decreased	 proliferation	 and	
increased	apoptosis	of	male	GC	(Boyer	et	al.,	2012;	Das	et	al.,	2013).	In	this	context,	
one	of	 the	 factors	 for	 sex	determination	during	 fetal	development	 is	 another	PG,	
PGD2.	Translocation	of	SOX9	to	the	nucleus	in	NT2	cells	is	dependent	on	cAMP	and	




PGD2	 and	 PGE2	 have	 differentiated	 roles	 in	 cell	 function.	 However,	 may	 of	 the	
pathways	they	affect	are	similar,	such	as	the	modification	in	cAMP	and	PKA	(Ricciotti	









these	 results	 is	 that	 the	 analgesic-induced	 modifications	 in	 specific	 pathways	 of	
gonad/GC	development	are	not	dramatic,	and	hence	it	is	difficult	to	find	definitive	
consequences	or	detrimental	effects	resulting	from	the	altered	expression	of	these	












rat	 ovaries	 and	 testes	 (Dean	 et	 al.,	 2016).	 Another	 publication	 reported	 similar	
reduction	 in	 ovarian	 GC	 number	 after	 mice	 were	 exposed	 to	 different	 doses	 of	
paracetamol	in	utero	(Holm	et	al.,	2016).	However,	the	results	of	this	thesis	are	the	
first	to	reveal	a	similar	effect	of	analgesics	on	GC	number	in	human	fetal	gonads.	The	










human	 fetal	 testis	 GC	 (Mitchell	 et	 al.,	 2010).	 GC	 number	 reduction	 seen	 in	 2nd	
trimester	 human	 fetal	 xenografts	 as	 a	 consequence	 of	 paracetamol/ibuprofen	
exposure	was	most	 pronounced	 for	 the	 AP2γ+	 gonocytes	 compared	 to	 the	more	
differentiated	 pre-spermatogonia	 (MAGEA4+),	 suggesting	 a	 possible	 effect	 of	
analgesics	targeted	to	a	specific	GC	subpopulation.	Furthermore,	NT2	cells,	which	are	
more	akin	to	gonocytes	than	to	pre-spermatogonia,	showed	a	similar	reduction	in	





analgesic	 exposure	 is	 a	 decrease	 in	 cell	 proliferation.	 This	 was	 further	 studied	








different	 treatments.	 The	 lack	 of	 a	 statistically	 significant	 reduction	 in	 GC	
proliferation	after	analgesic	exposure	of	2nd	trimester	samples	may	be	due	to	the	low	
number	 of	 experimental	 replicates	 in	 these	 experiments.	 Another	 possible	
explanation	for	the	differences	in	the	reduction	of	proliferation	found	between	1st	




The	 study	 of	 changes	 in	 cell	 proliferation	 in	 the	NT2	model	 as	 a	 consequence	 of	
analgesic	exposure	was	performed	by	studying	their	cell	cycle.	These	results	showed	
important	 differences	 in	 cell	 cycle	 behaviour	 between	 NT2	 cells	 exposed	 to	
paracetamol,	ibuprofen	or	EP2+EP4	antagonists,	revealing	that	paracetamol	seemed	
to	 arrest	 NT2	 cells	 in	 the	 G2/M	 phase,	 which	 could	 explain	 the	 reduction	 in	 cell	
number	after	paracetamol	exposure,	while	 ibuprofen	did	not	show	any	difference	
and	EP2+EP4	antagonists	reduced	the	number	of	cells	in	G2/M.	Further	studies	on	
the	 expression	 of	 markers	 for	 the	 cell	 cycle	 stages	 confirmed	 that	 paracetamol	
exposure	of	NT2	cells	increased	the	expression	of	markers	of	G2/M	and	decreased	








in	 NT2	 cell	 number,	 demonstrate	 the	 robust	 nature	 of	 the	 effect,	 raising	 the	
possibility	 of	 similar	 effects	 of	 analgesics	 on	 fetal	 GC	 in	 human	 pregnancy.	 A	
reduction	in	GC	number	in	fetal	gonads	is	relevant	because	the	majority	of	pregnant	






studies	 by	 this	 lab	 showed	 how	 a	 reduction	 in	 GC	 number	 in	 rats	 during	 fetal	
development	as	a	consequence	of	analgesic	exposure,	reduced	adult	ovary	weight	
and	the	fertility	of	females,	measured	by	pups	per	litter,	yet	no	effect	was	seen	in	
males	 (Dean	 et	 al.,	 2016).	 This	 is	 probably	 because	 female	 GC	 can	 no	 longer	
proliferate	after	their	entry	into	meiosis,	which	happens	from	week	9	of	gestation	in	
humans	 (Bendsen	 et	 al.,	 2006;	 Gondos	 et	 al.,	 1986),	 meaning	 that	 GC	 reduction	




after	 birth	 as	 well	 as	 from	 puberty	 	 through	 to	 adulthood,	 while	 female	 GC	
proliferation	is	stopped	during	fetal	development	(Kocer	et	al.,	2009;	Tingen	et	al.,	
2009);	it	seems	likely	that	a	similar	male-female	difference	would	apply	in	humans.	












An	 important	aim	of	 the	 research	of	 this	 thesis	was	 to	 study	 the	mechanisms	via	
which	 analgesics	 affected	 GCs.	 The	 mechanism	 studied	 in	 this	 thesis	 was	 the	














to	PGE2	 receptor	antagonists	 for	48h,	which	 resulted	 in	a	 similar	 reduction	 in	cell	





GC/NT2	numbers	 and	gene	expression	 changes.	Regarding	 the	 latter,	 the	present	
results	 have	 shown	 that	 PGE2	 antagonism	 induced	 similar	 gene	 expression	
modifications	in	NT2	cells	as	analgesics	induced	in	both	rat	(fetal	gonad	cultures	and	
in	vivo)	and	human	(NT2	cells).	The	effect	of	PGE2	in	regulating	GC/NT2	proliferation	






Focusing	 on	 other	 well-known	 effects	 of	 PGE2	 on	 different	 cell	 types,	 GC/NT2	















pluripotency	 marker	 expression	 including	OCT4	 and	 LIN28A	 (Ben	Maamar	 et	 al.,	
2017).	
	
The	 consequences	 of	 the	 analgesic-induced	 alteration	 in	 GC	 differentiation	 in	 a	
human	 context	 might	 be	 related	 to	 TGCC,	 the	 commonest	 malignancy	 amongst	
young	men,	as	arrested	fetal	GC	differentiation	is	now	accepted	to	be	the	primary	
cause	 (Mitchell	 et	 al.,	 2014).	 However,	 the	 reduction	 in	 GC	 pluripotency	 gene	
expression	as	a	consequence	of	analgesic	exposure	seen	in	NT2	cells	and	in	the	other	
models	 in	 published	 research,	 appears	 to	 be	 in	 the	 opposite	 direction	 to	what	 is	





earlier	 GCs	 (gonocytes)	 (Mamsen	 et	 al.,	 2011).	 If	 analgesics	 caused	 earlier	
differentiation	 of	 GCs,	 it	 could	 be	 a	 possible	 explanation	 for	 the	 reduction	 in	
proliferation	seen	in	human	fetal	GCs	as	a	consequence	of	paracetamol	or	ibuprofen	
exposure	and	the	consequential	 reduction	 in	GC/NT2	cells.	Moreover,	 this	 idea	of	
advanced	GC	development	as	a	consequence	of	analgesic	exposure	would	square	
well	 with	 the	 results	 suggesting	 that	 analgesics	 affect	 gonocytes	more	 than	 pre-
spermatogonia.	This	 is	because	a	 reduction	 in	proliferation	would	probably	affect	
more	the	gonocytes	subpopulation,	as	it	is	a	more	proliferative	cell	type.	However,	
this	should	also	be	addressed	in	future	experiments	by	studying	in	more	detail	the	





exposure.	 Moreover,	 a	 higher	 sample	 number	 would	 help	 to	 clarify	 differences	
between	 the	 reductions	 in	 proliferation	 comparing	 gonocytes	 and	 pre-
spermatogonial	GCs.	
	
My	 studies	 also	 focused	 on	 specific	 pathways	 of	 action	 potentially	 affected	 by	
analgesics	 (and	potentially	 by	 PGE2).	 These	 showed	 that	mRNA	expression	 of	 the	
specificity	proteins	Sp1	 and	Sp2	were	modified	 in	 fetal	gonads	by	paracetamol	or	
indomethacin	exposure	in	vivo	in	the	rat	as	also	were	different	epigenetic	regulators,	
such	as	TET1,	EZH2,	DNMT3A	and	DNMT3B,	expression	of	which	was	modified	by	
paracetamol	 and	 ibuprofen	 or	 indomethacin	 in	 both	 the	 rat	 and	NT2	models.	 SP	
proteins	 are	 involved	 in	 the	 regulation	 of	 a	 wide	 variety	 of	 genes	 related	 to	
fundamental	cellular	processes,	 including	cell	growth,	apoptosis	or	differentiation.	
Moreover,	SP	proteins	are	gene	specific,	cell	specific	and	are	known	to	regulate	some	





















and	EZH2	 expression	when	 rat	 fetal	 gonad	cultures	or	NT2	 cells	were	exposed	 to	
EP2+EP4	antagonists.	TET1	and	EZH2	are	both	epigenetic	regulators	related	to	the	
PRC2	complex,	and	hence	increased	expression	of	these	genes	should	in	theory	result	
in	 an	 increased	 presence	 of	 the	 histone	 methylation	 marker	 H3K27me3;	 this	
hypothesis	 was	 confirmed	 in	 further	 experiments	 in	 NT2	 cells	 exposed	 to	
paracetamol,	ibuprofen	or	to	EP2+EP4	antagonists.	At	least	one	earlier	publication	
had	 already	 related	 PGE2	 action	 to	H3K27me3	 (Arosh	 et	 al.,	 2015).	However,	 the	
present	 studies	 are	 the	 first	 to	 show	 that	 analgesics/PGE2	 receptor	 inhibitors	 can	
modify	H3K27me3	in	a	fetal	GC-like	cell	type.	It	is	now	fully	accepted	that	H3K27me3	







The	 expression	 of	 other	 epigenetic	 regulatory	 genes	 potentially	 modified	 by	
analgesics	or	PGE2	antagonists,	 such	as	 the	methyltransferases	enzymes	DNMT3A	
and	DNMT3B,	was	also	analysed.	The	expression	of	both	those	genes	was	decreased	


















other	 marker	 (H3K27me3)	 is	 increased,	 probably	 because	 both	 epigenetic	
modifications	are	markers	of	gene	repression	(Hagarman	et	al.,	2013).	Alterations	in	







whereas	that	used	 in	 this	 thesis	 is	a	 fetal	GC-like	cell	 line.	Therefore	the	different	
results	 could	 be	 a	 reflection	 of	 the	 different	 cell	 types	 behaving	 differently	 to	
alterations	 in	 the	 PGE2	 pathway,	 although,	 so	 far,	 the	 modifications	 shown	 in	
different	publications	using	different	cell	types	after	altering	the	PGE2	pathway	have	
shown	 a	 high	 degree	 of	 agreement	 (Jones	 et	 al.,	 2010;	 Nandi	 et	 al.,	 2017;	
Sumpownon	et	al.,	2015;	Wang	et	al.,	2013;	Yun	et	al.,	2009;	2012).	The	findings	of	



















One	 important	 topic	 to	 discuss	 about	 the	 epigenetic	 modifications	 derived	 from	
analgesic	exposure	is	the	possibility	of	these	modifications	being	transmitted	to	the	




the	 previous	 studies	 by	my	 lab	 showing	 that	 the	 F2	 females	 derived	 from	 either	
females	 or	 males	 exposed	 to	 paracetamol	 while	 fetuses	 (F1),	 exhibited	 smaller	
ovaries	 and	 reduced	 follicle	 numbers	 during	 puberty	 and	 adulthood	 (Dean	 et	 al.,	
2016).	The	results	of	that	publication	were	not	truly	inter-generational,	as	only	the	




models	 easier	 for	 transgenerational	 studies,	 such	 as	 C.	 Elegans	 or	 Drosophila	






The	 findings	 shown	 in	 this	 thesis	 can	 only	 be	 viewed	 as	 providing	 circumstantial	
support	for	the	possibility	that	analgesics	might	induce	epigenetic	modifications	in	
fetal	GC	 in	 human	pregnancy.	However,	 the	 similar	 results	 found	 in	 the	different	
model	systems	provide	methods	that	can	be	used	 in	the	future	to	 investigate	this	











The	studies	presented	 in	 this	 thesis	have	many	different	 limitations.	The	 first	and	
probably	most	important	one	is	that	none	of	the	models	accurately	recreates	in-vivo	
human	 conditions.	 The	 human	 xenograft	 and	 culture	 models	 recreate	 important	
















Leydig	 cell	 function	 and	 subsequently	 on	 testosterone	production.	GC	and	 Leydig	
cells	can	communicate	with	each	other	(Spradling,	Fuller,	Braun,	&	Yoshida,	2011),	







potential	 to	have	 indirect	effects	on	other	gonadal	cell	 types.	 In	that	sense,	other	
possible	 studies	 that	 could	 be	 done	 using	 the	 human	 fetal	 gonad	 samples	 is	 the	
analyses	 of	 hormone	 production	 after	 analgesic	 exposure.	 This	 has	 been	 studied	
already	 in	previous	analyses	on	human	samples	 (Mazaud-Guittot	et	al.,	2013;	van	
den	Driesche	et	al.,	2015),	which	have	shown	a	decrease	in	testosterone	production	














to	discuss	 the	need	 for	 studies	of	girls	born	 to	mothers	 in	whom	analgesic	use	 in	






explore	 multiple	 endpoints	 in	 resulting	 offspring	 (male	 and	 female),	 from	
reproductive	to	behavioral,	etc.,	would	be	justified	and,	indeed,	looks	to	be	essential	










The	 studies	 shown	 in	 this	 thesis	 cover	 a	 broad	 spectrum	 of	 the	 study	 of	 the	
consequences	of	fetal	exposure	to	analgesics,	especially	focused	on	GCs.	This	thesis	
showed	important	results	confirming	that	at	least	some	of	the	phenotypic	changes	
described	 as	 a	 consequence	 of	 analgesic	 exposure	 of	 fetal	 gonads	 result	 from	
alterations	 in	the	PGE2	pathway.	Furthermore,	the	results	presented	here	showed	
that	 analgesics/PGE2	 can	 modify	 the	 GC	 pluripotency	 state	 and	 the	 epigenetic	












other	 regulators	 of	 the	 PRC2	 complex	 or	 either	 using	 the	 same	 inhibitors,	 but	 at	
different	concentrations.	Moreover,	a	deeper	analysis	should	be	done	to	see	what	
are	 the	effects	of	altering	H3K27me3	by	 studying	genes	 regulated	by	 this	histone	
repressive	 marker	 and	 investigating	 whether	 any	 alterations	 are	 produced	 by	
analgesic	exposure.	The	study	of	the	modifications	of	different	genes/pathways	as	a	
consequence	 of	 the	 alteration	 of	 H3K27me3	 could	 be	 investigated	 in	 different	
models.	 However,	 it	 should	 probably	 be	 started	 in	NT2	 cells,	 as	 they	 are	 a	more	
















source	 of	 information	 and	 would	 help	 to	 find,	 not	 only	 modified	 genes,	 but	
potentially	to	find	the	mechanisms	by	which	they	were	altered	as	well.	Any	identified	
genes/pathways	 could	 then	 be	 investigated	 in	 the	 human	 fetal	 gonad	
culture/xenograft	models	 and	 /or	 in	 vivo	 in	 rats	 to	 see	whether	 or	 not	 they	 are	
consistently	modified	by	analgesic	and/or	EP2/EP4	antagonist	exposure.	Moreover,	




so	far.	 It	would	be	 important	to	do	some	studies	to	 investigate	whether	analgesic	
exposure	 induces	modifications	at	 the	protein	 level	 that	would	correlate	with	 the	
gene	expression	changes	 shown	using	qPCR.	Another	valuable	 set	of	experiments	
would	be	 to	 rescue	analgesic	effects.	 	 The	use	of	EP2+EP4	agonists	 to	 rescue	 the	
decrease	in	NT2	cell	number	was	helpful	to	prove	the	role	of	the	PGE2	pathway	in	the	
effects	seen	after	paracetamol	exposure.	However,	it	should	also	be	investigated	if	
EP2+EP4	 agonists	 can	 rescue	 ibuprofen	 effects.	 Furthermore,	 studies	 on	 gene	
expression	should	be	done	to	see	if	EP2+EP4	agonists	could	rescue	the	modifications	





experiment	should	be	 repeated	 in	more	physiological	models,	 such	as	 the	human	
fetal	gonad	cultures	or	the	xenografts	model.	
	
In	 the	 same	 line	 of	 inquiry,	 another	 side	 of	 the	 research	 that	 would	 be	 worth	
exploring	 would	 be	 a	 deeper	 research	 on	 the	 human	 fetal	 testis	 xenograft	 to	
delineate	the	long-term	consequences	of	analgesics.	The	xenograft	model	offers	the	
possibility	of	exposing	the	gonads	for	1	week	to	an	analgesic	but	keeping	the	samples	
inside	 the	 host	mice	 for	 a	 longer	 period	 to	 study	 if	 the	 consequences	 (or	 which	
consequences)	of	 the	analgesic	exposure	are	 compensated	or	not	over	 time.	This	
would	be	 interesting	because,	as	 shown	 in	previous	experiments	by	my	 lab	 in	 rat	
models,	 the	 reduction	 in	 GCs	 in	 male	 fetuses	 produced	 by	 analgesics	 can	 be	
compensated	for	postnatally	(Dean	et	al.,	2016).	
	
The	 main	 focus	 of	 this	 thesis	 was	 the	 study	 of	 the	 consequences	 of	 analgesic	
exposure	 on	 fetal	 gonad	 development.	 However,	 some	 of	 the	 results	 revealed	
possible	therapeutic	use	of	the	analgesics	and	the	JMJD3	inhibitor.	As	shown	in	this	
thesis,	the	exposure	of	NT2	cells	to	paracetamol,	ibuprofen	or	EP2+EP4	antagonists	
resulted	 in	 a	 decrease	 in	 cell	 number	 and	 a	 decrease	 in	 the	 expression	 of	 GC	
pluripotency	 markers.	 Moreover,	 exposure	 to	 JMJD3	 inhibitor	 produced	 a	 high	
detrimental	effect	on	theNT2	cells.	These	experiments	 in	NT2	cells,	which	derived	
from	 TGCC,	 showed	 a	 possible	 use	 of	 these	 different	 exposures	 as	 a	 potential	
treatment	for	TGCC.	Using	the	hanging	drop	or	the	xenograft	systems,	TGCC	tissue	
could	be	exposed	 to	 analgesics,	 PGE2	 receptor	 antagonists	 or	 JMJD3	 inhibitors	 to	















well,	 such	 as	 changes	 in	 gene	 expression	 and	 modifications	 of	 the	 epigenetic	
regulatory	 machinery.	 These	 effects	 of	 analgesic	 exposure	 were	 robust,	 were	
conserved	among	the	different	rat	and	human	model	systems,	and	are	probably	a	
consequence	of	alterations	of	the	PGE2	pathway.	Even	if	these	results	can	probably	
be	 translated	 to	 human	 pregnancy,	 this	 has	 to	 be	 considered	 with	 caution.	
Nonetheless,	 the	 robust	 nature	 of	 the	 results	 of	 this	 thesis	 and	 the	 possible	
involvement	 of	 a	 conserved	 mechanism,	 support	 the	 recommendation	 of	 using	




for	 a	 range	 of	 effects	 of	 analgesics	 during	 pregnancy	 that	 have	 been	 reported	 in	
different	publications	during	 the	 last	decade	 (Hurtado-Gonzalez	&	Mitchell,	2017;	





for	 properly	 designed	 prospective	 studies	 in	 order	 to	 find	 more	 definitive	























































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































 CURRENTOPINION Analgesic use in pregnancy and male reproductive
development
Pablo Hurtado-Gonzalez and Rod T. Mitchell
Purpose of review
Male reproductive disorders are common and increasing in incidence in many countries. Environmental
factors (including pharmaceuticals) have been implicated in the development of these disorders. This review
aims to summarize the emerging epidemiological and experimental evidence for a potential role of in-utero
exposure to analgesics in the development of male reproductive disorders.
Recent findings
A number of epidemiological studies have demonstrated an association between in utero exposure to
analgesics and the development of cryptorchidism, although these findings are not consistent across all
studies. Where present, these associations primarily relate to exposure during the second trimester of
pregnancy. In vivo and in vitro experimental studies have demonstrated variable effects of exposure to
analgesics on Leydig cell function in the fetal testis of rodents, particularly in terms of testosterone
production. These effects frequently involve exposures that are in excess of those to which humans are
exposed. Investigation of the effects of analgesics on human fetal testis have also demonstrated effects on
Leydig cell function. Variation in species, model system, dosage and timing of exposure is likely to
contribute to differences in the findings between studies.
Summary
There is increasing evidence for analgesic effects on the developing testis that have the potential to impair
male reproductive function. However, the importance of these findings in relation to human-relevant
exposures and the risk of male reproductive disorders remain unclear.
Keywords
analgesics, male reproduction, NSAIDS, paracetamol, testis
INTRODUCTION
Development of the male reproductive system is
dependent on normal formation and function of
the testis during fetal life. Failure of normal develop-
ment may result in disorders that manifest in the
neonatal period (cryptorchidism and hypospadias),
or in adulthood (testicular cancer and poor semen
quality) [1,2&].
In humans, cryptorchidism occurs in 1–4.6% of
newborns, although it will often resolve naturally
leading to a prevalence of !1% at 1 year [3,4].
Cryptorchidism is associated with an increased risk
of testicular cancer, the commonest malignancy
amongst young men, which is believed to arise from
aberrant development of a population germ cells,
known as gonocytes, during fetal life [5]. Cryptorch-
idism is also associated with impaired spermatogen-
esis resulting in a 30–60% risk of infertility in
adulthood [6]. Hypospadias is also a relatively com-
mon disorder occurring in approximately 0.2–0.6%
of male newborns [7]. The term Testicular
Dysgenesis Syndrome is frequently used to describe
the association of these disorders as a result of events
that occur during fetal life and their relationship
with deficient androgen production or action [8].
Indeed, a critical period from embryonic day
(e)15.5–e18.5, known as the ‘‘masculinization pro-
gramming window’’ (MPW), has been described in
fetal rats during which reduction in androgen pro-
duction or action leads to the subsequent develop-
ment of cryptorchidism and hypospadias [9&&]. A
similar period of sensitivity has been postulated to
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REVIEW
occur in the first trimester in humans based in part
on the timing of divergence in anogenital distance
(AGD; an indicator of fetal androgen exposure)
between males and females [10].
These common male reproductive disorders
have increased in incidence over recent decades
indicating that in addition to genetic abnormalities,
environmental factors such as life style, diet, and
chemical (including pharmaceutical) exposures are
likely to play a role in their development [1,11&].
Recently, there has been an increasing literature on
the potential role of in utero exposure to analgesics,
including paracetamol and nonsteroidal anti-
inflammatory drugs (NSAIDS; e.g., ibuprofen or
aspirin), on male reproductive development. This
review will describe the emerging epidemiological
and experimental evidence in relation to analgesic
exposure and its potential effects on male reproduc-
tive development.
ANALGESIC USE DURING PREGNANCY
Women are generally advised to avoid taking medi-
cations during pregnancy where possible. However,
despite this, the majority of women take one or
more analgesics such as paracetamol or NSAIDS,
at some point during pregnancy [12]. A large Danish
study (n¼46,500) reported analgesic use in 55%
of pregnant women [13], whereas a US study
(n¼10,533) reported 65% of pregnant women used
paracetamol (15% in combination with ibuprofen)
[12]. A smaller (n¼895) French study reported an
even higher frequency of analgesic use (81%) in
pregnant women [14]. Furthermore, the overall con-
sumption of analgesics has increased significantly in
the majority of European countries during the past
20 years [15&]. These analgesics are able to cross the
placenta and hence have the potential to cause
direct effects on the fetus [16–18]. It is not ethical
to test the effects of analgesics on pregnant women
directly and hence the evidence for associations
between analgesic use during pregnancy and the
development of male reproductive disorders derives
from a combination of epidemiological and experi-
mental studies conducted largely over the past
two decades.
EPIDEMIOLOGICAL STUDIES RELATING TO
ANALGESIC EXPOSURE AND
DEVELOPMENT OF MALE REPRODUCTIVE
DISORDERS
Association between analgesic use and
cryptorchidism
A significant association between the overall use of
mild analgesics during pregnancy and cryptorchid-
ism in the offspring has been demonstrated in three
studies with adjusted odds ratio (OR) of 1.93 (con-
fidence interval [CI]: 1.03–3.62) [19&], 2.12 (CI:
1.17–3.83) [20], and 2.30 (CI: 1.12–4.73) [21&&].
Another study did not demonstrate a significant
association (OR: 1.1; CI: 0.31–3.6) [14] (Table 1).
In two of the studies that demonstrated an associ-
ation this only reached statistical significance for
analgesic use during the second trimester with no
significant association during the first trimester
[20,21&&]. Interestingly, Kristensen et al. describe
data on two separate Scandinavian populations.
The significant associations were restricted to the
Danish cohort, whereas in the Finnish cohort, there
were no statistically significant associations [13].
Differences between cohorts may relate to variations
in methodology, prevalence of cryptorchidism, or
study power. Duration of exposure may also be
important with a significant association between
prolonged (>2 weeks) use of mild analgesics during
pregnancy (includes first and second trimester) and
cryptorchidism (OR: 2.47; CI: 1.02–5.96) [21&&].
Several of these studies have also investigated the
effects of specific agents on the development
of cryptorchidism.
Paracetamol exposure and risk of
cryptorchidism
Three studies investigating associations between
paracetamol use during pregnancy and cryptorchid-
ism have described adjusted OR>1.0; however,
these do not reach statistical significance (Table 1)
[13,19&,20]. In one of these studies, exposure during
the second trimester was significantly associated
with cryptorchidism (OR: 1.89; CI: 1.01–3.51),
similar to their results for mild analgesics overall
[20], whilst this was not the case in the other studies
KEY POINTS
# Analgesics are used by the majority of women
during pregnancy.
# Use of mild-analgesics during pregnancy has been
associated with an increased risk of cryptorchidism in
some studies.
# Exposure to analgesics results in Leydig cell effects in a
number of experimental animal models of fetal
testis development.
# The importance of human-relevant in-utero exposures to
analgesic in relation to male reproductive health
remains to be determined.
Androgens
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[13,21&&]. Timing of exposure is also likely to be
important based on the evidence for an MPW in
rodents, postulated to occur between 8 and 14 weeks
in humans [9&&]. Analysis of data from 8 to 14 weeks
demonstrated a hazard ratio (HR) of 1.14 (0.97–
1.34), which was significant for exposure>4 weeks
duration; OR: 1.38 (CI: 1.05–1.83) [13]. A second
study also demonstrated a significant association
OR: 2.78 (1.13–6.84) following prolonged (>2
weeks) exposure to paracetamol, similar to that
described for mild analgesics in general [21&&].
Again, this association was restricted to the Danish
and not the Finnish cohort.
NSAID exposure and risk of cryptorchidism
The association between cryptorchidism and
exposure to NSAIDS, for example, ibuprofen and
aspirin, has also been investigated (Table 1)
[13,20,21&&]. No significant associations were dem-
onstrated for overall use of ibuprofen or aspirin
during pregnancy [13,21&&]. However, Kristensen
et al. [21&&] demonstrated a significant increase in
cryptorchidism following exposure to ibuprofen
(OR: 4.59; CI: 1.10–19.0) and aspirin (OR: 3.76;
CI: 1.15–12.3) during the second trimester. A
similar significant association between exposure
specifically during the second trimester has also
been demonstrated in relation to ‘‘other’’ analgesics
(i.e., analgesics excluding paracetamol) [20].
These results may indicate the importance of
simultaneous use of more than one analgesic during
pregnancy. The use of $ 2 agents was associated with
a significant increase in the risk of cryptorchidism
(OR: 7.72; CI: 2.09–28.6) in one study [21&&], whilst a
second study did not demonstrate a significant
association (OR: 1.07; CI: 0.82–1.40) [13].
Association between analgesic exposure and
risk of hypospadias
The majority of studies investigating analgesic use
during pregnancy and the incidence of hypospadias
have not shown significant associations (Table 1)
[20,22,23&]. A study assessing analgesic exposure
from one month prior until 4 months after con-
ception showed a significantly increased risk of
hypospadias for ibuprofen (OR: 1.20; CI: 1.00–
1.30), whereas no association was reported for para-
cetamol or aspirin [24]. Another study reported a
significant association between the use of aspirin
and hypospadias (OR: 3.5; CI: 1.4–8.8) [25].
Analgesic exposure and anogenital distance
Cryptorchidism and hypospadias are associated
with a reduction in androgen production or action
during fetal life [9&&]. AGD has been shown to be a
reliable and robust measure of fetal androgen
exposure in rodents [13,20,21&&] and reduced AGD
has been associated with cryptorchidism and hypo-
spadias in humans [26,27]. It should be emphasized
that measurement of AGD in humans can be tech-
nically challenging and it is important that those
performing the measurements are sufficiently
skilled to avoid inter- and intra-observer bias. A
recent study investigated 1027 mother-child pairs,
recruited from 10 to 27 weeks of gestation, to deter-
mine the association between analgesic exposure in
mothers and AGD in the offspring at 3 months of
age [28&&]. No association was found between
exposure to paracetamol or NSAID and AGD; how-
ever, exposure to a combination of paracetamol and
‘‘other’’ analgesics (including NSAIDS) was associ-
ated with reduced AGDAS (ano-scrotal AGD; 32.3 vs.
36.2 mm; P ¼0.03) but not for AGDAP (ano-penile
AGD) which may relate to technical issues in con-
ducting these measurements. In addition, this group
included relatively small numbers (n¼20). Further
investigation of the association between AGD and in
utero exposure to analgesics are warranted.
Taken together, the epidemiological evidence
indicates that there may be an association between
in utero exposure to analgesics, particularly during
the second trimester, and cryptorchidism. The evi-
dence for such an association with hypospadias is
less convincing. There are a number of limitations to
these studies relating to obtaining accurate infor-
mation regarding the dosage, timing, and duration
of analgesics exposure. This is particularly import-
ant for retrospective studies in which recall bias is a
potential limitation [19&,20].
EXPERIMENTAL STUDIES RELATING TO
ANALGESIC EXPOSURE AND
DEVELOPMENT OF MALE REPRODUCTIVE
DISORDERS
Effect of analgesics on Leydig cell function in
the fetal testis
Testicular descent requires the action of two hor-
mones produced by Leydig cells, namely testoster-
one and Insulin-like growth factor 3 (Insl3) [29&].
Several studies have investigated the effect of anal-
gesic exposure on Leydig cell function in the fetal
testis. This includes in vivo, ex-vivo and in vitro
model systems of paracetamol (Table 2) and NSAID
(Table 3) exposure using rodent and human tissues.
Analgesics and testosterone production
Testosterone production can be measured directly
(e.g., serum or intratesticular) or indirectly (e.g.,
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AGD). Paracetamol exposure has been linked to
a reduction of fetal testicular testosterone pro-
duction in several studies [21&&,30&&,31] (Table 2).
In-vivo exposure of fetal rats to paracetamol
(350 mg/kg/d) during the MPW significantly
decreased AGD by up to 10% in late fetal life
[21&&,30&&], whereas another study only demon-
strated a significant effect on AGD (15% reduction)
at 10 weeks postnatally with no effect at 4, 6, or
8 weeks [32&]. One of these studies also described
a significant reduction (40%) in intratesticular
testosterone and in mRNA expression of two key
steroidogenic enzymes (CYP17a1 and CYP11a1)
indicating a potential mechanism for the effect on
steroidogenesis [30&&]. Another study in rats did not
demonstrate an effect of exposure during this time-
window on AGD at birth, although there was an
effect of exposure to a chemical ‘‘mixture’’ that






Tesosterone Aspirin Rat In vivo 7 200 GD13 # (!60%)b Kristensen et al. 2011 [21]
In vitro 1 10 mmol/L e14.5 # (!70%) Kristensen et al. 2011,2012 [21,31]
Human In vitro 3 100 mmol/L 8–10 GW  Mazaud-Guittot, 2013 [34]
In vitro 3 1 mmol/L 10–12 GW $ Mazaud-Guittot et al. 2013 [34]
Indomethacin Rat In vivo 3 0.8 e15.5 $ Dean et al. 2013 [36]
In vitro 1 10 mmol/L e14.5 # (!30%) Kristensen et al. 2012 [31]
Human In vitro 2 10 mmol/L 8–12 GW " (!20%) Mazaud-Guittot et al. 2013 [34]
AGD Aspirin Rat In vivo 7 250 GD13 $ Kristensen et al. 2011 [21]
In vivo 3 150 GD11 # (!20%) Gupta and Goldman, 1986 [35]
Indomethacin In vivo 3 1 GD11 # (!20%) Gupta and Goldman, 1986 [35]
In vivo 3 0.8 e15.5 $ Dean et al. 2013 [36]
Insl3 Aspirin Human In vitro 3 10 mmol/L 8–12 GW $ Mazaud-Guittot et al. 2013 [34]
Indomethacin In vitro 3 10 mmol/L 8–12 GW $ Mazaud-Guittot et al. 2013 [34]
For significant effects ("/#), the result shown represents the minimum dose and shortest duration showing significance. For nonsignificant effects ($), the highest
dose and longest duration is shown. e, embryonic day; GD, gestational day; GW, gestational weeks.
aDoses are given by mg/kg/day unless otherwise stated.
bOnly significant after 3 h incubation (150 mg/kg/d—no significant effect).






Testosterone Rat In vivo 7 350 GD13 $ Kristensen et al., 2011 [21]
In vivo 3 350 e13.5 # (!40%) van den Driesche et al., 2015 [30&&]
In vitro 2 1 mmol/L e14.5 # (!50%) Kristensen et al., 2011 [21]
In vitro 2 1 mmol/L e14.5 # (!25%) Kristensen et al., 2012 [31]
Human In vitro 1 10 mmol/L 8–12 GW $ Mazaud-Guittot et al., 2013 [34]
Xenograft 7 60 14–20 GW # (!50%) van den Driesche et al., 2015 [30&&]
AGD Rat In vivo 7 150 GD13 # (!10%) Kristensen et al., 2011 [21]
In vivo 6 350 GD13 $ Axelstad et al., 2015 [33]
In vivo 3 350 e13.5 # (!10%) van den Driesche et al., 2015 [30&&]
Mouse In vivo 13 150 GD7 # (!15%) Holm et al., 2015 [32&]
INSL3 Rat In vivo 3 350 e13.5 $ van den Driesche et al., 2015 [30&&]
In vitro 3 100 mmol/L e14.5 $ Kristensen et al., 2012 [31]
Human In vitro 3 10 mmol/L 10–12 GW # (!40%) Mazaud-Guittot et al., 2013 [34]
For significant effects ("/#), the result shown represents the minimum dose and shortest duration showing significance. For nonsignificant effects ($), the highest
dose and longest duration is shown. e, embryonic day; GD, gestational day; GW, gestational weeks.
aDoses are given by mg/kg/day unless otherwise stated.
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included paracetamol [33]. In vitro studies have also
demonstrated analgesic effects during the MPW.
Exposure of e14.5 rat fetal testis to 1 mmol/L para-
cetamol for 48 h resulted in a 15–50% reduction in
testosterone with significant reductions described
across a range of doses (0.5–10 mmol/L) at 72 h,
whereas a similar approach using culture of human
fetal testis (8–12 weeks gestation) did not demon-
strate any effect on testosterone production follow-
ing exposure to 10 mmol/L for 24, 48, or 72 h [34&&].
One study has investigated the effect of exposure to
a therapeutic regimen (60 mg/kg/d) of paracetamol
(60 mg/kg/d) on human fetal testis (14–20 weeks
gestation) xenografts. In this study 7 day exposure
to paracetamol significantly reduced seminal vesicle
(androgen dependent organ) weight (18% reduction)
and serum testosterone (45% reduction) in the cas-
trate nude mice hosts compared to vehicle controls,
whilst a similar effect did not occur following a
shorter (1 day) exposure [30&&]. Differences between
the results of the two studies using human fetal testis
may relate to the different gestational ages or alter-
natively may reflect differences in model system.
Similar studies have been performed using
NSAIDs. In vivo studies have demonstrated a sig-
nificant reduction in AGD (!20% reduction) in
males exposed to aspirin (150 mg/kg/day) or indo-
methacin (1 mg/kg/day) from GD11 to 14 [35],
whereas no reduction in AGD was found in similar
studies involving exposure during the MPW in rats
[21&&,35], although in one of these studies testoster-
one production was reduced in the case of aspirin
[21&&] but not indomethacin [36]. However, in vitro
rat fetal testis studies have demonstrated a reduction
in testosterone production following 24 h exposure
to aspirin (70% reduction; 10 mmol/L) and indome-
thacin (30% reduction; 10 mmol/L) from e14.5
[21&&,31]. These findings contrast with studies using
in vitro culture of human testis [34&&]. Exposure of
human fetal testis (8–12 GW) to indomethacin for
48 h resulted in a significant increase in testosterone
(!20%; 10 mmol/L). A similar increase was demon-
strated for aspirin exposure, although this was
restricted to 8–10GW, with no effect at 10–12GW
[34&&]. The reason for the discrepancy between the
effect of NSAID exposure on testosterone pro-
duction in the fetal rat and human testis is unclear
and may relate to the model systems or to genuine
species differences; however, this clearly illustrates
potential limitations of extrapolating effects in
rodent model systems directly into the human.
Analgesic exposure and Insl3 production
INSL3 is responsible for the first phase of testicular
descent and mutations in INSL3 gene may lead to
cryptorchidism in mice [37]. Paracetamol exposure
(350 mg/kg/d) did not result in a change in Insl3
mRNA in rat fetal testis following in-utero exposure
from e13.5 to e16.5 [30&&]. This was also the case for
Insl3 measured in the media following in vitro
culture of rat fetal testis (e14.5) for 72 h [31]. How-
ever, in human fetal (8–12GW) testis cultures
paracetamol (10 mmol/L; 72 h) exposure resulted
in a significant reduction in Insl3 production, whilst
no effect was observed following exposure to the
same concentrations of aspirin or indomethacin
[34&&].
Overall, the experimental studies suggest that
exposure to analgesics can result in effects on Leydig
cells in the fetal testis which may have the potential
to result in male reproductive disorders. Whilst this
conclusion is supported by the results of studies
utilizing human fetal testis tissue there remain some
important questions relating to the dose and
duration of exposure and the degree of hormonal
suppression that might be required to induce male
reproductive disorders in humans. In addition, the
mechanism by which analgesics might affect Leydig
cell function requires further elucidation.
Effect of analgesics on prostaglandins
Prostaglandins have been proposed to play a role in
mediating the effects of paracetamol exposure on
Leydig cell function. Culture of e14.5 fetal rat testis
showed a significant decrease in prostaglandin D2
(PGD2) after 24 h exposure to 1 mmol/L paracetamol
[21&&]. However, there were no significant
reductions across a range of doses (1–100 mmol/L)
for 24, 48, and 72 h in a subsequent study by the
same authors [31]. For human fetal testis (7–12
weeks) in vitro exposure to paracetamol (10 mmol/
L) for 72 h did not reduce prostaglandin D2 (PGD2)
production, but it did significantly reduce prosta-
glandin E2 (PGE2) [34&&].
For NSAIDS, the effect of exposure on prosta-
glandins appears to depend on the specific agent. A
dose dependent reduction in PGD2 after exposure to
aspirin was demonstrated in culture of e14.5 fetal rat
testis after 48 and 72 h [21&&]; however, this was not
confirmed in a subsequent study, with nonsignifi-
cant reductions only occurring at 100 mmol/L [31].
Similarly, for human fetal testis culture (7–12
weeks), no effect on PGD2 was observed following
aspirin (10 mmol/L) exposure. However, similar to
results for paracetamol there was a significant
reduction in PGE2 following aspirin exposure
[34&&]. For indomethacin, PGD2 was reduced follow-
ing in vivo and in vitro exposure of the fetal rat testis
during the MPW [21&&,36,38&&], which again was not
demonstrated in human fetal testis cultures [34&&].
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As with paracetamol and aspirin, exposure to indo-
methacin did result in a significant reduction in
PGE2, albeit this was restricted to 7–10 weeks of
gestation. Taken together, the present data relating
to the effect of analgesics on prostaglandins appear
to indicate variable effects on prostaglandins
dependent, at least in part to the specific agents
and the model species.
Effect of analgesics on germ cell
development and fertility
Recent studies have begun to focus on the potential
for analgesics to affect germ cell development and
fertility including inter-generational effects
[38&&,39&&]. Dean et al. investigated the effects of
exposure of pregnant rats to 350 mg/kg/day para-
cetamol or 0.8 mg/kg/day indomethacin, during a
period of gestation that includes the MPW. Pups
exposed to indomethacin (male and female) showed
!50% decreased GC number and a decreased gona-
dal weight at e21.5 [38&&]. For females, this resulted
in reduced fertility, as indicated by a reduced num-
ber of pups per litter, whereas in males no effect on
fertility was seen. For paracetamol exposure, there
was a similar effect on females with significant
reduction in germ cell number, gonadal weight,
and pups per litter [38&&], with effects on fertility
also described for female mice exposed to paraceta-
mol in-utero [39&&]. However, for males, despite an
overall reduction in germ cell number and gonadal
weight at e21.5, there was no significant effect on
fertility [38&&]. Investigation of the reduced germ cell
numbers in males revealed premature loss of gon-
ocytes following exposure to both paracetamol and
indomethacin. The loss of this proliferative popu-
lation of germ cells is likely to result in the reduced
germ cell number; however, this is compensated for
by early puberty [38&&]. Another study involving
paracetamol (50 mg/kg/d) exposure in mice (e7–
e13.5) showed no effect on male germ cells at
e13.5 or on germ cells or testicular weight in adult-
hood [32&]. The differences between the findings in
terms of the gonocyte population in fetal life may
relate to differences in species, paracetamol dose, or
timing of exposure.
Interestingly, recent studies have demonstrated
effects of analgesic exposure on the F2 generation of
rats exposed to paracetamol in utero. The F2 females
exhibited a significant reduction in ovarian weight
and in primordial follicle number at pnd25.
Remarkably, this was seen independent of whether
the F1 parent was male or female, raising the intri-
guing possibility that this may be as a result of
epigenetic modification of the germline in both
sexes [38&&].
These recent rodent studies demonstrate that
analgesic exposure can affect germ cell development
in the fetal testis; however, these findings need to be
reproduced in human studies, including epidemio-
logical and experimental approaches.
CONCLUSION
Over the past 5 years, several studies have investi-
gated the potential effect of analgesic exposure to
(paracetamol and NSAIDS) on the development of
male reproductive disorders. Epidemiological evi-
dence exists for associations between exposures to
several analgesics and the development of cryp-
torchidism. Experimental studies in rodents have
also demonstrated effects during fetal life on Leydig
cell function (including testosterone production)
and fertility. Recent in vitro and ex vivo (xenograft)
studies using human fetal testicular tissue have lent
support to the concept that analgesic exposure may
interfere with Leydig cell function in the fetal testis.
However, differences remain between the findings
of these studies that are likely to reflect variations in
species, model system, dosing schedule, and timing
of exposure. Further work is required to determine
the potential risk that analgesics may pose to human
reproductive health at human-relevant exposures.
Whilst the current evidence does not support a
definitive answer to this question, avoiding pain
or pyrexia is important for fetal health. With this
in mind, a pragmatic approach would be to use




Financial support and sponsorship
RTM is supported by a Wellcome Trust Intermediate





Papers of particular interest, published within the annual period of review, have
been highlighted as:
& of special interest
&& of outstanding interest
1. Gabrielsen JS, Tanrikut C. Chronic exposures and male fertility: the impacts of




Bonde JP, Flachs EM, Rimborg S, et al. The epidemiologic evidence linking
prenatal and postnatal exposure to endocrine disrupting chemicals with male
reproductive disorders: a systematic review and meta-analysis. Human
Reproduction Update 2017; 23:104–125.
Meta-analysis describing effects of prenatal and postnatal exposure to endocrine
disruptors on male reproduction.
Analgesic use in pregnancy and male reproductive development Hurtado-Gonzalez and Mitchell
1752-296X Copyright ! 2017 Wolters Kluwer Health, Inc. All rights reserved. www.co-endocrinology.com 231
3. Radmayr C, Dogan HS, Hoebeke P, et al. Management of undescended
testes: European Association of Urology/European Society for Paediatric
Urology Guidelines. J Pediatr Urol 2016; 12:335–343.
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In light of growing evidence that analgesic exposure during pregnancy can target the fetal 
gonads, including germ cells (GC) in rodents, we investigated whether therapeutically relevant 
doses of acetaminophen and ibuprofen affect GC development in the human fetal testis and 
ovary using in vitro (hanging drop culture) and xenograft model systems. We show that in 
fetal gonad culture the presence of analgesic reduces AP2γ+ (gonocyte) GC number in both 1st 
trimester fetal testes (22-28% reduction) and ovaries (43-49% reduction). Exposure of 
xenografted 2nd trimester fetal testes to 1 or 7 days acetaminophen led to reductions of 17% 
and 30%, respectively in AP2γ+ GC number. To determine mechanism of action, a human GC 
tumor-derived cell line (NT2) that exhibits fetal GC characteristics was used. This revealed 
that exposure to analgesics or prostaglandin E2 (PGE2) antagonists similarly reduced NT2 cell 
number, and PGE2 agonists prevented acetaminophen-induced cell loss. Both analgesics and 
PGE2 antagonists reduced expression of GC pluripotency genes and altered expression of key 
genes that regulate DNA and histone methylation in NT2 cells. Similar gene expression 
changes were induced in rat fetal testis/ovary cultures as well as in vivo after acetaminophen 
exposure of pregnant rats, demonstrating translatability of in vitro findings to in vivo and 
across species. Our results demonstrate robust GC/NT2 cell effects of analgesics, involving 
PGE2 pathways, and raise concerns that similar effects might occur following analgesic use in 





Analgesics are used by the majority (55-80%) of pregnant women at some point during 
pregnancy (1-3). This primarily involves use of ‘mild’ analgesics, such as acetaminophen 
(paracetamol) and ibuprofen (a non-steroidal anti-inflammatory drug; NSAID), which are 
available without medical prescription (3, 4). Acetaminophen and NSAIDS are able to cross 
the placenta into the fetal circulation and as a result have the potential to affect fetal 
development (5-8). 
  
Epidemiological studies suggest that fetal exposure to analgesics has adverse effects on the 
male reproductive tract by consistently identifying an association between analgesic use 
during pregnancy and an increased risk of cryptorchidism in their sons (1, 2, 9-11). Testicular 
descent is under the influence of testosterone produced by the Leydig cells of the fetal testis, 
and experimental studies have shown that the analgesics, acetaminophen, ibuprofen and 
aspirin all reduce testosterone production by the fetal testis in the rat (10, 12, 13).   More 
limited studies using human fetal testis tissue from relevant periods of gestation also 
demonstrate effects of acetaminophen exposure on hormone (including testosterone) 
production (13, 14). 
  
Suboptimal androgen production or action during fetal life is associated with the development 
of the common male reproductive disorders cryptorchidism and hypospadias, but also with 
risk of testicular germ cell cancer and effects on fertility (15). Consequently, more recent 
studies have investigated analgesic exposure during pregnancy in relation to fetal germ cell 
(GC) development and later reproductive function in rodents (16, 17). Modifications in fetal 
GC might not only affect the future reproductive potential of the exposed fetus, but can 
potentially be passed on to affect future generations. In experimental rat studies, gestational 
exposure to indomethacin or acetaminophen reduced fetal GC number by 40-50% in both 
sexes, with demonstrable consequences for adult fertility in females (16). Moreover, it was 
shown that such fetal exposure to analgesics leads to abnormal ovarian development and 
function in the second generation, an inter-generational effect that was transmitted via both 
paternal and maternal lines (16). It is hypothesized that such effects are indicative of 
epigenetic changes to the GC as a consequence of analgesic exposure in fetal life (16), but this 
has not so far been investigated. 
  
	 4	
One potential mechanistic pathway that might link analgesics and epigenetic alterations is the 
prostaglandin (PG) pathway, through which acetaminophen, indomethacin (an NSAID) and 
ibuprofen all act. Somatic and germ cells in the fetal gonads of both sexes in rats and humans 
are sources and targets of PGs as they express the PG-synthesizing COX2 enzyme and PGE 
receptors (16, 18). Numerous studies have shown that PGE2 exerts a range of effects on normal 
and cancerous cells, in vivo and in vitro. These include alterations in cell proliferation (19) 
and stem cell pluripotency (20, 21).  Changes in epigenetic markers, such as DNA and histone 
methylation, are also described and reported to be mediated by PGE2-induced changes in the 
expression of key epigenetic regulatory factors including DNA methyltransferases (DNMT3a 
and b) and enhancer of zeste homolog 2 (EZH2) (22-24). 
  
With this emerging background, the present study aimed to determine the effect of analgesic 
exposure, at therapeutically relevant levels, on GC number and pluripotency in the human 
fetal testis and ovary, to identify if this involves the PGE2 pathway, and whether it results in 
changes in expression of key epigenetic regulatory factors. We show that exposure to either 
acetaminophen or ibuprofen can reduce GC number in human fetal gonads. Further analysis 
in NTERA-2 (NT2) cells, a human embryonal carcinoma (germ cell tumour) cell-line, showed 
a reduced cell number after analgesics exposure and PGE2 receptor antagonists. Moreover, 
experiments on NT2 cells and in rats, both in vitro and in vivo, demonstrate consistent 
modifications in expression of genes involved in GC pluripotency and epigenetic regulation. 
We identify robust and species-independent GC effects of analgesics, which raise the 







The effect of common analgesics was studied in a variety of model systems in vitro and in 
vivo. The models and their specific treatment regimens are shown in Figure 1. 
 
Effects of 7-day acetaminophen or ibuprofen exposure on GC in hanging drop cultures 
of 1st trimester human fetal gonads  
Analgesic effects during pregnancy may depend on the gestational period (9, 10), so we 
investigated effects in both 1st and 2nd trimester fetal gonads. The effect of acetaminophen or 
ibuprofen exposure on GC during the 1st trimester was investigated using a hanging drop model 
(25), in which testis and ovary samples were exposed to vehicle or analgesic (acetaminophen 
or ibuprofen; both 10µM) for 7 days (Figure 1A). Cultured tissue pieces appeared healthy. 
Total GC number and the ratio of gonocytes to pre-spermatogonial subpopulations were 
calculated using activating enhancer-binding protein 2 (AP2!	or	TFAP2C;	gonocytes) and 
melanoma-associated antigen 4 (MAGE-A4; pre-spermatogonia) as GC markers, and sex 
determining region Y-box 9 (SOX9) to mark Sertoli cells (Figure  2A,B and C).  
 
Acetaminophen exposure significantly reduced total GC number (AP2!+ + MAGE-A4+) and 
the number of gonocytes (AP2!+) by 18% (P<0.001) and 28% (P<0.01) respectively (Figure 
2D and E). Although ibuprofen similarly reduced total GC number and AP2!+ GC, only the 
reduction in AP2!+ GC was statistically significant (22% reduction, P<0.01; Figure 2E). 
Presence of MAGE-A4+ GC was so infrequent in 1st trimester fetal testes that their numbers 
were insufficient to enable meaningful statistical analysis. Apoptosis was studied using and 
Cleaved caspase 3, but apoptotic cells were rarely identified across all treatments and 
therefore, quantification was not performed (Supplemental figure 1). 
 
As the reduced germ cell number in analgesic-exposed samples could not be explained by an 
increase in apoptosis, we used Ki-67 co-immunostaining (Figure 2F) to investigate whether 
altered GC proliferation was a possible explanation. Exposure to either analgesic resulted in 
a reduction in the proportion of proliferative AP2!+ gonocytes with a similar level of reduction 
for acetaminophen (22%, P<0.05) and ibuprofen (28%, P<0.05) (Figure 2G).  
 
For fetal ovary analyses, we followed a similar approach, staining AP2!+ GC and using 
Hoechst as a counterstain (Figure 3A,B and C); MAGE-A4 staining was not included since it 
is not a marker of ovarian GC differentiation. The number of AP2!+ GC was significantly 
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reduced (Figure 3D) by exposure to either acetaminophen (43% reduction; P<0.05) or 
ibuprofen (49% reduction; P<0.01). Ovarian AP2!+ GC proliferation was calculated in the 
same way as for fetal testes and revealed significant reductions in GC proliferation after 
culture with acetaminophen (25% reduction, P<0.01) or ibuprofen (35% reduction, P<0.01) 
(Figure 3E).  
 
Effect of 7-day acetaminophen or ibuprofen exposure on GC in 2nd trimester human fetal 
testis xenografts 
Second trimester testis tissue samples were xenografted into nude mice as described 
previously (13). Treatment of host mice with analgesics for 7 days (Figure 1B) led to a 
reduction in total GC number (AP2!+ + MAGE-A4+) for acetaminophen (38%; P<0.05; Figure 
4A) and ibuprofen (53%; P<0.05; Figure  4E), respectively, in comparison with vehicle–
treated hosts. In acetaminophen-exposed samples, this reduction appeared to result mainly 
from a decrease in the AP2!+ GC subpopulation (30% reduction, P<0.05; Figure 4B), and 
although a similar trend was evident for ibuprofen-exposed samples this was not statistically 
significant (Figure 4F).  The MAGE-A4+ GC subpopulation was not significantly modified by 
either of the analgesic treatments (Supplemental figure 2). Proliferation of total GC and AP2!+ 
GC did not show a significant reduction after acetaminophen or ibuprofen exposure 
(Supplemental figure 3). 
 
Effect of 1-day acetaminophen exposure on GC in 2nd trimester human fetal testis 
xenografts 
As acetaminophen usage in pregnancy is likely to be for short periods (≤24h), we investigated 
whether 1-day exposure to acetaminophen, followed by 6 days of vehicle treatment would 
affect GC number and proliferation in the xenograft model (Figure 1B). This exposure led to 
a significant reduction in total GC (22%; P<0.05) and AP2!+ GC number (17%; P<0.05) in 
xenografts (Figure 4C and D), although the reduction was less pronounced compared to 7-day 
acetaminophen exposure (Figure 4A and B). MAGE-A4+ GC number was not significantly 
altered by 1-day acetaminophen exposure (Supplemental figure 2). GC proliferation (total or 
AP2!+) showed a trend towards a reduction after 1 day exposure to acetaminophen, similar to 
that seen with 7 day exposure to acetaminophen and ibuprofen, but this was not statistically 
significant (Supplemental figure S3).  
 
Effects of acetaminophen, ibuprofen and EP2+EP4 antagonists on NT2 cell number  
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In view of the effects of analgesic exposure on GC number in human fetal testis tissue, we 
utilized a more tractable system to dissect possible mechanisms of analgesic action. We chose 
NT2 cells, a pluripotent human embryonal carcinoma cell line derived from an adult testicular 
GC cancer patient. Due to the fetal origin of testicular GC cancer, NT2 cells express markers 
of fetal GC, such as AP2! and hence they are commonly used as a fetal GC model (26). 
 
Ibuprofen/NSAIDs and acetaminophen can act via PG signaling pathways (27-29), including 
in the fetal rat ovary in which we have previously described effects of analgesic exposure on 
fetal GC number (16). Therefore, in addition to investigating the effects of acetaminophen and 
ibuprofen on NT2 cells, we also investigated whether blockade of PGE2 action via combined 
exposure to an EP2 (PF-04418948, 10µM) and an EP4 (L-161,982, 10µM) receptor 
antagonist, could induce effects similar to those of acetaminophen and ibuprofen. NT2 cells 
were exposed for 48h to different doses of acetaminophen (10-50µM), ibuprofen (10µM) or 
EP2+EP4 antagonists (10µM each; Figure 1C). All three types of exposures significantly 
reduced the number of NT2 cells after 48h (Figure 5A-C) suggesting that the analgesic-
induced decrease in NT2 cell number could involve inhibition of the PGE2 pathway. To test 
this, we cultured NT2 cells either with acetaminophen (10µM), with EP2+EP4 agonists 
(Butaprost 10μM + CAY10598 10nM) or with the two treatments combined (Figure 1C). 
Exposure to the EP2+EP4 agonists alone had no significant effect on NT2 cell number, 
whereas exposure to acetaminophen significantly reduced (P<0.05) cell number (Figure 5D). 
The effect of acetaminophen was completely prevented by co-culture with the EP2+EP4 
agonists, demonstrating that acetaminophen-induced NT2 cell loss involves an intact PGE 
signaling pathway (Figure 5D).   
 
Effects of acetaminophen, ibuprofen or EP2+EP4 antagonists on expression of GC 
differentiation markers in NT2 cells 
A previous study has shown that analgesic exposure of rats during gestation resulted in 
premature loss of expression of the gonocyte pluripotency marker octamer-binding 
transcription factor 4 (OCT4 or POU5F1) in the fetal testis (16). We therefore investigated 
whether in-vitro culture of NT2 cells with acetaminophen, ibuprofen or EP2+EP4 antagonists 
altered expression of the established GC pluripotency markers OCT4, AP2! and NANOG (30).  
Acetaminophen exposure significantly reduced expression of all three genes in NT2 cells 
(Figure 6A), while ibuprofen caused a significant reduction only in OCT4 expression (Figure 
6C). Culture of NT2 cells with EP2+EP4 antagonists also significantly reduced expression of 
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OCT4, AP2! and NANOG (Figure 6E) to a similar degree to that seen with acetaminophen 
exposure.  
 
Effects of acetaminophen, ibuprofen or EP2+EP4 antagonists on expression of epigenetic 
regulatory genes in NT2 cells 
Following previous studies showing inter-generational consequences of in utero 
acetaminophen/NSAID exposure in rats (16) and other evidence that PGE2 may fundamentally 
regulate the epigenetic machinery (22, 24), we hypothesized that exposure to acetaminophen, 
ibuprofen or EP2+EP4 antagonists might exert similar effects on epigenetic regulatory genes 
in NT2 cells. We focused on DNA and histone methylation. Thus, we studied expression of 
the DNA methyltransferases DNMT3a and DNMT3b, Ten-eleven translocation 1 (TET1), 
which plays a role in DNA and histone methylation, and EZH2 which is the enzymatic 
component of the polycomb repressive group 2 (PRC2) complex, in charge of adding the 
repressive H3K27me3 histone methylation mark.  
  
DNMT3a expression by NT2 cells was decreased by ibuprofen and unaffected by either 
acetaminophen, or EP2+EP4 antagonists, whereas DNMT3b expression was reduced after 
culture with acetaminophen or EP2+EP4 antagonists, but not by ibuprofen (Figure 6B,D and 
F). Conversely, expression of TET1 was increased when NT2 cells were cultured with 
acetaminophen, ibuprofen or EP2+EP4 antagonists, while EZH2 expression was only 
increased significantly by EP2+EP4 antagonists (Figure 6B,D and F). However, the relative 
amount of H3K27me3, as measured by ELISA, was significantly increased after culture of 
NT2 cells with acetaminophen, ibuprofen or EP2+EP4 antagonists (Figure 6G).  
 
In vivo and in vitro effects of acetaminophen, ibuprofen or EP2+EP4 antagonists on fetal 
rat gonads  
Having established that PGE2 is involved in mediating effects of analgesic on NT2 cell number 
and gene expression (and thus likely also for effects on GC number in human fetal gonads), 
we next investigated whether similar gene expression changes could be induced in vivo. As it 
is not possible to perform in-vivo human studies, we performed these studies in the rat, as we 
have already shown that analgesic exposure in pregnancy will reduce fetal GC numbers in 
both sexes (16). Initially, we confirmed the findings relating to the epigenetic regulatory genes 
using fetal rat ovarian or testicular tissue in hanging drop culture. Tissue pieces were cultured 
for 48h with or without exposure to acetaminophen (10μM), ibuprofen (10μM) or EP2+EP4 
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antagonists (10μM L-161,982 + 10μM PF04418948; Figure 1D). In fetal testes and ovaries, 
Tet1 expression was increased by all treatments while Ezh2 expression was significantly 
increased by acetaminophen and ibuprofen but not by EP2+EP4 antagonists in both testis and 
ovary cultures (Figure 7A-F), similar to that described for NT2 cells for TET1 (all treatments) 
and EZH2 (EP2/EP4 antagonists). Expression of Dnmt3b was significantly reduced by 
exposure to EP2+EP4 antagonists in both testis and ovary cultures (Figure 7C and F) whereas 
expression of Dnmt3a was only reduced in ovary cultures (Figure 7F);  
 
To provide in vivo evidence for the relevance of the identified gene expression changes 
induced by analgesics, we used pregnant rats, which were administered 350mg/kg 
acetaminophen (a human equivalent dose of ~60mg/kg based on calculation of body surface 
area) (31) by gavage once daily from e13.5 until the day before sampling (either e15.5 or 
e17.5) (Figure 1E), as described previously (16);. Similar to the in vitro culture studies, 
acetaminophen exposure in vivo significantly increased expression of Tet1 in both the fetal 
testis (e15.5 and e17.5; Figure 8A and B) and ovary (e15.5 only; Figure 8C and D), while 
Ezh2 expression was significantly increased only in e17.5 testes (Figure 8B) and e15.5 ovaries 
(Figure 8C). Acetaminophen exposure significantly reduced expression of Dnmt3a, but not 
Dnmt3b, in e15.5 ovaries (Figure 8C), consistent with in vitro findings already described 
(Figure 7F). 
Discussion 
Our results show that exposure to the analgesics acetaminophen and ibuprofen, used 
commonly by pregnant women, causes significant reductions in GC number in both human 
fetal testes and ovaries under our experimental test conditions, as well as altering expression 
of GC-differentiation markers and epigenetic regulatory genes in a consistent manner in NT2 
cells, a surrogate for fetal GC. The analgesic-induced reduction in GC number in the fetal 
testis was evident across the gestational range examined and could be induced even with a 1-
day treatment (acetaminophen only) at a human-relevant therapeutic dose. These results are 
important because the majority of women take at least one analgesic during pregnancy and 
previous studies in pregnant rats have shown that analgesic exposure can affect the future 
fertility of newborn females (16, 17). Our results also provide robust evidence that these 
effects of analgesics are likely to involve, or be mediated through the PGE2 pathway, and that 
one consequence of affecting this pathway is altered expression of a number of genes that play 
key roles in epigenetic regulation. This raises the possibility that analgesic exposure might 
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alter the epigenome of fetal GC, which could potentially affect the next generation, as 
previously demonstrated by in vivo studies in the rat (16).  
 
As direct translation of our earlier findings of adverse effects of analgesic exposure on fetal 
GC in the rat (16) to the human is not possible, we employed in vitro and ex vivo (xenograft) 
model systems using fetal testicular or ovarian tissue or NT2 cells. Despite their respective 
limitations, exposure to either acetaminophen or ibuprofen at human-relevant concentrations 
reduced GC/NT2 cell number in all of these systems. These findings are similar to those of 
previous studies in the rat and mouse that showed a decrease in GC number after analgesic 
exposure during pregnancy (16, 17).  In the human fetal testis, in culture (1st and 2nd trimester) 
or in xenografts (2nd trimester) the analgesic-induced reduction in GC number was most 
apparent for the AP2!+ gonocytes compared to the more differentiated pre-spermatogonia 
(MAGE-A4+), raising the possibility that the analgesic effect is targeted mainly to a specific 
fetal GC subpopulation. The AP2!+ GC in the human fetal testis are highly proliferative (32), 
and in keeping with this it appeared that analgesics most likely induced GC loss via reduced 
proliferation, although this is a tentative conclusion. In fetal human ovary cultures, the highly 
proliferative premeiotic oogonia (AP2!+) were similarly reduced in number following 
analgesic exposure. Analgesic targeting of AP2!+ GC may be related to the probable 
mechanism of analgesic action via PGE2, as discussed below, as the PGE2 pathway appears to 
be important in modulating proliferation of (pluripotent) stem cells in various other systems 
(19, 23, 33, 34).  
 
In the xenograft model, which has been shown to recapitulate normal human fetal testis GC 
development (32), AP2!+ GC number was significantly reduced by a single day’s exposure to 
acetaminophen using a human-relevant exposure regimen. Similarly, in the in vitro human 
fetal gonad cultures, reduction in GC number by analgesics occurred at concentrations in the 
lower range of	 levels reported in blood after normal human usage of acetaminophen or 
ibuprofen (14, 35, 36). Moreover, our findings that analgesic exposure induced similar levels 
of GC loss in the human fetal testis and ovary in each model system used, as well as causing 
similar GC loss in rats in fetal gonads after analgesic exposure in vivo (16), demonstrates the 
robust nature of the effect. This raises the possibility that analgesic use in human pregnancy 
will result in similar GC loss. The potential consequences of analgesic-induced fetal GC 
reduction in humans are unknown. In rats, fetal GC reduction in males can be completely 
compensated postnatally as the differentiated GC resume proliferation after birth (16), and it 
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is likely that this would also occur in human males. However, proliferation of GC in the human 
female is restricted by subsequent entry to meiosis, which occurs from 9 weeks gestation (37, 
38), so that any GC loss during or after this period could have long-term consequences for 
oocyte reserves and reproductive lifespan (39). In keeping with this, previous studies in 
pregnant rats showed that analgesic-induced decrease in fetal GC number translated into a 
decrease in adult ovarian weight and reduced fertility as indicated by a reduction in pups per 
litter after mating (16). This concern might be possible to address in humans by relating 
analgesic use in pregnancy to blood levels of anti-müllerian hormone (AMH) in resulting 
female offspring, as AMH levels are related to oocyte reserve under certain conditions (40). 
 
An important aim of our experiments was to establish a likely mechanism for the analgesic 
effects on fetal GC. Both analgesics have well established effects on prostaglandin pathways 
(27-29). Our in vivo rat studies had shown that analgesic exposure reduced PGE2 levels in the 
fetal gonads (16) and that fetal GC in both the rat (16) and human (18) are PGE2 targets, so we 
focused on this pathway. As isolation and culture of human fetal GC was not feasible, we 
decided to use a more tractable model for fetal human GC, NT2 cells. These cells represent a 
human pluripotent embryonal carcinoma (EC) cell line that expresses markers (e.g. AP2!, 
OCT4, NANOG) similar to undifferentiated (pluripotent) human fetal GC (41). The present 
data show that analgesic effects on NT2 cell number and pluripotency gene expression are 
mimicked by culturing with EP2+EP4 receptor antagonists (which block PGE2 action), and 
that the acetaminophen-induced decrease in NT2 cell number can be prevented by 
concomitant exposure to EP2+EP4 agonists. This demonstrates that analgesic effects on NT2 
cells are dependent on a functional PGE2 pathway. This is further reinforced by the finding 
that PGE2 antagonism induced similar gene expression changes to those induced by analgesics 
in both human (NT2 cells) and rat (fetal gonad) systems.  
 
Our studies with NT2 cells suggest that one effect of analgesic exposure or PGE2 antagonism 
is to reduce expression of GC pluripotency genes, such as OCT4, AP2! and NANOG. This is 
consistent with previous studies showing that exposure of mouse embryonic stem cells to an 
EP2 antagonist led to down-regulation of pluripotency genes, such as Oct4 and Nanog (42), 
and abundant other evidence for a fundamental role for PGE2 in regulating both stem cell and 
cancer cell proliferation and differentiation status in numerous cell types (23, 34, 43, 44). 
Moreover, experiments exposing human fetal testis explants to ibuprofen also found a 
reduction in specific germ cell genes involved in pluripotency including OCT4 and LIN28A 
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(45). In a human context, arrested differentiation of fetal GC is now accepted as being the 
primary pathway to development of testicular GC cancer (TGCC), the commonest malignancy 
amongst young men (46).  However, analgesic-induced reduction in expression of 
pluripotency genes in NT2 cells, as well as in vitro (this study) and in vivo in the rat fetal testis 
(16), appears to be in the opposite direction to what is thought to underlie the origin of TGCC. 
 
Our demonstration that analgesic exposure induces robust changes in expression of epigenetic 
regulatory genes in NT2 cells as well as in fetal ovaries and testes from the rat (in vitro and in 
vivo) could be a consequence of selective loss of a specific cell subtype in the test systems, 
for example loss of pluripotent GC in fetal rat gonads. An alternative possibility is that the 
analgesic-induced changes in expression of epigenetic regulatory genes could alter the 
epigenome in exposed GC with unknown consequences. This would be consistent with our 
finding that fetal exposure of rats to analgesics results in inter-generational transmission of 
effects via both paternal and maternal lines (16). Our present demonstration that total 
H3K27me3 was significantly increased in NT2 cells by acetaminophen, ibuprofen and 
EP2/EP4 antagonists, could suggest that alterations in this repressive histone mark in specific 
genes has occurred, and is less easily reconciled with selective loss of a particular GC 
population.  In this respect, H3K27me3 is highly expressed and dynamically regulated in fetal 
GC and is thought to be an important factor in fetal GC differentiation and development (47, 
48), although our studies did not delineate which genes might have been affected by the global 
change in H3K27me3. We also showed that analgesics and PGE2 antagonism decreased 
expression of the key methyltransferase enzymes DNMT3a and DNMT3b, in agreement with 
previous studies linking PGE2 action with DNA methylation (22, 23, 49). As fetal GC undergo 
extensive de- and then re-methylation during fetal or early postnatal development (48, 50), 
analgesic exposure could potentially impact this process via their effects on DNMT 
expression. 
 
Whilst our findings can only be viewed as circumstantial support for the possibility that 
analgesics might induce epigenetic changes in fetal GC in human pregnancy, our different 
model systems provide the means via which this can be investigated more directly than at 
present. What seems clear from our present and previous results is that PGs, and specifically 
PGE2, appear to play a fundamental and conserved role in modulating key components of the 
cellular epigenetic regulatory machinery in the fetal gonads, as is the case in other tissues (22, 
24). This raises the possibility that analgesic use/exposure might have other effects (beneficial 
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or adverse), besides their current use and that these could be targeted for additional therapeutic 
purposes.  
 
Our study has limitations. While none of the models can accurately recreate in vivo conditions 
for humans, the xenograft and culture models have been shown to recapitulate key aspects of 
normal human fetal development, including GC proliferation and differentiation (25, 32, 51) 
and may provide some insight into in utero exposure. Our use of NT2 cells also has limitations, 
as it is not a true fetal GC line. However, NT2 cells derive from TGCC precursor cells, which 
are believed to originate from fetal GC (26). Despite these limitations, the consistency of 
GC/NT2 cell effects and the concordance of gonadal tissue GC/NT2 cell and gene expression 
changes between humans and rats, including in vivo in the latter, suggest that the mechanisms 
involved in analgesic/PGE2 effects are highly conserved and therefore likely to operate in vivo 
in humans.   
 
In conclusion, the present data show that exposure of human fetal ovaries or testes to 
therapeutically-relevant concentrations of acetaminophen and ibuprofen, which are commonly 
used by pregnant women, causes a consistent decrease in fetal GC number as well as inducing 
changes in gene expression and, potentially, epigenetic modifications. These effects are 
robust, conserved in rat and human across different model systems, and are likely to result 
from disruption of PGE2 pathways.  Although translation of these results to human pregnancy 
has to be considered with caution, the robust nature of our findings and the apparent 
involvement of a conserved mechanism, support recommendations that analgesic use in 
human pregnancy should only be used if needed, and then only for the shortest period 
necessary to manage symptoms. Our present findings, taken together with a growing body of 
evidence for other effects of analgesics during pregnancy on a range of human developmental 
outcomes (10, 13, 14, 52, 53), and the high prevalence of analgesic use during pregnancy, 
suggest that properly designed prospective studies to investigate potential associations 
between analgesic use and outcomes in offspring, should be a research priority.    
  
	 14	
Materials and Methods 
 
Experimental design 
Given the reported association between maternal use of common analgesics and effects on 
fetal GCs and fertility, we aimed to determine whether exposure to acetaminophen or 
ibuprofen affects GC number and to further examine the mechanisms involved. Effects of 
exposure were studied in human fetal gonads taken from different stages of pregnancy using 
hanging drop culture (1st trimester testes and ovaries) and a xenograft system (2nd trimester 
testes). Samples were exposed to analgesics in the lower range of human-equivalent 
therapeutic exposure. Experiments to determine mechanism of analgesic action on GC were 
conducted in a GC-tumor derived cell line (NT2) and end-points evaluated included cell 
number, proliferation status and expression of pluripotency markers and epigenetic regulators. 
Further in vitro and in vivo studies in rats allowed us to demonstrate similar analgesic effects 
and mechanism as in human and translatability of our findings from in vitro to in vivo 
(pregnancy). Inclusion criteria and measured endpoints were defined before the start of the 
study. For human fetal gonad experiments, the sample sizes (minimum n=3) were based on 
those required to achieve statistical significance in previous studies using the same 
methodology (54, 55). The study was stopped once the required number of experiments had 
been conducted, and data were analyzed after the cessation of the study. For fluorescence 
immunohistochemistry, all samples from the same experiment were stained in the same run. 
GC/NT2 number was determined blind to the treatment group. To compare the effects of 
treatment versus vehicle in xenografts for each individual human fetal testis, we grafted tissue 
from each fetus into three to six replicate host mice and randomly allocated these to receive 
either acetaminophen/ibuprofen or vehicle treatment. For the rat studies, pregnant dams were 
randomly allocated to receive either acetaminophen or vehicle via oral administration. 
 
Animals 
All aspects of animal housing, management and treatment conformed to UK Home Office 
guidelines. Wistar rats were housed under standard conditions and nude mice were housed in 
IVCs. All animals had free access to tap water and soy-free diet (SDS; Dundee, Scotland). For 
rat studies, timed-matings were established by the presence of a vaginal plug, defined as 
embryonic day 0.5 (e0.5).  
 
Human fetal gonad ‘hanging drop’ cultures 
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Culture of 1st trimester human fetal testes (n=4; 8-11 gestational weeks) and ovaries (n=3 9-11 
gestational weeks) were cultured based on previous tissue cultures studies (12, 14, 25). Gonads 
were dissected and cut into ~1mm3 pieces. Single pieces were cultured in hanging drops 
containing 30μL culture medium (Alpha-MEM; Lonza) supplemented with 10% fetal bovine 
serum (Life Technologies), 10μL/mL penicillin/streptomycin (Sigma-Aldrich), 1% 200mM 
L-glutamine (100X) (Gibco), 1% MEM NEAA non-essential amino acids (100X) (Gibco), 
2% sodium pyruvate 100mM (100X) (Gibco) and 1% Insulin-transferrin-Selenium (100x) 
(Gibco). Plates were incubated for 8 days at 37ºC under 5% CO2. The medium was changed 
every day. Samples were cultured with hCG alone during the first day, and thereafter the 
medium was supplemented with hCG plus vehicle (DMSO) or analgesic (10μM 
acetaminophen or 10μM ibuprofen) for the remainder of the culture period (Figure 1). hCG 
(0.1U/ml; Pregnyl, Organon Laboratories) was added in order to mimic the in-utero 
environment. The analgesic concentrations are in the lower range of serum concentrations 
reported in humans following therapeutic analgesic exposure (12, 14, 36). At the end of the 
culture period, tissue samples were fixed in Bouins (Clin-Tech) for 2h for subsequent analysis 
by fluorescence immunohistochemistry. 
 
Human fetal testis xenograft studies  
Second trimester human fetal testis tissue was used for ex-vivo xenografts studies, which 
provides a more physiological model to study gonad development (32). Second trimester 
samples are larger than 1st trimester, and thus provide sufficient testis tissue to perform the 
xenografts. Previous attempts by our lab using human fetal ovarian tissue xenografts did not 
achieve good viability, therefore xenograft experiments were only performed with testis 
tissue. Fetal testes (n= 8; 14-17 gestational weeks) were cut into ~1mm3 pieces and 
xenografted into castrate nude mice as described previously (13). Male CD1 nude (host) mice 
(aged 4-6 weeks; n= 44; Charles River UK) were used for the xenograft studies. Mice were 
anesthetized by isoflurane inhalation and castrated through a scrotal incision at least 2 weeks 
before the xenograft procedure. Analgesia (Carprofen, Pfizer) was given in the drinking water 
for 3 days after castration. Four to six pieces of testis tissue were grafted subcutaneously under 
the dorsal skin of each host mice using a 13-gauge cancer implant needle (Popper and Sons); 
grafts were placed on either side of the dorsal midline. Grafts were maintained in the host for 
7 days, in order to allow them to establish a blood supply, followed by 1 or 7 days of analgesic 
exposure (Figure 1B). Host mice also received subcutaneous injections of 20 IU hCG every 
72h in order to mimic the in-utero environment (13). Mice were randomly allocated to receive 
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vehicle or analgesic for either 1-day (followed by 6 days of no treatment) or 7-days. Host mice 
received vehicle (corn oil), acetaminophen (20mg/kg three times daily; Sigma-Aldrich) or 
ibuprofen (10mg/kg three times daily; Sigma-Aldrich); both analgesics were suspended in 
corn oil and administered by gavage. Host mice were sacrificed by cervical dislocation and 
grafts were retrieved and weighed before fixation in Bouins. Sections of this fixed tissue were 
subsequently used for fluorescence immunohistochemistry.  
 
Cell culture 
NT2 cells were used to study potential mechanisms of analgesic action on GC. For expansion, 
cells were cultured in DMEM media (Life Technologies), supplemented with 10% fetal calf 
serum (Life Technologies), 1% penicillin/streptomycin (Sigma-Aldrich) and 1% L-glutamine 
(Gibco). Cell cultures were washed with 1x Phosphate-buffered saline (PBS) (Life 
technologies), and disaggregated with TRypLE™ Express (Gibco). Cells were cultured at 
37ºC under 5% CO2 and split 1:2 or 1:4 for passage when confluent. Cells (200,000/well) were 
cultured in 6-well plates (Corning) for 48h at 37ºC under 5% CO2. Media was supplemented 
with either vehicle (DMSO), 10 or 50μM acetaminophen, 10μM ibuprofen or 10μM L-
161,982 (EP2 antagonist) + 10μM PF04418948 (EP4 antagonist) (Figure 1C).  
 
For analysis with EP2+EP4 agonists, NT2 cells (excluding vehicle) were first exposed to 
10μM Butaprost (EP2 agonist; Abcam) and 10nM CAY10598 (EP4 agonist; Abcam) for 4h 
before the medium was changed to the subsequent treatment: 10μM Butaprost + 10nM 
CAY10598, 10μM acetaminophen or the combination of acetaminophen + EP2/EP4 agonists 
(Figure 1C). The total length of exposure was 48h. After treatment, cells were either 
disaggregated with TRypLE for cell counting or protein analysis (ELISA), or collected for 
gene expression with Trizol (Life Technologies). All experiments were run in triplicate (n=3-
4). Cell number was determined using a NucleoCounter (Chemometec) according to the 
manufacturer’s guidelines. Disaggregated cells were re-suspended in medium and treated with 
lysis and stabilization buffer (Chemometec). Cells were counted using a NucleoCassete 
(Chemometec) on a NucleoCounter machine (Chemometec). Cell death was determined at the 
end of the experiment by flow cytometry (Supplemental figure 4). Propidium iodide (75μM; 
BD biosciences) was added to the disaggregated cells to identify the proportion of dead cells 




Rat fetal gonad ‘hanging drop’ cultures 
Rat fetal (e15.5) testes and ovaries were dissected and cut into ~1mm3 pieces (n=13-30). Each 
piece was cultured as described for human hanging drop cultures. Tissues were cultured for 
48h in either vehicle, acetaminophen (10μM), ibuprofen (10μM) or L-161,982 (EP2 
antagonist; 10μM) + PF0441848 (EP4 antagonist; 10μM) (Figure 1D). Samples were then 
collected for fixation in Bouins or snap-frozen for gene expression analysis.  
 
Rat fetal in vivo studies. 
Pregnant female rats (n= 21) were administered acetaminophen (350 mg/kg/day by oral 
gavage) suspended in corn oil from e13.5 until the day before sampling (e15.5 or e17.5), as 
described previously (15, 16) (Figure 1E). This dose equates to a human equivalent dose of 
~60mg/kg (i.e. typical daily consumption in humans) based on calculation of body surface 
area (31), and has been shown to be non-toxic (13). Control dams were administered corn oil 
according to the same regimen. After treatment, rats were sacrificed by cervical dislocation 
and fetal gonads were dissected and frozen for gene expression analysis. 
 
Fluorescence immunohistochemistry 
To identify specific testicular and ovarian cell populations, fluorescence immunostaining was 
used to identify Sertoli cells (SOX9; Merck, Millipore), pre-granulosa cells (FOXL2; Abcam) 
and GC subpopulations, namely gonocytes (AP2!; Santa Cruz Biotechology) and pre-
spermatogonia (MAGE-A4; Gift from Giulio Spagnoli). Proliferative GC were identified by 
co-immunostaining for Ki-67 (Abcam). Apoptosis was studied using Cleaved caspase (Cell 
signalling technologies) Sections (5μm) were mounted onto coated slides (BDH Chemicals), 
dewaxed in xylene and rehydrated using graded ethanol series. Sections were then subjected 
to antigen retrieval by pressure-cooking in 0.01M citrate buffer (pH 6.0) for 30 seconds at 
125oC, and sections remained in the decloaking chamber for a further 20 minutes after it cooled 
to 90oC.  Samples were then incubated in 3% (vol/vol) hydrogen peroxide (VWR chemicals) 
in methanol (Fisher Chemical) to block endogenous peroxidase activity. Sections were then 
washed with tris-buffered saline [TBS: 0.05 m Tris, 0.85% NaCl (pH 7.4)] and incubated for 
30 min with 20% chicken serum, 5% bovine serum albumin (BSA) (Sigma) in TBS to block 
non-specific binding of the antibodies. Slides were then incubated with primary antibody, 
diluted in TBS, in a humidified chamber overnight at 4ºC. This step was followed by 
incubation with the appropriate secondary antibody IgG conjugated to horseradish peroxidase 
(HRP; Santa Cruz Biotechnology), at a concentration of 1:200 in TBS for 30 min at room 
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temperature. Sections were then incubated for 10 min with Tyramide (TSA Plus Cyanine 3 
System, PerkinElmer Life Sciences) according to the manufacturer’s instructions. 
 
For double/triple immunohistochemistry, for each subsequent primary antibody, sections 
underwent further antigen retrieval by boiling in 0.01M citrate buffer (pH 6.0) for 2 min in a 
decloaking chamber. This was followed by blocking, overnight incubation with the primary 
antibody, incubation with the appropriate secondary antibody and Tyramide as described 
above. In some cases, this step was followed by a final incubation with the nuclear 
counterstain, Hoechst (Thermo Fisher), diluted 1:4000 in TBS for 10 min. Slides were washed 
in TBS and mounted in aqueous mounting medium (Permafluor; Beckman Coulter, High 
Wycombe). Images were acquired using a Provis microscope (Olympus Optical) fitted with a 
DCS330 digital camera (Eastman Kodak).  
 
Quantification of GC number and GC proliferation in human fetal gonads 
As only small pieces of fetal testicular and ovarian tissue were used for culture, analysis of 
GC number had to take account of tissue section area (ovaries) or seminiferous cord area (1st 
trimester testes), as this varied between samples, as previously described (16). Seminiferous 
cord area was defined by the delineated structures containing Sertoli cells (SOX9+). For 2nd 
trimester fetal testes we expressed GC number relative to Sertoli cell number, the main 
somatic cell component of the seminiferous cords, as previously described (13). Thus, fetal 
testis sections (1 per cultured or xenografted tissue piece) were co-immunostained using 
antibodies for SOX9 (Sertoli), AP2! (gonocytes) and MAGE-A4 (pre-spermatogonia).  The 
number of cells from the different cell populations was counted manually and the area was 
determined (using ZEN software) by a single observer who was blinded to treatment. The total 
number of AP2!+ and MAGE-A4+ GC per section was expressed relative to the total area of 
the seminiferous cords in that section. Three different populations were quantified: Total GC 
(AP2!+ + MAGE-A4+), AP2!+ GC and MAGE-A4+ GC per µm2. For 2nd trimester fetal testes, 
the number of GC was expressed relative to the total number of Sertoli cells (SOX9+) in each 
section as previous studies have shown that Sertoli cell number in human fetal testis is 
unaffected by exposure to ibuprofen (45).  Three ratios were determined: Total GC (AP2!+ + 
MAGE-A4+) per Sertoli cell, AP2!+ GC per Sertoli cell and MAGE-A4+ GC per Sertoli cell. 
For quantification of GC proliferation, sections were immunostained for AP2!, MAGE-A4 
and Ki-67. Proliferative GC (Ki67+) were quantified for total GC (AP2!+ or MAGE-A4+), 
AP2!+ GC and MAGE-A4+ GC populations as described above.  
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For the fetal ovary analysis, sections (1 per cultured piece) were co-immunostained using an 
AP2! antibody (to identify all the GC) and Hoechst as a counterstain. The total number of 
AP2!+ GC per section was quantified and expressed relative to the total tissue section area. 
The number of AP2!+ GC per µm2 was calculated and compared between vehicle and 
treatments. Proliferative AP2!+ GC (Ki67+) were quantified as described for fetal testes.  
 
Gene expression analysis 
RNA extraction was performed using the RNeasy® Micro Kit (Qiagen) according to the 
manufacturer’s instructions. For hanging drop cultures, all tissue pieces from the same gonad 
were pooled. For in-vivo rat studies, both ovaries from the same fetus were pooled, whilst a 
single testis from each fetus was ample to yield a sufficient quantity of cDNA. The RNA phase 
of the Trizol was separated and converted into cDNA using a Vilo kit (Invitrogen) according 
to the manufacturer’s instructions. Gene expression analysis from the cDNA was performed 
using the Applied Biosystems TaqmanTM RT kit (Applied Biosystems). Quantitative real time 
PCR (qRT-PCR) was performed using the ABI Prism Sequence Detection System (Applied 
Biosystems). Expression of human (TET1, EZH2, DNMT3a, DNMT3b, OCT4, AP2! and 
NANOG) and rat (Tet1, Ezh2, Dnmt3a and Dnmt3b) genes were determined using the Roche 
Universal Probe Library (Roche Applied Sciences, Burgess Hill, UK). The ribosomal 18s 
internal control (Applied Biosystems) and the transcription factor TATA-binding protein 
(TBP) (NT2 cell analysis only) were used as reference genes to correct the expression of the 
gene of interest. All samples were analyzed in duplicate. Human primers: TET1 forward 
primer: 5’-gatgacagaggttcttgcacat-3’, reverse primer: 5’-aggttgcacggtctcagtgt-3’, probe 
number #86 (cat. no. 04689119001); EZH2 forward primer: 5’-aagaagagaagaaagatgaaacttcg-
3’, reverse primer: 5’-ttggtgtttgacaccgagaat-3’, probe number #82 (cat. no. 04689054001); 
DNMT3a forward primer: 5’-cctgaagcctcaagagcagt-3’, reverse primer: 5’-
tggtctccttctgttctttgc-3’, probe number #46 (cat. no. 04688066001); DNMT3b forward primer: 
5’-ggtgcactgagctcgaaag-3’, reverse primer: 5’- aagaggtgtcggatgacagg-3’, probe number #3 
(cat. no. 04685008001); OCT4 forward primer: 5’-cttcggatttcgtcttctcg-3’, reverse primer: 5’-
cttagccaggtccgaggat-3’, probe number #22 (cat. no. 04686969001); AP2! forward primer: 5’-
gagccaaatcgaaaaatgga-3’, reverse primer: 5’-gccaaatgaacagcttcacc-3’, probe number #7 (cat. 
no. 04685059001); NANOG forward primer: 5’-atgcctcacacggagactgt-3’, reverse primer: 5’-
cagggctgtcctgaataagc-3’, probe number #69 (cat. no. 04688686001); TBP forward primer: 5’-
gcccatagtgatctttgcagt-3’, reverse primer 5’-cgctggaactcgtctcacta-3’, probe number #67 (cat. 
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no. 04688660001). Rat primers: Tet1 forward primer: 5’-agagggaaaagaagcccaaa-3’, reverse 
primer: 5’-aacaaacccaacctttgctc-3’, probe number #60 (cat. no. 04688589001); Ezh2 forward 
primer: 5’-gactggtgaagagttgttctttga-3’, reverse primer: 5’-ctcgttcgatgcccacata-3’, probe 
number #122 (cat. no. 04693566001), Dnmt3a forward primer: 5’-aacggaagcgggatgagt-3’, 
reverse primer: 5’-gcaatcaccttggctttctt-3’, probe number #75 (cat. no. 04688988001);	
Dnmt3b forward primer: 5’-caaatccagggacttgcag-3’, reverse primer: 5’-
acccactagcaccctcttctt-3’, probe number #94 (cat. no. 04692110001).	
 
H3K27me3 ELISA 
Treated NT2 cells (n=3 experiments, each in triplicate) were collected and the crude histones 
were extracted using the trimethylated lysine 27 at histone 3 (H3K27me3) ELISA kit (Active 
motif, Belgium) according to the manufacturer’s instructions. ELISA plates were already pre-
coated with an H3 antibody. H3K27me3 standards and the extracted crude histones from each 
sample were added to the appropriate well. After incubation, the primary antibody was added 
and incubated for 1h. A secondary HRP conjugated antibody was then added followed by 
incubation for 1h. The colorimetric reaction was then initiated with a developing solution, 
which reacts with the HRP conjugate and produces a colorimetric signal. The reaction was 
stopped after 5 mins by adding a stop solution to all wells. All samples were determined in 
duplicate. Absorbance was measured using a spectrophotometer (LabSystems; 450nm 
wavelength). Known H3K27me3 standards were used to construct a standard curve, which 
was used to calculate total H3K27me3 per well. Total H3K27me3 was expressed relative to 




For human fetal gonad culture and xenograft studies, results were analyzed by two-way 
ANOVA to account for inter-individual variation between fetuses and xenograft replicates 
from the same fetus, as previously described (55). The same method was used for NT2 cell 
studies. For rat in vivo and in vitro studies, analysis was performed using unpaired, 2-tailed t-
tests. P< 0.05 was used to determine significance.  
 
Ethics statement 
Human fetal testes were obtained after elective termination of pregnancy, according to the 
Declaration of Helsinki–Ethical Principles for Medical Research Involving Human Subjects. 
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Ethical approval for the study was obtained from the South East Scotland Research Ethics 
Committee (reference number LREC08/S1101/1). Women gave written informed consent. 
Animal studies received specific approval by the UK Home Office (PPL 60/4564), including 
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Figure 1. Exposure/treatment regimens and the different investigative models 
used in the present studies. Each panel shows a different experimental model 
together with the exposure/treatment (coloured circles) regimen employed, including 
timescale. A hanging drop culture of 1st trimester human fetal testes and ovaries. B 
xenografts of 2nd trimester human fetal testes grafted into nude mice. Note 
experimental treatments commenced 7 days after grafting in order to allow 
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vascularisation of the grafts. C NTERA-2 (NT2; testicular germ cell tumor cell line) 
cell culture. D hanging drop culture of fetal (e15.5) rat testes and ovaries. E in vivo 
exposure of fetal rat testes and ovaries by treatment of pregnant rats (e15.5 and 
e17.5). Note that the order of panels corresponds with the order of models presented 
in Results.  
Figure 2 
 
Figure 2. Effect of analgesic exposure of 1st trimester fetal human testis tissue 
for 7 days in hanging drop culture on germ cell (GC) number. Testis tissue pieces 
(~1mm3) from 5 fetuses (8-11 gestational weeks) were cultured for 7 days with 
vehicle, acetaminophen (10µM) or ibuprofen (10µM). Tissue was immunostained for 
SOX9 (Sertoli cells - red), AP2 (GC - green) and MAGE-A4 (differentiated GC - 
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blue) as depicted in panels A-C. Scale bar, 20µm. Individual data points represent 
counts from a single tissue piece in panels D and E together with the mean ± SEM 
for each fetus/treatment; the overall mean ± SEM for each treatment group is also 
shown (Total). Panel F shows an example of a testis tissue section from a vehicle-
exposed sample, triple-immunostained for the proliferation marker Ki67 (red) and the 
GC markers AP2 (green) and MAGE-A4 (blue). White arrows refer to proliferative 
GC showing double staining for Ki67 and AP2 (upper panel) or MAGE-A4 (lower 
panel). Quantification of the % of proliferative (Ki67+) AP2+ GC from the different 
treatment groups is shown in panel G. Data analysed by 2-factor ANOVA (*p<0.05, 




Figure 3. Effect of analgesic exposure of 1st trimester fetal human ovary tissue 
for 7 days in hanging drop culture on germ cell (GC) number. Ovary tissue pieces 
(~1mm3) from 3 fetuses (9-11 gestational weeks) were cultured for 7 days with either 
vehicle, acetaminophen (10µM) or ibuprofen (10µM). Tissue was fixed and double-
immunostained for AP2 (GC - green) and Hoechst (counterstaining - blue) as 
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depicted in panels A-C. Scale bar, 20µm.  Individual data points represent GC counts 
(AP2+) from a single tissue piece in panel D together with the mean ± SEM for each 
fetus/treatment; the overall mean ± SEM for each treatment group is also shown 
(Total). Quantification of the proliferative (Ki67+) AP2+ GC from the different 
treatment groups is shown in panel E. Data in D and E was analysed by 2-factor 







Figure 4. Effect of acetaminophen or ibuprofen exposure of 2nd trimester fetal 
human testis tissue xenografts on germ cell (GC) number. Testis tissue pieces 
(~1mm3) from 4 fetuses (7-day acetaminophen) or 3 fetuses (1-day acetaminophen, 
ibuprofen), all within 14-17 gestational weeks, were xenografted into nude mice. Host 
mice were administered vehicle, acetaminophen (20mg/kg x3 per day) or ibuprofen 
(10mg/kg x3 per day) before xenograft recovery. Tissue was fixed and triple-
immunostained for SOX9 (Sertoli cells - red), AP2 (GC - green) and MAGE-A4 
(differentiated GC - blue). Individual data points represent GC counts from a single 
tissue piece in panel panels A and B for 7-days acetaminophen exposure, panels C 
and D for 1-day acetaminophen exposure and panels E and F for ibuprofen exposure, 
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together with the mean ± SEM for each fetus/treatment; the overall mean ± SEM for 
each treatment group is also shown (Total) together with the results of statistical 
analysis (2-factor ANOVA); *p<0.05, versus corresponding vehicle-exposed group. 
Corresponding MAGE-A4+ GC counts and their % proliferation are shown in figs. S1 




Figure 5. Effect of exposure of NT2 cells to analgesics or prostaglandin E2-
receptor modulators on cell number. NT2 cells (2x105; n=3-4) were cultured for 
48h in medium supplemented with either vehicle (Veh), acetaminophen (10-50µM), 
ibuprofen (10µM), EP2+EP4 antagonists [EP-antags: 10M L-161,982 (EP2 
antagonist) + 10M PF04418948 (EP4 antagonist)], or with EP2+EP4 agonists [EP-
ags: 10M Butaprost (EP2 agonist) + 10nM CAY10598 (EP4 agonist)] or the 
combination of acetaminophen + EP2/EP4 agonists (Acet+EP-ags). The mean ± 
SEM NT2 cell number for each treatment is shown in panels A – D. Panel D shows 
that co-culture of NT2 cells with PGE2 agonists blocks the negative effect of 
acetaminophen exposure on cell number. Graphs show means ± SEM from three 
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independent experiments with three replicates each and statistical analysis was by 2-
factor ANOVA; *p<0.05, **p<0.01, ***p<0.001, ****p<0.0001 versus corresponding 
vehicle-exposed group. Panel D analysis was followed by a comparison between 
Acet and Acet+EP-ags columns. Corresponding data for NT2 cell death as a 





Figure 6. Effect of exposure of NT2 cells to analgesics or prostaglandin E2 
antagonists on mRNA expression of GC pluripotency markers, epigenetic 
regulatory genes and overall H3K27me3 levels.  NT2 cells (105; n=3) were cultured 
for 48h in medium supplemented with vehicle (Veh), acetaminophen (Acet; 10-50µM), 
ibuprofen (Ibu; 10µM) or EP2+EP4 antagonists [EP-antags (10M L-161,982; EP2 
antagonist + 10M PF04418948; EP4 antagonist)]. Results show mRNA expression 
relative to the vehicle complementary DNA (open bars) for the GC pluripotency 
markers OCT4, AP2 and NANOG (A, C and E) and for the epigenetic regulatory 
genes TET1, EZH2, DNMT3a and DNMTb (B, D and F) after exposure of NT2 cells 
to acetaminophen (blue), ibuprofen (orange) or EP2+EP4 antagonists (maroon) 
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(n=3). Panel G shows relative amount of H3K273 present in the NT2 cells after culture 
with the different treatments. Graphs show means ± SEM from three independent 
experiments with three replicates each and statistical analysis was by 2-factor 
ANOVA; *p<0.05, **p<0.01, ***p<0.001, in comparison with corresponding vehicle or 
vehicle complementary DNA.  
Figure 7 
 
Figure 7. Effect of exposure of rat fetal gonads to analgesics or prostaglandin 
E2 antagonists in vitro on mRNA expression of epigenetic regulatory genes. 
Testis and ovary tissue pieces (~1mm3) from e15.5 fetal rats were cultured for 48h 
with either vehicle (open bars), acetaminophen (blue; 10µM), ibuprofen (orange; 
10µM) or EP2+EP4 antagonists [Maroon; 10M L-161,982 (EP2 antagonist) + 10
M PF04418948 EP4 antagonist)]. Panels A to F show mRNA expression relative to 
the vehicle complementary DNA (open bars) for Tet1, Ezh2, Dnmt3a and Dnmt3b for 
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cultured fetal testes (A to C) or ovaries (D to F) (Mean ±SEM, n=13-30). Data were 









Figure 8. Effect of exposure of pregnant rats to acetaminophen on mRNA 
expression of epigenetic regulatory genes in fetal testes and ovaries. Pregnant 
rats were administered acetaminophen (350mg/kg/day x1), commencing on e13.5, 
and fetal gonadal tissue was collected on e15.5 or e17.5, 3 hours after the final 
maternal treatment. Panels A to D show mRNA expression relative to the vehicle 
cDNA for the same genes after acetaminophen exposure in vivo for e15.5 (A) and 
e17.5 (B) testes and for e15.5 (C) and e.17.5 (D) ovaries (Means ± SEM n=7-25). 
Data were analyzed by two-tailed, unpaired t-test; *p<0.05, ***p<0.001, in comparison 





Supplementary figure legends 
Supplemental figure 1 
 
Supplemental figure 1. Effect of analgesic exposure on apoptosis. Apoptosis as 
a consequence of analgesic exposure was studied in 3 different systems: 1st 
trimester fetal testis (A-C) and ovary (D-F) culture, and 2nd trimester fetal testis 
xenograft (G-I) exposed to human relevant doses of acetaminophen and ibuprofen. 
	 39	
Tissue was immunostained for Cleaved caspase 3 (red) and Hoescht 
(counterstaining - blue). Scale bar, 20µm.  
	 40	
Supplementary figure 2 
 
 
Supplemental figure 2. Effect of acetaminophen or ibuprofen exposure of 2nd 
trimester fetal human testis tissue xenografts on MAGE-A4+ germ cell (GC) 
number. Testis tissue pieces (~1mm3) from 4 fetuses (7-day acetaminophen), 3 
fetuses (1-day acetaminophen) or 3 fetuses (ibuprofen) were xenografted into nude 
mice. Host mice were administered vehicle, acetaminophen (20mg/kg x3 per day) or 
ibuprofen (10mg/kg x3 per day) before xenograft recovery. Tissue was fixed and 
triple-immunostained for Ki67 (proliferating cells) and MAGE-A4 (subpopulations of 
GCs). MAGE-A4+ GC counts for each tissue piece for each fetus for each treatment 
are shown by the individual symbols in panels A and B and C for 1 day 
acetaminophen, 7 days acetaminophen and 7 days ibuprofen respectively, together 
with the mean ± SEM for each fetus/treatment; the overall mean ± SEM for each 
treatment group is also shown (Total) together with the results of statistical analysis 




Supplemental figure 3 
 
Supplemental figure 3. Effect of acetaminophen or ibuprofen exposure of 2nd 
trimester fetal human testis tissue xenografts on germ cell (GC) proliferation. 
Further results obtained from the exposure of 2nd trimester human testis xenografts 
to acetaminophen or ibuprofen. Quantification of the % of proliferative GC (Ki67+) 
after 1 day and 7 days exposure to acetaminophen are respectively shown in panels 
A and C. Quantification of the % of proliferative (Ki67+) AP2+ GC after 1 day 
acetaminophen, 7 days acetaminophen or 7 days ibuprofen are respectively shown 
in panels B, D and E together with the mean ± SEM for each fetus/treatment; the 
overall mean ± SEM for each treatment group is also shown (Total) together with the 





Supplemental figure 4 
 
 
Supplemental figure 4. Effect of exposure of NT2 cells to analgesics or 
prostaglandin E2-receptor modulators on cell death. NT2 cells (105; n=3) were 
cultured for 48h in medium supplemented with either vehicle (Veh), acetaminophen 
(10-50µM), ibuprofen (10µM) or EP2+EP4 antagonists [EP-antags: 10M L-161,982 
(EP2 antagonist) + 10M PF04418948 (EP4 antagonist)]. The % of NT2 dead cells 
at the end of the experiment for each treatment is shown in panels A – C. Graphs 
show means ± SEM from three independent experiments with three replicates each 
and statistical analysis was by 2-factor ANOVA; *p<0.05, ***p<0.001, ****p<0.0001 
versus corresponding vehicle-exposed group.  
